<!DOCTYPE html><html lang="en" class="scroll-smooth"><head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Pharmacology Test - I - Brain And Scalpel</title>
    <link rel="preload" href="assets/background.jpg" as="image">
    <script src="https://cdn.tailwindcss.com"></script>
    <!-- HLS.js for M3U8 support -->
    <script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
    <style>
        
/* Liquid Glass Morphism Universal Theme - Enhanced & Mobile-First */
:root {
  --glass-bg: rgba(0, 0, 0, 0.6);
  --glass-bg-light: rgba(255, 255, 255, 0.1);
  --glass-bg-medium: rgba(255, 255, 255, 0.15);
  --glass-bg-heavy: rgba(255, 255, 255, 0.2);
  --glass-border: rgba(255, 255, 255, 0.2);
  --glass-border-light: rgba(255, 255, 255, 0.1);
  --text-primary: rgba(255, 255, 255, 0.95);
  --text-secondary: rgba(255, 255, 255, 0.7);
  --text-tertiary: rgba(255, 255, 255, 0.5);
  --accent-blue: #60a5fa;
  --accent-purple: #a855f7;
  --accent-green: #34d399;
  --accent-orange: #fb923c;
  --accent-red: #f87171;
  --accent-yellow: #fbbf24;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

html {
  scroll-behavior: smooth;
}

body {
  margin: 0;
  min-height: 100vh;
  font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  position: relative;
  overflow-x: hidden;
  color: var(--text-primary);
  background-color: #000;
}

/* iOS Background Fix */
body::before {
  content: '';
  position: fixed;
  top: 0;
  left: 0;
  height: 100vh;
  width: 100vw;
  z-index: -2;
  background: url("assets/background.jpg") center center / cover no-repeat;
}

body::after {
  content: "";
  position: fixed;
  inset: 0;
  background: rgba(0, 0, 0, 0.4);
  backdrop-filter: blur(10px);
  -webkit-backdrop-filter: blur(10px);
  z-index: -1;
}

/* Glass morphism components */
.glass {
  background: var(--glass-bg);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-light {
  background: var(--glass-bg-light);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid var(--glass-border-light);
  border-radius: 12px;
}

.glass-medium {
  background: var(--glass-bg-medium);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-heavy {
  background: var(--glass-bg-heavy);
  backdrop-filter: blur(25px);
  -webkit-backdrop-filter: blur(25px);
  border: 1px solid var(--glass-border);
  border-radius: 20px;
}

.glass-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.glass-card:hover {
  transform: translateY(-8px);
  background: rgba(255, 255, 255, 0.12);
  border-color: rgba(255, 255, 255, 0.25);
  box-shadow: 0 20px 60px rgba(0, 0, 0, 0.4);
}

.glass-button {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.8), rgba(168, 85, 247, 0.8));
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: white;
  font-weight: 600;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 4px 20px rgba(96, 165, 250, 0.3);
  cursor: pointer;
  border: none;
}

.glass-button:hover {
  transform: translateY(-2px);
  box-shadow: 0 8px 30px rgba(96, 165, 250, 0.4);
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.9), rgba(168, 85, 247, 0.9));
}

.glass-button:disabled {
  opacity: 0.5;
  cursor: not-allowed;
  transform: none;
}

.glass-input {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: var(--text-primary);
  transition: all 0.3s ease;
}

.glass-input:focus {
  outline: none;
  border-color: var(--accent-blue);
  background: rgba(255, 255, 255, 0.12);
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.3);
}

.glass-input::placeholder {
  color: var(--text-tertiary);
}

/* Performance analysis styles */
.performance-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.score-circle {
  position: relative;
  width: 150px;
  height: 150px;
  margin: 0 auto;
}

.score-circle svg {
  transform: rotate(-90deg);
}

.score-circle .circle-bg {
  fill: none;
  stroke: rgba(255, 255, 255, 0.1);
  stroke-width: 8;
}

.score-circle .circle-progress {
  fill: none;
  stroke-width: 8;
  stroke-linecap: round;
  transition: stroke-dasharray 2s cubic-bezier(0.4, 0, 0.2, 1);
}

.score-text {
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  text-align: center;
}

/* Review question styles */
.review-question {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.1);
  border-radius: 16px;
  padding: 20px;
  margin-bottom: 20px;
}

.review-question.correct {
  border-left: 4px solid #22c55e;
}

.review-question.incorrect {
  border-left: 4px solid #ef4444;
}

.review-question.not-attempted {
  border-left: 4px solid #6b7280;
}

/* Gradient backgrounds for accents */
.gradient-blue {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
}

.gradient-purple {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
}

.gradient-green {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
}

.gradient-orange {
  background: linear-gradient(135deg, var(--accent-orange), #f97316);
}

.gradient-red {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
}

.gradient-yellow {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
}

/* Navigation button styles */
.nav-btn-not-attempted {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  color: rgba(255, 255, 255, 0.7);
}

.nav-btn-current {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.4);
}

.nav-btn-correct {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-incorrect {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-bookmarked {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-marked-review {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-answered {
  background: linear-gradient(135deg, #6b7280, #4b5563);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

/* Option button styles - REVISED FOR INLINE FEEDBACK */
.option-button {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.15);
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  position: relative;
  overflow: hidden;
  width: 100%;
  text-align: left;
  padding: 1rem;
  border-radius: 12px;
  color: var(--text-primary);
  cursor: pointer;
  display: flex;
  align-items: center;
  gap: 1rem;
  font-size: 1rem;
}

.option-button:hover {
  background: rgba(255, 255, 255, 0.1);
  border-color: rgba(96, 165, 250, 0.5);
  transform: translateX(8px);
}

.option-button.selected {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.3), rgba(59, 130, 246, 0.3));
  border-color: var(--accent-blue);
  transform: translateX(8px);
}

#optionsContainer.answered .option-button:hover {
    transform: translateX(0); /* Disable hover effect after answering */
}

#optionsContainer.answered .option-button {
    cursor: not-allowed;
    pointer-events: none;
}

#optionsContainer.answered .option-button:not(.correct):not(.incorrect) {
    opacity: 0.5;
}

.option-button.correct {
    background: linear-gradient(135deg, #22c55e, #16a34a);
    border-color: #22c55e;
    color: white;
    transform: translateX(0);
}

.option-button.incorrect {
    background: linear-gradient(135deg, #ef4444, #dc2626);
    border-color: #ef4444;
    color: white;
    transform: translateX(0);
}

.option-letter {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  transition: all 0.3s ease;
  width: 2.5rem;
  height: 2.5rem;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  color: var(--text-primary);
  flex-shrink: 0;
}

.option-button.selected .option-letter {
  background: var(--accent-blue);
  border-color: var(--accent-blue);
  color: white;
}

.option-button.correct .option-letter, .option-button.incorrect .option-letter {
    background: rgba(255, 255, 255, 0.2);
    border-color: rgba(255, 255, 255, 0.3);
}

.option-text {
  flex: 1;
  font-size: 1rem;
  line-height: 1.5;
}

/* Stats bar responsive grid */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(5, 1fr);
  gap: 1rem;
  align-items: center;
  justify-items: center;
}

@media (max-width: 768px) {
  .stats-grid {
    grid-template-columns: repeat(3, 1fr);
    gap: 0.5rem;
  }
 
  .stats-grid > div:nth-child(4),
  .stats-grid > div:nth-child(5) {
    grid-column: span 1;
  }
}

@media (max-width: 480px) {
  .stats-grid {
    grid-template-columns: repeat(2, 1fr);
  }
 
  .stats-grid > div:last-child {
    grid-column: span 2;
    justify-self: center;
  }
}

/* Animations */
@keyframes float {
  0%, 100% { transform: translateY(0px); }
  50% { transform: translateY(-20px); }
}

@keyframes pulse-glow {
  0%, 100% { box-shadow: 0 0 20px rgba(96, 165, 250, 0.3); }
  50% { box-shadow: 0 0 40px rgba(96, 165, 250, 0.6); }
}

@keyframes checkmark {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(180deg); }
  100% { transform: scale(1) rotate(360deg); }
}

@keyframes cross {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(90deg); }
  100% { transform: scale(1) rotate(180deg); }
}

.animate-float {
  animation: float 6s ease-in-out infinite;
}

.animate-pulse-glow {
  animation: pulse-glow 2s ease-in-out infinite;
}

.animate-checkmark {
  animation: checkmark 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

.animate-cross {
  animation: cross 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

/* Custom scrollbar */
::-webkit-scrollbar {
  width: 8px;
}

::-webkit-scrollbar-track {
  background: rgba(255, 255, 255, 0.05);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb {
  background: rgba(255, 255, 255, 0.2);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb:hover {
  background: rgba(255, 255, 255, 0.3);
}

/* --- MOBILE RESPONSIVE STYLES --- */
.quiz-container {
    display: flex;
    flex-direction: column;
    gap: 1.5rem;
}

#mobile-nav-toggle {
    display: none; /* Hidden on desktop */
}

@media (min-width: 1024px) {
    .quiz-container {
        flex-direction: row;
        gap: 2rem;
    }
}

@media (max-width: 1023px) {
    .quiz-sidebar {
        position: fixed;
        top: 0;
        left: 0;
        width: 300px;
        height: 100%;
        z-index: 100;
        transform: translateX(-100%);
        transition: transform 0.3s ease-in-out;
        box-shadow: 10px 0px 30px rgba(0,0,0,0.5);
    }
    .quiz-sidebar.open {
        transform: translateX(0);
    }
    #mobile-nav-toggle {
        display: flex;
        position: fixed;
        bottom: 20px;
        left: 20px;
        z-index: 50;
    }
    .quiz-main-content {
        width: 100%;
    }
}

@media (max-width: 768px) {
    .glass-card, .glass {
        border-radius: 16px;
    }
    h1 { font-size: 2.5rem; }
    #questionText { font-size: 1.125rem; }
    .controls-container {
        flex-direction: column;
        gap: 1rem;
    }
    .controls-container button {
        width: 100%;
    }
}

    </style>
</head>
<body>
    <!-- Mode Selection Modal -->
    <div id="modeModal" class="fixed inset-0 bg-black bg-opacity-70 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-md w-full mx-4 shadow-2xl">
            <h2 class="text-2xl font-bold text-white mb-6 text-center">Choose Study Mode</h2>
            
            <div class="space-y-4">
                <button onclick="selectMode('study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Study Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Interactive learning with immediate feedback</p>
                        </div>
                        <div class="gradient-blue w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('test')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Test Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Practice test with performance analysis at end</p>
                        </div>
                        <div class="gradient-purple w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 2a1 1 0 000 2h2a1 1 0 100-2H9z"></path>
                                <path fill-rule="evenodd" d="M4 5a2 2 0 012-2v1a1 1 0 001 1h6a1 1 0 001-1V3a2 2 0 012 2v6a2 2 0 01-2 2H6a2 2 0 01-2-2V5zm3 4a1 1 0 000 2h.01a1 1 0 100-2H7zm3 0a1 1 0 000 2h3a1 1 0 100-2h-3z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Study</h3>
                            <p class="text-sm text-white text-opacity-70">Study with time pressure and immediate feedback</p>
                        </div>
                        <div class="gradient-green w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_exam')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Exam</h3>
                            <p class="text-sm text-white text-opacity-70">Real exam simulation with strict timing</p>
                        </div>
                        <div class="gradient-red w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M12.395 2.553a1 1 0 00-1.45-.385c-.345.23-.614.558-.822.88-.214.33-.403.713-.57 1.116-.334.804-.614 1.768-.84 2.734a31.365 31.365 0 00-.613 3.58 2.64 2.64 0 01-.945-1.067c-.328-.68-.398-1.534-.398-2.654A1 1 0 005.05 6.05 6.981 6.981 0 003 11a7 7 0 1011.95-4.95c-.592-.591-.98-.985-1.348-1.467-.363-.476-.724-1.063-1.207-2.03z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
            </div>
        </div>
    </div>

    <!-- Performance Analysis Modal -->
    <div id="performanceModal" class="hidden fixed inset-0 bg-black bg-opacity-80 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-4xl w-full mx-4 shadow-2xl max-h-[90vh] overflow-y-auto">
            <div class="flex items-center justify-between mb-8">
                <h2 class="text-3xl font-bold text-white">Performance Analysis</h2>
                <button onclick="closePerformanceModal()" class="glass-light p-2 rounded-lg text-white hover:bg-white hover:bg-opacity-20">
                    <svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
            
            <!-- Score Overview -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="performance-card p-6 text-center">
                    <div class="score-circle mb-4">
                        <svg width="150" height="150" class="mx-auto">
                            <circle class="circle-bg" cx="75" cy="75" r="65"></circle>
                            <circle id="scoreCircle" class="circle-progress" cx="75" cy="75" r="65" stroke="#22c55e" stroke-dasharray="0 408"></circle>
                        </svg>
                        <div class="score-text">
                            <div class="text-3xl font-bold text-white" id="accuracyScore">0%</div>
                            <div class="text-sm text-white text-opacity-70">Accuracy</div>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Results Summary</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Questions:</span>
                            <span class="text-white font-semibold" id="totalQuestionsResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-green-400">Correct:</span>
                            <span class="text-green-400 font-semibold" id="correctResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-red-400">Incorrect:</span>
                            <span class="text-red-400 font-semibold" id="incorrectResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-gray-400">Not Attempted:</span>
                            <span class="text-gray-400 font-semibold" id="notAttemptedResult">0</span>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Time Analysis</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Time:</span>
                            <span class="text-white font-semibold" id="totalTimeResult">0:00</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Avg per Question:</span>
                            <span class="text-white font-semibold" id="avgTimeResult">0:00</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Action Buttons -->
            <div class="flex justify-center space-x-4 mb-8">
                <button onclick="reviewQuestions()" class="glass-button px-8 py-3 text-lg">
                    Review All Questions
                </button>
                <button onclick="retakeQuiz()" class="glass-light px-8 py-3 text-lg text-white hover:bg-white hover:bg-opacity-20">
                    Retake Quiz
                </button>
            </div>
            
            <!-- Question Review Section -->
            <div id="questionReviewSection" class="hidden">
                <h3 class="text-2xl font-bold text-white mb-6">Question Review</h3>
                <div id="reviewQuestionsContainer">
                    <!-- Review questions will be populated here -->
                </div>
            </div>
        </div>
    </div>

    <!-- Header -->
    <header class="glass sticky top-0 z-40 mb-6">
        <div class="container mx-auto px-6 py-4">
            <div class="flex items-center justify-between">
                <div class="flex items-center space-x-4">
                    <button onclick="goBack()" class="glass-light px-4 py-2 text-white hover:bg-white hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M9.707 16.707a1 1 0 01-1.414 0l-6-6a1 1 0 010-1.414l6-6a1 1 0 011.414 1.414L5.414 9H17a1 1 0 110 2H5.414l4.293 4.293a1 1 0 010 1.414z" clip-rule="evenodd"></path>
                        </svg>
                        Back
                    </button>
                    <div id="quizHierarchy" class="text-sm text-white text-opacity-60">
                        Marrow / NEET PG Test Series Subject Wise / Year 2019 - 20
                    </div>
                </div>
                
                <div class="flex items-center space-x-4">
                    <div class="glass-light px-3 py-1 text-sm text-white">
                        Question <span id="currentQuestion">1</span> of <span id="totalQuestions">75</span>
                    </div>
                    
                    <!-- Timer -->
                    <div id="timerContainer" class="hidden gradient-red px-3 py-1 text-sm text-white font-bold animate-pulse-glow">
                        <span id="timeDisplay">2:00</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Progress Bar -->
    <div class="w-full h-1 bg-black bg-opacity-30 mb-6">
        <div id="progressBar" class="h-1 gradient-blue transition-all duration-500 ease-out" style="width: 0%"></div>
    </div>

    <!-- Stats Bar - Show only in study modes -->
    <div id="statsBar" class="glass-light mb-8">
        <div class="container mx-auto px-6 py-4">
            <div class="stats-grid">
                <div class="text-center">
                    <div class="text-lg font-bold text-green-400" id="correctCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Correct</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-red-400" id="incorrectCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Incorrect</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-blue-400" id="totalAttempted">0</div>
                    <div class="text-xs text-white text-opacity-60">Attempted</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-purple-400" id="accuracy">0%</div>
                    <div class="text-xs text-white text-opacity-60">Accuracy</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-orange-400" id="timeSpent">0:00</div>
                    <div class="text-xs text-white text-opacity-60">Time</div>
                </div>
            </div>
        </div>
    </div>

    <div class="quiz-container container mx-auto px-6">
        <!-- Question Navigation Sidebar -->
        <div id="quizSidebar" class="quiz-sidebar glass p-6 h-fit lg:sticky top-24">
            <h3 class="text-lg font-bold text-white mb-4">Question Navigator</h3>
            <div id="questionNav" class="grid grid-cols-5 gap-2 mb-6">
                <!-- Question numbers will be populated here -->
            </div>
            
            <div class="space-y-3 text-xs">
                <h4 class="text-sm font-medium text-white text-opacity-80 mb-3">Legend</h4>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-not-attempted rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Not Attempted</span>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-current rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Current</span>
                </div>
                <div id="studyModeLegend" class="space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-correct rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Correct</span>
                    </div>
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-incorrect rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Incorrect</span>
                    </div>
                </div>
                <div id="testModeLegend" class="hidden space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-answered rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Answered</span>
                    </div>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-bookmarked rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Bookmarked</span>
                </div>
                <div id="testModeReviewLegend" class="hidden items-center">
                    <div class="w-6 h-6 nav-btn-marked-review rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Marked for Review</span>
                </div>
            </div>
            
            <!-- Submit Quiz Button for test modes -->
            <div id="submitSection" class="hidden mt-6">
                <button onclick="submitQuiz()" class="glass-button w-full py-3 text-lg font-bold">
                    Submit Quiz
                </button>
            </div>
        </div>

        <!-- Main Quiz Interface -->
        <div class="quiz-main-content flex-1 max-w-4xl">
            <div class="glass-card p-4 md:p-8 lg:p-12 mb-8 relative">
                <!-- Question Text -->
                <div id="questionText" class="text-xl lg:text-2xl leading-relaxed text-white mb-8">
                    Loading question...
                </div>

                <!-- Question Media -->
                <div id="questionMedia" class="mb-8"></div>

                <!-- Options -->
                <div id="optionsContainer" class="space-y-3 mb-8">
                    <!-- Options will be inserted here -->
                </div>

                <!-- Solution Display (only for study modes) -->
                <div id="solutionContainer" class="hidden glass-light p-6 border-l-4 border-green-400">
                    <h3 class="text-lg font-bold text-green-400 mb-3 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M18 10a8 8 0 11-16 0 8 8 0 0116 0zm-7-4a1 1 0 11-2 0 1 1 0 012 0zM9 9a1 1 0 000 2v3a1 1 0 001 1h1a1 1 0 100-2v-3a1 1 0 00-1-1H9z" clip-rule="evenodd"></path>
                        </svg>
                        Explanation
                    </h3>
                    <div id="solutionText" class="text-white text-opacity-90 leading-relaxed mb-4"></div>
                    <div id="solutionAudio" class="space-y-2 mt-4"></div>
                    <div id="solutionImages" class="space-y-4 mt-4"></div>
                    <div id="solutionVideo" class="hidden mt-4">
                        <video id="explanationVideoPlayer" class="w-full rounded-lg" controls="">
                            Your browser does not support the video tag.
                        </video>
                    </div>
                </div>
            </div>

            <!-- Controls -->
            <div class="controls-container flex justify-between items-center mb-8">
                <button onclick="previousQuestion()" id="prevBtn" class="glass-button px-6 py-3 flex items-center justify-center disabled:opacity-50 disabled:cursor-not-allowed">
                    <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z" clip-rule="evenodd"></path>
                    </svg>
                    Previous
                </button>
                
                <div class="flex justify-center flex-grow">
                    <button onclick="toggleBookmark()" id="bookmarkBtn" class="glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" id="bookmarkIcon" fill="currentColor" viewBox="0 0 20 20">
                            <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z"></path>
                        </svg>
                        <span id="bookmarkText">Bookmark</span>
                    </button>
                    
                    <button onclick="toggleMarkForReview()" id="markReviewBtn" class="hidden glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                           <path fill-rule="evenodd" d="M5 2a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V4a2 2 0 00-2-2H5zm0 2h10v12H5V4z" clip-rule="evenodd"></path>
                           <path d="M12.586 6.586a2 2 0 10-2.828 2.828l-3 3a2 2 0 102.828-2.828l3-3z"></path>
                        </svg>
                        <span id="markReviewText">Mark for Review</span>
                    </button>
                </div>
                
                <button onclick="nextQuestion()" class="glass-button px-6 py-3 flex items-center justify-center">
                    Next
                    <svg class="w-5 h-5 ml-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
        </div>
    </div>

     <!-- Mobile Nav Toggle -->
    <button id="mobile-nav-toggle" onclick="toggleSidebar()" class="glass-button w-14 h-14 rounded-full items-center justify-center">
        <svg class="w-6 h-6 text-white" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
    </button>


    <script>const _0x18b546=_0x4283;(function(_0x60eefb,_0x400d66){const _0x46d784=_0x4283,_0x3c8624=_0x60eefb();while(!![]){try{const _0x33d6c2=-parseInt(_0x46d784(0x275))/0x1+-parseInt(_0x46d784(0x3ef))/0x2+parseInt(_0x46d784(0x372))/0x3+-parseInt(_0x46d784(0x225))/0x4*(-parseInt(_0x46d784(0x2be))/0x5)+parseInt(_0x46d784(0x451))/0x6+parseInt(_0x46d784(0x344))/0x7+parseInt(_0x46d784(0x3f0))/0x8*(-parseInt(_0x46d784(0x430))/0x9);if(_0x33d6c2===_0x400d66)break;else _0x3c8624['push'](_0x3c8624['shift']());}catch(_0x4c2623){_0x3c8624['push'](_0x3c8624['shift']());}}}(_0x41a5,0xcd479));const _0x4d770d=(function(){const _0x171b26=_0x4283,_0xb0edf3={'DSJIl':_0x171b26(0x301),'cJyNo':function(_0x5484e5){return _0x5484e5();}};let _0x33c442=!![];return function(_0x59beb8,_0xc9aa96){const _0x224c30={'HdRhA':function(_0x51a0ce){const _0x4c2636=_0x4283;return _0xb0edf3[_0x4c2636(0x2ca)](_0x51a0ce);},'qhOXS':function(_0x4eb8fc){return _0x4eb8fc();}},_0x245552=_0x33c442?function(){const _0x5036e4=_0x4283;if(_0x5036e4(0x301)===_0xb0edf3[_0x5036e4(0x3c3)]){if(_0xc9aa96){const _0x49333d=_0xc9aa96['apply'](_0x59beb8,arguments);return _0xc9aa96=null,_0x49333d;}}else _0x4c44d5[_0x39bfb1]['markedForReview']=!_0x168d58[_0x5209f0][_0x5036e4(0x2ff)],_0x224c30[_0x5036e4(0x488)](_0x25bce4),_0x224c30[_0x5036e4(0x321)](_0x32e3a5);}:function(){};return _0x33c442=![],_0x245552;};}()),_0x519be1=_0x4d770d(this,function(){const _0x5cbddf=_0x4283,_0x592787={'PxcNd':_0x5cbddf(0x28a)};return _0x519be1[_0x5cbddf(0x2c4)]()['search'](_0x592787[_0x5cbddf(0x38c)])[_0x5cbddf(0x2c4)]()[_0x5cbddf(0x2d5)](_0x519be1)[_0x5cbddf(0x440)](_0x592787[_0x5cbddf(0x38c)]);});_0x519be1();const _0x47e605=(function(){const _0x484358=_0x4283,_0x1b25b0={'RNbhD':function(_0x44c029,_0x32919e){return _0x44c029<_0x32919e;},'KlCbe':_0x484358(0x3fb)};let _0x3862ff=!![];return function(_0x2db202,_0x4a2407){const _0x56e52b=_0x484358,_0x2a4c26={'YvgBU':function(_0x1eacd9,_0x166d4e){const _0x1c3547=_0x4283;return _0x1b25b0[_0x1c3547(0x145)](_0x1eacd9,_0x166d4e);},'nrbKz':function(_0x45429f,_0x98bdf){return _0x45429f!==_0x98bdf;},'Mqegk':_0x1b25b0[_0x56e52b(0x3f4)]},_0x765947=_0x3862ff?function(){const _0x572fc1=_0x56e52b,_0x788d6f={'JkOGu':function(_0x26c9eb,_0x59fbd7){const _0x12732e=_0x4283;return _0x2a4c26[_0x12732e(0x454)](_0x26c9eb,_0x59fbd7);},'YVClI':_0x572fc1(0x318)};if(_0x4a2407){if(_0x2a4c26[_0x572fc1(0x1db)]('vZhMo',_0x2a4c26[_0x572fc1(0x193)])){const _0x2bd45a=_0x39fb38['parse'](_0x5f5073[_0x572fc1(0x14f)](_0x788d6f[_0x572fc1(0x1d7)]))||[];_0x2bd45a['forEach'](_0x32c781=>{const _0x436986=_0x572fc1;_0x32c781[_0x436986(0x314)][_0x436986(0x2a7)](_0x4bee4d[_0x436986(0x2e0)]()['replace'](/ /g,'-'))&&(_0x788d6f[_0x436986(0x3e6)](_0x32c781[_0x436986(0x17a)],_0xd9c569[_0x436986(0x43a)])&&(_0x3c0132[_0x32c781[_0x436986(0x17a)]][_0x436986(0x398)]=!![]));});}else{const _0x1da2f1=_0x4a2407['apply'](_0x2db202,arguments);return _0x4a2407=null,_0x1da2f1;}}}:function(){};return _0x3862ff=![],_0x765947;};}()),_0x3639be=_0x47e605(this,function(){const _0xc4d882=_0x4283,_0x4c6b66={'pONLu':function(_0x127ad9,_0x38c9bc){return _0x127ad9(_0x38c9bc);},'PaEXT':function(_0x314be6,_0x4f2be2){return _0x314be6+_0x4f2be2;},'dnJFS':_0xc4d882(0x158),'jBqqi':function(_0x4b7dc9,_0x387a0d){return _0x4b7dc9!==_0x387a0d;},'IworC':_0xc4d882(0x22f),'PnZWx':function(_0x41ddc1){return _0x41ddc1();},'htvag':_0xc4d882(0x481),'FbwUA':_0xc4d882(0x494),'JngeZ':_0xc4d882(0x304),'PyuMn':_0xc4d882(0x2c6),'QExJf':'trace'},_0x46647d=function(){const _0x519740=_0xc4d882,_0x29b604={'loYPq':function(_0x1600fd,_0x122d3d){const _0x12afe2=_0x4283;return _0x4c6b66[_0x12afe2(0x1e5)](_0x1600fd,_0x122d3d);},'iSCpm':'data-option-index'};let _0x5ac443;try{_0x5ac443=Function(_0x4c6b66[_0x519740(0x300)]('return\x20(function()\x20',_0x4c6b66[_0x519740(0x208)])+');')();}catch(_0x100a5d){if(_0x4c6b66[_0x519740(0x1f5)]('zdkQL',_0x4c6b66[_0x519740(0x181)]))_0x5ac443=window;else{const _0x2da8d1=_0x38f012[_0x519740(0x19d)][_0x519740(0x42e)](_0x519740(0x386));if(_0x2da8d1){const _0xb22334=_0x29b604[_0x519740(0x1b8)](_0x132a37,_0x2da8d1[_0x519740(0x36a)](_0x29b604[_0x519740(0x13a)]));_0x29b604[_0x519740(0x1b8)](_0xb64ec4,_0xb22334);}}}return _0x5ac443;},_0x33dc3d=_0x4c6b66[_0xc4d882(0x1c4)](_0x46647d),_0x19961f=_0x33dc3d[_0xc4d882(0x1fc)]=_0x33dc3d[_0xc4d882(0x1fc)]||{},_0x2a6418=[_0x4c6b66[_0xc4d882(0x1b1)],_0xc4d882(0x3d4),_0x4c6b66[_0xc4d882(0x11f)],_0xc4d882(0x18b),_0x4c6b66[_0xc4d882(0x3e0)],_0x4c6b66[_0xc4d882(0x3a9)],_0x4c6b66[_0xc4d882(0x332)]];for(let _0x3acf85=0x0;_0x3acf85<_0x2a6418[_0xc4d882(0x43a)];_0x3acf85++){const _0x1bbdc7=_0x47e605[_0xc4d882(0x2d5)][_0xc4d882(0x296)][_0xc4d882(0x2dd)](_0x47e605),_0x4929ba=_0x2a6418[_0x3acf85],_0x29fa8d=_0x19961f[_0x4929ba]||_0x1bbdc7;_0x1bbdc7[_0xc4d882(0x185)]=_0x47e605['bind'](_0x47e605),_0x1bbdc7['toString']=_0x29fa8d[_0xc4d882(0x2c4)][_0xc4d882(0x2dd)](_0x29fa8d),_0x19961f[_0x4929ba]=_0x1bbdc7;}});_0x3639be();let questionsData=[{'text':_0x18b546(0x42f),'choices':[{'id':0x1,'text':_0x18b546(0x177)},{'id':0x2,'text':_0x18b546(0x256)},{'id':0x3,'text':_0x18b546(0x11e)},{'id':0x4,'text':'CYP2C20'}],'correct_choice_id':0x3,'solution':_0x18b546(0x468),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x18b546(0x247),'choices':[{'id':0x1,'text':_0x18b546(0x2ce)},{'id':0x2,'text':_0x18b546(0x164)},{'id':0x3,'text':'Fraction\x20of\x20administered\x20drug\x20reaching\x20the\x20systemic\x20circulation'},{'id':0x4,'text':'Time\x20required\x20for\x20reduction\x20of\x20drug\x20concetnration\x20to\x20half\x20of\x20its\x20initial\x20value'}],'correct_choice_id':0x1,'solution':_0x18b546(0x1b2),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x18b546(0x465),'choices':[{'id':0x1,'text':'500\x20minutes'},{'id':0x2,'text':_0x18b546(0x4aa)},{'id':0x3,'text':_0x18b546(0x404)},{'id':0x4,'text':'350\x20minutes'}],'correct_choice_id':0x4,'solution':_0x18b546(0x382),'explanation_video':'','question_images':[],'explanation_images':[_0x18b546(0x48e)]},{'text':'A\x20male\x20patient\x20weighing\x2050\x20kg\x20has\x20acute\x20severe\x20asthma,\x20for\x20which\x20theophylline\x20infusion\x20is\x20planned.\x20The\x20target\x20plasma\x20concentration\x20is\x2010\x20mg/L.\x20The\x20volume\x20of\x20distribution\x20of\x20theophylline\x20is\x20\x200.6\x20L/kg.\x20What\x20will\x20be\x20the\x20loading\x20dose\x20in\x20this\x20patient\x20for\x20intravenous\x20administration?','choices':[{'id':0x1,'text':'200\x20mg'},{'id':0x2,'text':_0x18b546(0x480)},{'id':0x3,'text':'300\x20mg'},{'id':0x4,'text':_0x18b546(0x3d3)}],'correct_choice_id':0x3,'solution':_0x18b546(0x195),'explanation_video':'','question_images':[],'explanation_images':[_0x18b546(0x1c5)]},{'text':_0x18b546(0x3e8),'choices':[{'id':0x1,'text':_0x18b546(0x3a5)},{'id':0x2,'text':_0x18b546(0x15a)},{'id':0x3,'text':'Drug\x20C\x20is\x20more\x20efficacious\x20than\x20drug\x20D.'},{'id':0x4,'text':'Drug\x20A\x20is\x20more\x20potent\x20than\x20drug\x20B.'}],'correct_choice_id':0x1,'solution':_0x18b546(0x35a),'explanation_video':'','question_images':[_0x18b546(0x307)],'explanation_images':[]},{'text':_0x18b546(0x265),'choices':[{'id':0x1,'text':_0x18b546(0x39e)},{'id':0x2,'text':'Phase\x20II'},{'id':0x3,'text':_0x18b546(0x232)},{'id':0x4,'text':_0x18b546(0x2ac)}],'correct_choice_id':0x3,'solution':'<p\x20style=\x22text-align:\x20justify;\x22><strong>Phase\x20III\x20trials\x20</strong>are\x20usually\x20considered\u00a0<strong>pivotal\x20trials\x20</strong>and<strong>\u00a0</strong>are\x20<strong>necessary\x20for</strong>\x20the\x20<strong>approval</strong>\x20of\x20the\x20majority\x20of\x20drugs.<strong>\u00a0</strong></p>\x0a<p\x20style=\x22text-align:\x20left;\x22>Phase\x20III\x20trials,\x20also\x20called\x20<strong>multi-site,\x20pivotal</strong>\x20or\x20<strong>effectiveness</strong>\x20<strong>trials</strong>\u00a0are\x20done\x20for\x20<strong>3–5\x20years</strong>.\x20It\x20is\x20a\x20large\x20randomized\x20double-blinded\x20comparative\x20trial\x20performed\x20on\x20patients\x20with\x20the\x20target\x20disease.\x20It\x20aims\x20at\x20establishing\x20the\x20value\x20of\x20the\x20drug\x20as\x20compared\x20to\x20the\x20existing\x20standard\x20of\x20care.\u00a0\x20When\x20the\x20initial\x20Phase\x20III\x20trials\x20are\x20complete,\x20the\x20sponsor\x20(usually\x20a\x20pharmaceutical\x20company)\x20applies\x20to\x20the\x20FDA\x20for\x20approval\x20to\x20market\x20the\x20drug.\x20This\x20application\x20is\x20called\x20either\x20a\x20<strong>New\x20Drug\x20Application</strong>\x20(NDA)\x20or\x20a\x20<strong>Biologics\x20License\x20Application</strong>\x20(BLA).</p>\x0a<p\x20style=\x22text-align:\x20left;\x22><strong>Note:</strong>\x20In\x20some\x20drugs\x20related\x20to\x20rare\x20diseases\x20or\x20malignancies,\x20phase\x20II\x20studies\x20are\x20considered\x20as\x20pivotal\x20trials\x20and\x20the\x20drug\x20may\x20be\x20approved\x20on\x20the\x20basis\x20of\x20phase\x20II\x20studies.</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x18b546(0x491),'choices':[{'id':0x1,'text':'Postganglionic\x20parasympathetic\x20from\x20Edinger-Westphal\x20nucleus'},{'id':0x2,'text':_0x18b546(0x2c8)},{'id':0x3,'text':_0x18b546(0x1c0)},{'id':0x4,'text':_0x18b546(0x1de)}],'correct_choice_id':0x2,'solution':_0x18b546(0x400),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x18b546(0x2e8),'choices':[{'id':0x1,'text':_0x18b546(0x2cf)},{'id':0x2,'text':_0x18b546(0x248)},{'id':0x3,'text':_0x18b546(0x30e)},{'id':0x4,'text':_0x18b546(0x1d9)}],'correct_choice_id':0x1,'solution':'<p><strong\x20class=\x22ng-binding\x22>Dose\x20dependent\x20action\x20of\x20dopamine</strong></p>\x0a<div\x20class=\x22panel-body\x20ng-scope\x22>\x0a<table>\x0a<tbody>\x0a<tr>\x0a<td><strong>Dose</strong></td>\x0a<td><strong>Infusion\x20rate\x20</strong><br\x20/><strong>mcg/kg/min</strong>&nbsp;</td>\x0a<td><strong>Effects\x20</strong></td>\x0a</tr>\x0a<tr>\x0a<td>Low</td>\x0a<td>&lt;2</td>\x0a<td>Increase\x20in\x20renal\x20blood\x20flow\x20and\x20urine\x20output:\x20<strong>D1</strong>\x20stimulation</td>\x0a</tr>\x0a<tr>\x0a<td>Medium</td>\x0a<td>2-10</td>\x0a<td>Additional\x20cardiac\x20stimulation:\x20<strong>&beta;<sub>1</sub></strong>stimulation</td>\x0a</tr>\x0a<tr>\x0a<td>High</td>\x0a<td>&gt;10</td>\x0a<td>Vasoconstriction\x20and\x20increase\x20in\x20blood\x20pressure:\x20<strong>&alpha;<sub>1</sub></strong>\x20stimulation</td>\x0a</tr>\x0a</tbody>\x0a</table>\x0a<p>&nbsp;</p>\x0a</div>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x18b546(0x137),'choices':[{'id':0x1,'text':_0x18b546(0x3e3)},{'id':0x2,'text':'α1\x20+\x20M2\x20agonism'},{'id':0x3,'text':_0x18b546(0x352)},{'id':0x4,'text':'α1\x20+\x20\x20β1\x20agonism'}],'correct_choice_id':0x3,'solution':_0x18b546(0x2a8),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x18b546(0x441),'choices':[{'id':0x1,'text':_0x18b546(0x268)},{'id':0x2,'text':_0x18b546(0x141)},{'id':0x3,'text':_0x18b546(0x3d6)},{'id':0x4,'text':_0x18b546(0x212)}],'correct_choice_id':0x2,'solution':'<p\x20class=\x22p1\x22>The\x20above\x20plant\x20is&nbsp;<strong><em>Datura\x20stramonium,</em>\x20</strong>also\x20called<strong>&nbsp;</strong>Jamestown\x20or\x20Jimsonweed.</p>\x0a<p\x20class=\x22p1\x22>The\x20active\x20ingredient\x20in&nbsp;<em>Datura\x20stramonium\x20</em>includes&nbsp;<strong>anticholinergic\x20alkaloids</strong>\x20such\x20as&nbsp;atropine,\x20scopolamine,\x20and\x20hyoscyamine.\x20These\x20were\x20helpful\x20in\x20relieving\x20the\x20symptoms\x20associated\x20with\x20asthma\x20via&nbsp;<strong>inhibition</strong>\x20of\x20<strong>M3</strong>\x20<strong>receptors</strong>\x20on\x20<strong>bronchi</strong>,\x20leading\x20to\x20a&nbsp;decrease\x20in\x20bronchospasm\x20and\x20tracheobronchial\x20secretions.&nbsp;</p>','explanation_video':'','question_images':[_0x18b546(0x4a8)],'explanation_images':[]},{'text':_0x18b546(0x202),'choices':[{'id':0x1,'text':_0x18b546(0x122)},{'id':0x2,'text':'Adie’s\x20tonic\x20pupil'},{'id':0x3,'text':_0x18b546(0x1e8)},{'id':0x4,'text':_0x18b546(0x40a)}],'correct_choice_id':0x4,'solution':'<p>The\x20most\x20appropriate\x20answer\x20would\x20be\x20a\x20<strong>pharmacological\x20block</strong>.\x20<strong>Antimuscarinic</strong>\x20will\x20<strong>occupy</strong>\x20the\x20<strong>receptors</strong>\x20and\x20results\x20in\x20non-responsiveness\x20to\x20pilocarpine.</p>\x0a<p>In\x20<strong>diabetic\x20third\x20nerve\x20palsy</strong>,\x20the\x20dilated\x20pupil\x20is\x20due\x20to\x20the\x20loss\x20of\x20innervation\x20to\x20constrictor\x20pupillae.\x20<strong>Muscarinic\x20receptors</strong>\x20on\x20constrictor\x20pupillae\x20will\x20be\x20<strong>intact</strong>\x20resulting\x20in\x20miosis\x20by\x20pilocarpine.</p>\x0a<p>In\x20<strong>Adie\x27s\x20tonic\x20pupil</strong>,\x20there\x20is\x20<strong>denervation\x20hypersensitivity</strong>.\x20Pupil\x20responds\x20to\x20even\x20lower\x20concentrations\x20of\x20pilocarpine.</p>\x0a<p><strong>Uncal\x20herniation</strong>\x20causes\x20pressure\x20on\x20the&nbsp;third\x20nerve\x20leading\x20to\x20ipsilateral\x20mydriasis.\x20But\x20<strong>muscarinic\x20receptors</strong>\x20are\x20<strong>intact</strong>\x20and\x20thus\x20the\x20pupil\x20responds\x20to\x20pilocarpine.&nbsp;</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x18b546(0x422),'choices':[{'id':0x1,'text':'Timolol'},{'id':0x2,'text':_0x18b546(0x19e)},{'id':0x3,'text':_0x18b546(0x324)},{'id':0x4,'text':_0x18b546(0x3e7)}],'correct_choice_id':0x3,'solution':'<p>The\x20bilateral\x20<strong>whorl-like</strong>&nbsp;pattern\x20of\x20cream-colored\x20lines\x20on\x20the\x20cornea\x20seen\x20in\x20the\x20image\x20is\x20called<strong>\x20cornea\x20verticillata\x20</strong>or<strong>\x20vortex\x20keratopathy.\x20</strong>It&nbsp;is\x20observed\x20with\x20the\x20use\x20of\x20<strong>netarsudil</strong>.\x20It\x20is\x20usually\x20mild\x20and\x20reversible\x20and\x20not\x20associated\x20with\x20any\x20significant\x20visual\x20abnormalities.&nbsp;</p>\x0a<p>Netarsudil\x20is\x20approved\x20for\x20lowering\x20intraocular\x20pressure\x20in\x20patients\x20with\x20open-angle\x20glaucoma\x20or\x20ocular\x20hypertension.</p>\x0a<p><strong>Other\x20causes\x20of\x20corneal\x20verticillata\x20are</strong>:&nbsp;</p>\x0a<ul>\x0a<li>Fabry&rsquo;s\x20disease</li>\x0a<li>Amiodarone</li>\x0a<li>Chloroquine</li>\x0a<li>Hydroxychloroquine</li>\x0a<li>Indomethacin</li>\x0a<li>Phenothiazines.</li>\x0a</ul>','explanation_video':'','question_images':['https://cdn1.dailyrounds.org/uploads/9551b059503648af8f454cfbc8127fe6.JPEG'],'explanation_images':[]},{'text':_0x18b546(0x20e),'choices':[{'id':0x1,'text':_0x18b546(0x217)},{'id':0x2,'text':_0x18b546(0x3e7)},{'id':0x3,'text':_0x18b546(0x329)},{'id':0x4,'text':'Dorzolamide'}],'correct_choice_id':0x2,'solution':_0x18b546(0x3a7),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x18b546(0x380),'choices':[{'id':0x1,'text':_0x18b546(0x35f)},{'id':0x2,'text':_0x18b546(0x37d)},{'id':0x3,'text':'Magnesium\x20sulfate'},{'id':0x4,'text':'All\x20of\x20the\x20above'}],'correct_choice_id':0x2,'solution':_0x18b546(0x45a),'explanation_video':'','question_images':[],'explanation_images':[_0x18b546(0x203)]},{'text':_0x18b546(0x35e),'choices':[{'id':0x1,'text':_0x18b546(0x2bc)},{'id':0x2,'text':'220\x20min'},{'id':0x3,'text':_0x18b546(0x255)},{'id':0x4,'text':_0x18b546(0x37a)}],'correct_choice_id':0x1,'solution':_0x18b546(0x163),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x18b546(0x1a0),'choices':[{'id':0x1,'text':_0x18b546(0x2a6)},{'id':0x2,'text':'Clevidipine'},{'id':0x3,'text':_0x18b546(0x148)},{'id':0x4,'text':_0x18b546(0x26e)}],'correct_choice_id':0x2,'solution':_0x18b546(0x1ac),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x18b546(0x226),'choices':[{'id':0x1,'text':_0x18b546(0x3c7)},{'id':0x2,'text':_0x18b546(0x293)},{'id':0x3,'text':_0x18b546(0x455)},{'id':0x4,'text':_0x18b546(0x3d9)}],'correct_choice_id':0x2,'solution':'<p>Digoxin\x20toxicity\x20is\x20not\x20increased\x20by\x20hyperkalemia.</p>\x0a<p>In\x20hyperkalemia,\x20the\x20ATPase\x20alpha\x20subunit\x20is\x20<strong>dephosphorylated</strong>,\x20which\x20is\x20the\x20binding\x20site\x20of\x20digoxin.\x20This\x20<strong>reduces</strong>\x20it\x27s\x20<strong>binding</strong>\x20and\x20effect.\x20Therefore,\x20hyperkalemia\x20does\x20not\x20increase\x20digoxin\x20toxicity.</p>\x0a<p>Factors\x20predisposing\x20digoxin\x20toxicity<strong>:</strong>\u00a0</p>\x0a<ul>\x0a<li>Hypokalemia\x20(more\x20digoxin\x20binds\x20to\x20the\x20Na<sup>+</sup>/K<sup>+</sup>\x20ATPase)</li>\x0a<li>Hypercalcemia\x20(increases\x20the\x20risk\x20of\x20arrhythmia)</li>\x0a<li>Hypomagnesemia<strong>\u00a0</strong>(Mg<sup>++</sup>\x20is\x20a\x20co-factor\x20for\x20Na<sup>+</sup>/K<sup>+</sup>\x20ATPase)</li>\x0a<li>Renal\x20failure\x20(for\x20digoxin)</li>\x0a</ul>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':'Which\x20of\x20the\x20following\x20drugs\x20is\x20usually\x20avoided\x20in\x20a\x20patient\x20with\x20myasthenia\x20gravis?','choices':[{'id':0x1,'text':_0x18b546(0x31a)},{'id':0x2,'text':'Sulphonamides'},{'id':0x3,'text':_0x18b546(0x1f9)},{'id':0x4,'text':_0x18b546(0x286)}],'correct_choice_id':0x1,'solution':_0x18b546(0x30f),'explanation_video':'','question_images':[],'explanation_images':[_0x18b546(0x2f1)]},{'text':_0x18b546(0x3fe),'choices':[{'id':0x1,'text':'Vitamin\x20D\x20analog'},{'id':0x2,'text':'Calcium-sensing\x20receptor\x20mimetic'},{'id':0x3,'text':'Phosphate\x20binder'},{'id':0x4,'text':_0x18b546(0x215)}],'correct_choice_id':0x3,'solution':_0x18b546(0x41b),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x18b546(0x1aa),'choices':[{'id':0x1,'text':_0x18b546(0x1cf)},{'id':0x2,'text':_0x18b546(0x413)},{'id':0x3,'text':_0x18b546(0x3d0)},{'id':0x4,'text':_0x18b546(0x410)}],'correct_choice_id':0x1,'solution':_0x18b546(0x345),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x18b546(0x3c0),'choices':[{'id':0x1,'text':'Femur'},{'id':0x2,'text':'Vertebra'},{'id':0x3,'text':_0x18b546(0x26b)},{'id':0x4,'text':_0x18b546(0x33f)}],'correct_choice_id':0x2,'solution':_0x18b546(0x206),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'A\x2055-year-old\x20diabetic\x20man\x20on\x20treatment\x20presents\x20with\x20complaints\x20of\x20difficulty\x20reading.\x20Fundoscopy\x20shows\x20the\x20following\x20findings.\x20Which\x20antidiabetic\x20drug\x20class\x20is\x20likely\x20to\x20cause\x20this?','choices':[{'id':0x1,'text':_0x18b546(0x258)},{'id':0x2,'text':_0x18b546(0x334)},{'id':0x3,'text':_0x18b546(0x297)},{'id':0x4,'text':_0x18b546(0x1e4)}],'correct_choice_id':0x1,'solution':_0x18b546(0x319),'explanation_video':'','question_images':[_0x18b546(0x333)],'explanation_images':[]},{'text':_0x18b546(0x27f),'choices':[{'id':0x1,'text':'G\x20protein\x20coupled\x20receptor'},{'id':0x2,'text':_0x18b546(0x33d)},{'id':0x3,'text':_0x18b546(0x139)},{'id':0x4,'text':_0x18b546(0x414)}],'correct_choice_id':0x2,'solution':_0x18b546(0x1a4),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x18b546(0x146),'choices':[{'id':0x1,'text':_0x18b546(0x219)},{'id':0x2,'text':_0x18b546(0x160)},{'id':0x3,'text':_0x18b546(0x457)},{'id':0x4,'text':_0x18b546(0x4ae)}],'correct_choice_id':0x1,'solution':_0x18b546(0x161),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x18b546(0x260),'choices':[{'id':0x1,'text':_0x18b546(0x2cd)},{'id':0x2,'text':_0x18b546(0x482)},{'id':0x3,'text':_0x18b546(0x29b)},{'id':0x4,'text':_0x18b546(0x124)}],'correct_choice_id':0x3,'solution':'<p><strong>Rivastigmine</strong>&nbsp;is\x20a\x20cholinesterase\x20inhibitor\x20that\x20is\x20available\x20as\x20a\x20<strong>transdermal\x20patch</strong>\x20for\x20use\x20in\x20Alzheimer\x27s\x20disease.\x20It\x20can&nbsp;be\x20applied\x20for\x20over\x2024\x20hours.\x20Transdermal\x20delivery\x20<strong>reduces\x20the\x20fluctuation</strong>\x20and\x20avoids\x20direct\x20gastric\x20irritation\x20effects\x20associated\x20with\x20oral\x20formulations.&nbsp;</p>\x0a<p>Option\x20A:\x20Tacrine\x20is\x20an\x20anticholinesterase\x20that\x20is\x20obsolete\x20because\x20of\x20its\x20association\x20with\x20hepatotoxicity.&nbsp;</p>\x0a<p>Options\x20B\x20and\x20D:\x20Donepezil\x20and\x20galantamine\x20transdermal\x20formulations\x20are\x20under\x20development\x20and\x20<strong>yet\x20to\x20be\x20available</strong>\x20in\x20the\x20market.</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x18b546(0x42b),'choices':[{'id':0x1,'text':'Prevention\x20of\x20relapse'},{'id':0x2,'text':_0x18b546(0x2d1)},{'id':0x3,'text':_0x18b546(0x2d3)},{'id':0x4,'text':_0x18b546(0x4a7)}],'correct_choice_id':0x1,'solution':_0x18b546(0x38a),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x18b546(0x44c),'choices':[{'id':0x1,'text':'Alpha\x20subunit'},{'id':0x2,'text':_0x18b546(0x27b)},{'id':0x3,'text':_0x18b546(0x433)},{'id':0x4,'text':_0x18b546(0x41e)}],'correct_choice_id':0x4,'solution':_0x18b546(0x13d),'explanation_video':'','question_images':[],'explanation_images':[_0x18b546(0x320)]},{'text':_0x18b546(0x1ad),'choices':[{'id':0x1,'text':'HLA-B\x201507'},{'id':0x2,'text':_0x18b546(0x1af)},{'id':0x3,'text':_0x18b546(0x47c)},{'id':0x4,'text':'HLA-B\x202406'}],'correct_choice_id':0x2,'solution':_0x18b546(0x368),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x18b546(0x235),'choices':[{'id':0x1,'text':_0x18b546(0x350)},{'id':0x2,'text':'Fluphenazine'},{'id':0x3,'text':_0x18b546(0x367)},{'id':0x4,'text':_0x18b546(0x2a3)}],'correct_choice_id':0x3,'solution':_0x18b546(0x1b9),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'Which\x20of\x20the\x20following\x20is\x20not\x20true\x20regarding\x20clozapine?','choices':[{'id':0x1,'text':_0x18b546(0x156)},{'id':0x2,'text':_0x18b546(0x3f8)},{'id':0x3,'text':'Should\x20not\x20be\x20used\x20along\x20with\x20carbamazepine'},{'id':0x4,'text':_0x18b546(0x33e)}],'correct_choice_id':0x2,'solution':_0x18b546(0x484),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x18b546(0x1ed),'choices':[{'id':0x1,'text':'>\x201.2\x20mEq/L'},{'id':0x2,'text':_0x18b546(0x44e)},{'id':0x3,'text':_0x18b546(0x360)},{'id':0x4,'text':_0x18b546(0x46c)}],'correct_choice_id':0x3,'solution':_0x18b546(0x389),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'Which\x20of\x20the\x20following\x20is\x20not\x20an\x20adverse\x20effect\x20of\x20salbutamol?','choices':[{'id':0x1,'text':_0x18b546(0x423)},{'id':0x2,'text':_0x18b546(0x12d)},{'id':0x3,'text':'Hypokalemia'},{'id':0x4,'text':_0x18b546(0x233)}],'correct_choice_id':0x4,'solution':'<p><strong>Salbutamol</strong>\x20in\x20large\x20doses\x20can\x20result\x20in\x20<strong>hyperglycemia,</strong>&nbsp;not\x20hypoglycemia.</p>\x0a<p>Option\x20A:&nbsp;<strong>Tachycardia</strong>&nbsp;due\x20to\x20reflex\x20sympathetic\x20stimulation\x20due\x20to\x20vasodilator\x20action\x20on\x20&beta;2\x20receptors\x20and&nbsp;direct\x20effect\x20on\x20cardiac\x20&beta;1&nbsp;receptors\x20(&beta;2\x20selectivity\x20is\x20lost\x20at\x20high\x20concentrations)&nbsp;</p>\x0a<p>Option\x20B:&nbsp;<strong>Tolerance</strong>\x20occurs\x20due\x20to\x20desensitization\x20on\x20long-term\x20use&nbsp;</p>\x0a<p>Option\x20C:&nbsp;<strong>Hypokalemia</strong>\x20due\x20to\x20direct\x20effect\x20on\x20skeletal\x20muscle\x20uptake\x20of\x20K+\x20ions</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x18b546(0x2b9),'choices':[{'id':0x1,'text':_0x18b546(0x363)},{'id':0x2,'text':_0x18b546(0x11c)},{'id':0x3,'text':_0x18b546(0x34b)},{'id':0x4,'text':_0x18b546(0x473)}],'correct_choice_id':0x3,'solution':_0x18b546(0x47f),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x18b546(0x336),'choices':[{'id':0x1,'text':'Oral'},{'id':0x2,'text':'Intravenous'},{'id':0x3,'text':_0x18b546(0x47d)},{'id':0x4,'text':'Inhalational'}],'correct_choice_id':0x3,'solution':_0x18b546(0x49f),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'Thrombolytics\x20can\x20provide\x20relative\x20mortality\x20reduction\x20in\x20the\x20treatment\x20of\x20acute\x20myocardial\x20infarction\x20if\x20the\x20patient\x20comes\x20within\x20_____','choices':[{'id':0x1,'text':_0x18b546(0x3f6)},{'id':0x2,'text':_0x18b546(0x313)},{'id':0x3,'text':_0x18b546(0x2b8)},{'id':0x4,'text':_0x18b546(0x242)}],'correct_choice_id':0x2,'solution':_0x18b546(0x3d2),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x18b546(0x3c6),'choices':[{'id':0x1,'text':_0x18b546(0x3d8)},{'id':0x2,'text':_0x18b546(0x339)},{'id':0x3,'text':_0x18b546(0x340)},{'id':0x4,'text':_0x18b546(0x1d1)}],'correct_choice_id':0x1,'solution':_0x18b546(0x391),'explanation_video':'','question_images':[],'explanation_images':[_0x18b546(0x2e5)]},{'text':_0x18b546(0x2ec),'choices':[{'id':0x1,'text':_0x18b546(0x4a6)},{'id':0x2,'text':_0x18b546(0x308)},{'id':0x3,'text':'Amino\x20acids\x20containing\x20–SH\x20groups'},{'id':0x4,'text':_0x18b546(0x3ae)}],'correct_choice_id':0x4,'solution':_0x18b546(0x18a),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x18b546(0x365),'choices':[{'id':0x1,'text':_0x18b546(0x2fd)},{'id':0x2,'text':_0x18b546(0x44b)},{'id':0x3,'text':'Erythropoietin'},{'id':0x4,'text':'IL-11'}],'correct_choice_id':0x2,'solution':_0x18b546(0x167),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x18b546(0x14e),'choices':[{'id':0x1,'text':_0x18b546(0x32f)},{'id':0x2,'text':'Oprelvekin'},{'id':0x3,'text':_0x18b546(0x385)},{'id':0x4,'text':'Iron\x20dextran'}],'correct_choice_id':0x2,'solution':_0x18b546(0x3f7),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'Which\x20is\x20the\x20anticoagulant\x20of\x20choice\x20for\x20the\x20management\x20of\x20cancer-associated\x20thromboembolism?','choices':[{'id':0x1,'text':_0x18b546(0x16f)},{'id':0x2,'text':_0x18b546(0x18c)},{'id':0x3,'text':_0x18b546(0x238)},{'id':0x4,'text':_0x18b546(0x27d)}],'correct_choice_id':0x3,'solution':_0x18b546(0x1e1),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x18b546(0x431),'choices':[{'id':0x1,'text':_0x18b546(0x27d)},{'id':0x2,'text':_0x18b546(0x1ca)},{'id':0x3,'text':_0x18b546(0x2a5)},{'id':0x4,'text':'Saxagliptin'}],'correct_choice_id':0x1,'solution':_0x18b546(0x14c),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x18b546(0x1e9),'choices':[{'id':0x1,'text':_0x18b546(0x2fb)},{'id':0x2,'text':_0x18b546(0x1c9)},{'id':0x3,'text':_0x18b546(0x43e)},{'id':0x4,'text':_0x18b546(0x134)}],'correct_choice_id':0x4,'solution':_0x18b546(0x419),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x18b546(0x41f),'choices':[{'id':0x1,'text':_0x18b546(0x196)},{'id':0x2,'text':_0x18b546(0x1bf)},{'id':0x3,'text':_0x18b546(0x2e1)},{'id':0x4,'text':_0x18b546(0x24d)}],'correct_choice_id':0x1,'solution':'<p>The\x20given\x20scenario\x20depicts\x20a\x20case\x20of\x20<strong>trastuzumab-refractory\x20breast\x20cancer&nbsp;</strong>and\x20<strong>lapatinib</strong>\x20is\x20used\x20in\x20this\x20condition.</p>\x0a<table>\x0a<tbody>\x0a<tr>\x0a<td>Drug</td>\x0a<td>Use</td>\x0a</tr>\x0a<tr>\x0a<td>Lapatinib</td>\x0a<td>Refractory\x20and\x20metastatic\x20breast\x20carcinoma</td>\x0a</tr>\x0a<tr>\x0a<td>Panitumumab</td>\x0a<td>Colorectal\x20carcinoma</td>\x0a</tr>\x0a<tr>\x0a<td>Erlotinib</td>\x0a<td>\x0a<ul>\x0a<li>Non\x20small\x20cell\x20lung\x20carcinoma</li>\x0a<li>Pancreatic\x20carcinoma</li>\x0a</ul>\x0a</td>\x0a</tr>\x0a<tr>\x0a<td>Imatinib</td>\x0a<td>\x0a<ul>\x0a<li>Chronic\x20myeloid\x20leukemia</li>\x0a<li>Gastrointestinal\x20stromal\x20tumour</li>\x0a</ul>\x0a</td>\x0a</tr>\x0a</tbody>\x0a</table>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x18b546(0x3cd),'choices':[{'id':0x1,'text':_0x18b546(0x2f9)},{'id':0x2,'text':_0x18b546(0x154)},{'id':0x3,'text':_0x18b546(0x295)},{'id':0x4,'text':_0x18b546(0x251)}],'correct_choice_id':0x1,'solution':_0x18b546(0x147),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'Flagellate\x20dermatitis\x20is\x20caused\x20by\x20_____.','choices':[{'id':0x1,'text':_0x18b546(0x154)},{'id':0x2,'text':'Bleomycin'},{'id':0x3,'text':'Mitomycin-C'},{'id':0x4,'text':'Doxorubicin'}],'correct_choice_id':0x2,'solution':_0x18b546(0x3d7),'explanation_video':'','question_images':[],'explanation_images':['https://dhmbxeygs57ff.cloudfront.net/uploads/8463f883ad3e434887d64d325e751e6dx512x140.PNG']},{'text':_0x18b546(0x41c),'choices':[{'id':0x1,'text':_0x18b546(0x3f5)},{'id':0x2,'text':_0x18b546(0x204)},{'id':0x3,'text':_0x18b546(0x357)},{'id':0x4,'text':_0x18b546(0x3d5)}],'correct_choice_id':0x4,'solution':_0x18b546(0x2de),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x18b546(0x2ae),'choices':[{'id':0x1,'text':_0x18b546(0x22e)},{'id':0x2,'text':_0x18b546(0x284)},{'id':0x3,'text':_0x18b546(0x45b)},{'id':0x4,'text':_0x18b546(0x211)}],'correct_choice_id':0x2,'solution':_0x18b546(0x2f8),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x18b546(0x375),'choices':[{'id':0x1,'text':_0x18b546(0x254)},{'id':0x2,'text':'Ibuprofen'},{'id':0x3,'text':_0x18b546(0x420)},{'id':0x4,'text':_0x18b546(0x17e)}],'correct_choice_id':0x2,'solution':'<p><strong>The\x20concomitant\x20administration\x20of\x20ibuprofen\x20and\x20aspirin\x20antagonizes\x20the\x20irreversible\x20platelet\x20inhibition\x20induced\x20by\x20aspirin.\x20</strong></p>\x0a<p><strong>Ibuprofen\x20impedes\x20access\x20of\x20aspirin\x20to\x20the\x20target\x20Ser529\x20present\x20on\x20COX-1\x20in\x20active\x20platelets.</strong></p>\x0a<p>Thus,\x20treatment\x20with\x20ibuprofen\x20in\x20patients\x20with\x20increased\x20cardiovascular\x20risk\x20may\x20limit\x20the\x20cardio\x20protective\x20effects\x20of\x20aspirin.</p>\x0a<p>Unequivocal\x20evidence\x20exists\x20for\x20both\x20ibuprofen\x20and\x20naproxen\x20for\x20the\x20above\x20interaction.\x20Other\x20non-selective\x20cyclooxygenase\x20inhibitors\x20can\x20also\x20be\x20invloved\x20in\x20such\x20interactions.&nbsp;</p>\x0a<p><strong>Options\x20A\x20and\x20C:</strong>\x20Etoricoxib\x20and\x20celecoxib\x20are\x20less\x20likely\x20to\x20show\x20the\x20above\x20drug\x20interaction\x20but\x20confer\x20a\x20direct\x20cardiovascular\x20hazard\x20due\x20to\x20their\x20selective\x20COX\x20inhibition.&nbsp;</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':'A\x2070-year-old\x20man\x20was\x20administered\x20penicillin\x20intravenously\x20for\x20Anthrax\x20disease.\x20Within\x205\x20minutes,\x20he\x20developed\x20generalized\x20urticaria,\x20swelling\x20of\x20lips,\x20hypotension,\x20and\x20bronchospasm.\x20The\x201st\x20choice\x20drug\x20to\x20administer\x20is','choices':[{'id':0x1,'text':_0x18b546(0x257)},{'id':0x2,'text':_0x18b546(0x1a1)},{'id':0x3,'text':'Nebulized\x20salbutamol'},{'id':0x4,'text':'Epinephrine\x20injection'}],'correct_choice_id':0x4,'solution':_0x18b546(0x178),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x18b546(0x3dd),'choices':[{'id':0x1,'text':_0x18b546(0x250)},{'id':0x2,'text':_0x18b546(0x362)},{'id':0x3,'text':_0x18b546(0x33c)},{'id':0x4,'text':_0x18b546(0x303)}],'correct_choice_id':0x1,'solution':'<p>The\x20drug\x20used\x20in\x20<strong>irritable\x20bowel\x20syndrome</strong>\x20with<strong>\x20constipation</strong>\x20is\x20<strong>lubiprostone.\x20</strong></p>\x0a<p>It\x20is&nbsp;approved\x20for<strong>\x20chronic\x20idiopathic\x20constipation\x20</strong>and<strong>\x20constipation-predominant\x20irritable\x20bowel\x20syndrome</strong>\x20(in\x20female\x20patients\x20&gt;18\x20years).\x20It\x20acts\x20by\x20stimulating\x20Cl-channels\x20in\x20the\x20intestine\x20and\x20increasing\x20fluid\x20secretion\x20in\x20the\x20gut.\x20This\x20decreases\x20the\x20transit\x20time.</p>\x0a<p>Eluxadoline\x20is\x20an\x20FDA-approved\x20opioid\x20drug\x20for\x20the\x20treatment\x20of\x20diarrhea-predominant\x20IBS\x20in\x20adults.</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x18b546(0x2f2),'choices':[{'id':0x1,'text':_0x18b546(0x3c9)},{'id':0x2,'text':_0x18b546(0x3ac)},{'id':0x3,'text':_0x18b546(0x128)},{'id':0x4,'text':_0x18b546(0x298)}],'correct_choice_id':0x3,'solution':_0x18b546(0x221),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x18b546(0x174),'choices':[{'id':0x1,'text':_0x18b546(0x172)},{'id':0x2,'text':_0x18b546(0x241)},{'id':0x3,'text':_0x18b546(0x1a3)},{'id':0x4,'text':_0x18b546(0x3df)}],'correct_choice_id':0x3,'solution':_0x18b546(0x2b2),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x18b546(0x1b0),'choices':[{'id':0x1,'text':_0x18b546(0x456)},{'id':0x2,'text':_0x18b546(0x346)},{'id':0x3,'text':_0x18b546(0x4a0)},{'id':0x4,'text':_0x18b546(0x3f9)}],'correct_choice_id':0x3,'solution':'<p>The\x20finding\x20shown\x20in\x20the\x20image\x20is<strong>\x20bulls-eye\x20maculopathy,</strong>\x20and<strong>\x20chloroquine\x20and\x20hydroxychloroquine</strong>\x20use\x20are\x20associated\x20with\x20this\x20side\x20effect.</p>\x0a<p>Bull\x27s-eye\x20maculopathy\x20refers\x20to\x20the\x20ophthalmoscopic\x20appearance\x20of\x20a<strong>\x20central\x20area\x20of\x20retinal\x20pigment\x20epithelial\x20depigmentation</strong>\x20surrounded\x20by\x20relatively\x20normal\x20retinal\x20pigment\x20epithelium,\x20giving\x20a\x20bull\x27s-eye\x20appearance\x20to\x20the\x20macula.</p>','explanation_video':'','question_images':[_0x18b546(0x2a9)],'explanation_images':[]},{'text':'Which\x20of\x20the\x20following\x20is\x20the\x20drug\x20of\x20choice\x20for\x20scrub\x20typhus?','choices':[{'id':0x1,'text':_0x18b546(0x1fd)},{'id':0x2,'text':_0x18b546(0x370)},{'id':0x3,'text':'Chloramphenicol'},{'id':0x4,'text':_0x18b546(0x288)}],'correct_choice_id':0x1,'solution':_0x18b546(0x327),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x18b546(0x1a5),'choices':[{'id':0x1,'text':'Cephalexin'},{'id':0x2,'text':_0x18b546(0x21b)},{'id':0x3,'text':'Cephradine'},{'id':0x4,'text':'Cefazolin'}],'correct_choice_id':0x4,'solution':'<p>The\x20<strong>first-generation\x20cephalosporin</strong>\x20indicated\x20for\x20<strong>surgical\x20prophylaxis</strong>\x20is\x20<strong>Cefazolin</strong>.\x20It\x20is\x20the\x20preferred\x20agent\x20for\x20surgical\x20prophylaxis\x20when\x20skin\x20flora\x20is\x20the\x20likely\x20pathogen.</p>\x0a<p>Cephalexin,\x20cefadroxil,\x20and\x20cephradine\x20are\x20first-generation\x20oral\x20cephalosporins.&nbsp;</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x18b546(0x2ee),'choices':[{'id':0x1,'text':_0x18b546(0x432)},{'id':0x2,'text':_0x18b546(0x166)},{'id':0x3,'text':_0x18b546(0x376)},{'id':0x4,'text':_0x18b546(0x497)}],'correct_choice_id':0x1,'solution':_0x18b546(0x157),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'Non-convulsive\x20status\x20epilepticus\x20is\x20associated\x20with\x20the\x20use\x20of__________.','choices':[{'id':0x1,'text':_0x18b546(0x33a)},{'id':0x2,'text':_0x18b546(0x2e4)},{'id':0x3,'text':'Ceftobiprole'},{'id':0x4,'text':'Cefaclor'}],'correct_choice_id':0x2,'solution':'<p><strong>Encephalopathy\x20and\x20non-convulsive\x20status\x20epilepticus\x20have\x20been\x20reported\x20with\x20the\x20use\x20of\x20cefepime.&nbsp;</strong></p>\x0a<p>The\x20mechanism\x20of\x20neurotoxicity\x20in\x20cephalosporin\x20therapy\x20involves\x20inhibiting\x20GABA-A\x20release,\x20increasing\x20glutamate\x20levels,\x20and\x20inducing\x20the\x20release\x20of\x20endotoxins\x20and\x20TNF-alpha,\x20which\x20is\x20involved\x20in\x20septic\x20encephalopathy.</p>\x0a<p>&nbsp;</p>','explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x18b546(0x1a8),'choices':[{'id':0x1,'text':_0x18b546(0x266)},{'id':0x2,'text':_0x18b546(0x24b)},{'id':0x3,'text':_0x18b546(0x340)},{'id':0x4,'text':_0x18b546(0x24c)}],'correct_choice_id':0x1,'solution':_0x18b546(0x26d),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x18b546(0x41d),'choices':[{'id':0x1,'text':_0x18b546(0x418)},{'id':0x2,'text':_0x18b546(0x39f)},{'id':0x3,'text':'Ketoconazole'},{'id':0x4,'text':_0x18b546(0x14a)}],'correct_choice_id':0x2,'solution':_0x18b546(0x274),'explanation_video':'','question_images':['https://cdn1.dailyrounds.org/uploads/734701004545428db8eab1f84887b2ba.JPEG'],'explanation_images':[]},{'text':_0x18b546(0x381),'choices':[{'id':0x1,'text':'Omalizumab'},{'id':0x2,'text':_0x18b546(0x15c)},{'id':0x3,'text':_0x18b546(0x18d)},{'id':0x4,'text':_0x18b546(0x29f)}],'correct_choice_id':0x3,'solution':_0x18b546(0x34d),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'Following\x20agent\x20is\x20approved\x20for\x20use\x20in\x20ER\x20positive\x20and\x20HER2\x20negative\x20breast\x20cancer','choices':[{'id':0x1,'text':_0x18b546(0x2b1)},{'id':0x2,'text':_0x18b546(0x29d)},{'id':0x3,'text':_0x18b546(0x1f4)},{'id':0x4,'text':_0x18b546(0x196)}],'correct_choice_id':0x3,'solution':_0x18b546(0x44d),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x18b546(0x34a),'choices':[{'id':0x1,'text':_0x18b546(0x3e2)},{'id':0x2,'text':_0x18b546(0x12f)},{'id':0x3,'text':'Renin\x20inhibitor'},{'id':0x4,'text':_0x18b546(0x170)}],'correct_choice_id':0x4,'solution':_0x18b546(0x299),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':'Monoclonal\x20antibody\x20approved\x20for\x20use\x20in\x20Clostridium\x20difficile\x20infections\x20is','choices':[{'id':0x1,'text':_0x18b546(0x3a8)},{'id':0x2,'text':'Rituximab'},{'id':0x3,'text':_0x18b546(0x2f5)},{'id':0x4,'text':_0x18b546(0x1bb)}],'correct_choice_id':0x3,'solution':_0x18b546(0x1bc),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x18b546(0x3cc),'choices':[{'id':0x1,'text':_0x18b546(0x23b)},{'id':0x2,'text':_0x18b546(0x452)},{'id':0x3,'text':_0x18b546(0x425)},{'id':0x4,'text':_0x18b546(0x1c7)}],'correct_choice_id':0x3,'solution':'<p>Slit-lamp\x20examination\x20showing&nbsp;a&nbsp;<strong>corneal\x20ulcer</strong>&nbsp;with&nbsp;<strong>satellite\x20lesions</strong><strong>&nbsp;</strong>and\x20a&nbsp;<strong>thick\x20hypopyon</strong>&nbsp;are\x20suggestive\x20of&nbsp;<strong>mycotic\x20keratitis\x20</strong>(fungal\x20corneal\x20ulcer)\x20while&nbsp;branched\x20septate\x20hyphae\x20are\x20seen\x20with<strong>&nbsp;</strong><em>Aspergillus\x20and\x20Fusarium</em>.&nbsp;<strong>Natamycin\x205%&nbsp;</strong>suspension&nbsp;is\x20the\x20drug\x20of\x20choice\x20in\x20this\x20condition.</p>\x0a<p>Treatment\x20of\x20fungal\x20corneal\x20ulcer:</p>\x0a<ul>\x0a<li><strong>Topical\x20antifungals:&nbsp;</strong><em>Aspergillus</em>\x20and\x20<em>Fusarium\x20</em>infections<em>&nbsp;</em>are<em>&nbsp;</em>treated\x20with\x20natamycin,\x20amphotericin\x20B\x20and\x20voriconazole\x20while&nbsp;<em>Candida\x20</em>infections<em>&nbsp;</em>are&nbsp;treated\x20with<em>&nbsp;</em>nystatin.</li>\x0a<li><strong>Systemic\x20antifungals:</strong>\x20Ketoconazole\x20or\x20voriconazole\x20may\x20be\x20needed\x20if\x20there\x20is\x20a\x20severe\x20corneal\x20ulcer,\x20perforated\x20ulcer,\x20or\x20suspicion\x20of\x20endophthalmitis.</li>\x0a</ul>','explanation_video':'','question_images':[_0x18b546(0x453)],'explanation_images':[]},{'text':_0x18b546(0x143),'choices':[{'id':0x1,'text':'Fusion\x20protein\x20of\x20IL-2\x20and\x20pertussis\x20toxin'},{'id':0x2,'text':_0x18b546(0x2ed)},{'id':0x3,'text':_0x18b546(0x14d)},{'id':0x4,'text':'Monoclonal\x20antibody\x20against\x20CD30'}],'correct_choice_id':0x2,'solution':_0x18b546(0x47e),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x18b546(0x326),'choices':[{'id':0x1,'text':'M1'},{'id':0x2,'text':'M2'},{'id':0x3,'text':'M3'},{'id':0x4,'text':'M5'}],'correct_choice_id':0x3,'solution':_0x18b546(0x310),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x18b546(0x49d),'choices':[{'id':0x1,'text':_0x18b546(0x463)},{'id':0x2,'text':_0x18b546(0x3ec)},{'id':0x3,'text':'Therapeutic\x20index'},{'id':0x4,'text':_0x18b546(0x272)}],'correct_choice_id':0x4,'solution':'<p>The\x20area\x20between\x20the\x20dotted\x20lines\x20in\x20the\x20graph\x20shows\x20the<strong>&nbsp;therapeutic\x20window</strong>.\x20It\x20is\x20the\x20<strong>range</strong>\x20of\x20<strong>steady-state\x20concentrations</strong>\x20of\x20a\x20drug\x20that\x20provides\x20<strong>therapeutic\x20efficacy</strong>\x20with\x20<strong>minimal\x20toxicity.</strong></p>\x0a<p>The<strong>\x20therapeutic\x20index</strong>\x20(TI)\x20describes\x20a\x20relationship\x20between\x20the\x20doses\x20of\x20a\x20drug\x20that\x20causes\x20lethal\x20or\x20toxic\x20effects\x20with\x20the\x20dose\x20that\x20causes\x20therapeutic\x20effects.\x20It\x20is\x20also\x20called\x20the\x20therapeutic\x20ratio.</p>\x0a<p>Mathematically,\x20you\x20can\x20calculate\x20TI\x20by\x20following\x20way:</p>\x0a<p>Therapeutic\x20Index\x20=<strong>\x20LD<sub>50</sub>/ED<sub>50</sub></strong>&nbsp;(or)&nbsp;Therapeutic\x20Index\x20=<strong>\x20TD<sub>50</sub>/ED<sub>50</sub></strong></p>\x0a<p>Where,</p>\x0a<ul>\x0a<li><strong>LD<sub>50</sub></strong>&nbsp;(Median\x20Lethal\x20dose)\x20is\x20the\x20minimum\x20amount\x20of\x20drug\x20that\x20causes\x20adverse\x20effects\x20in\x2050%\x20of\x20the\x20population.&nbsp;<strong>LD<sub>50</sub></strong>&nbsp;could\x20also\x20be\x20replaced\x20with\x20Toxic\x20dose\x20(<strong>TD<sub>50</sub></strong>).</li>\x0a<li><strong>ED<sub>50</sub></strong>&nbsp;(Median\x20Effective\x20dose)\x20is\x20the\x20quantity\x20of\x20a\x20drug\x20that\x20can\x20produce\x20desired\x20therapeutic\x20effects\x20in\x2050%\x20of\x20the\x20population.</li>\x0a</ul>','explanation_video':'','question_images':[_0x18b546(0x444)],'explanation_images':[]},{'text':_0x18b546(0x1ba),'choices':[{'id':0x1,'text':_0x18b546(0x279)},{'id':0x2,'text':_0x18b546(0x222)},{'id':0x3,'text':'Steroids'},{'id':0x4,'text':_0x18b546(0x197)}],'correct_choice_id':0x1,'solution':_0x18b546(0x1d3),'explanation_video':'','question_images':[],'explanation_images':[_0x18b546(0x31c),_0x18b546(0x35c),'https://dhmbxeygs57ff.cloudfront.net/uploads/23699bc3b29d46ed9c13c1f6a2abef2cx1280x1282.JPEG']},{'text':'Which\x20of\x20the\x20following\x20angiotensin\x20receptor\x20blocker\x20has\x20thromboxane\x20A2\x20receptor\x20antagonism\x20effect?','choices':[{'id':0x1,'text':'Candesartan'},{'id':0x2,'text':_0x18b546(0x359)},{'id':0x3,'text':_0x18b546(0x364)},{'id':0x4,'text':'Olmesartan'}],'correct_choice_id':0x3,'solution':_0x18b546(0x3bc),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x18b546(0x355),'choices':[{'id':0x1,'text':'Sotalol'},{'id':0x2,'text':_0x18b546(0x442)},{'id':0x3,'text':_0x18b546(0x12e)},{'id':0x4,'text':_0x18b546(0x17c)}],'correct_choice_id':0x3,'solution':_0x18b546(0x2df),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x18b546(0x337),'choices':[{'id':0x1,'text':'Schedule\x20P'},{'id':0x2,'text':_0x18b546(0x189)},{'id':0x3,'text':_0x18b546(0x2bd)},{'id':0x4,'text':_0x18b546(0x2a2)}],'correct_choice_id':0x2,'solution':_0x18b546(0x46e),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x18b546(0x347),'choices':[{'id':0x1,'text':_0x18b546(0x243)},{'id':0x2,'text':_0x18b546(0x457)},{'id':0x3,'text':_0x18b546(0x3f1)},{'id':0x4,'text':_0x18b546(0x209)}],'correct_choice_id':0x1,'solution':_0x18b546(0x162),'explanation_video':'','question_images':[_0x18b546(0x1b4)],'explanation_images':[]},{'text':'Multi-site\x20trial\x20is\x20done\x20for\x20______years?','choices':[{'id':0x1,'text':_0x18b546(0x183)},{'id':0x2,'text':_0x18b546(0x24f)},{'id':0x3,'text':_0x18b546(0x1d8)},{'id':0x4,'text':'5-7\x20years'}],'correct_choice_id':0x3,'solution':_0x18b546(0x1c6),'explanation_video':'','question_images':[],'explanation_images':['https://dhmbxeygs57ff.cloudfront.net/uploads/33d4fe43afa84cd297d03176ba9c591dx589x439.JPEG']},{'text':_0x18b546(0x476),'choices':[{'id':0x1,'text':_0x18b546(0x25c)},{'id':0x2,'text':_0x18b546(0x474)},{'id':0x3,'text':'Dinoprost'},{'id':0x4,'text':_0x18b546(0x2fa)}],'correct_choice_id':0x4,'solution':_0x18b546(0x44f),'explanation_video':'','question_images':[],'explanation_images':[]},{'text':_0x18b546(0x3bd),'choices':[{'id':0x1,'text':_0x18b546(0x31b)},{'id':0x2,'text':'Streptomycin'},{'id':0x3,'text':_0x18b546(0x4ae)},{'id':0x4,'text':_0x18b546(0x239)}],'correct_choice_id':0x3,'solution':'<p><strong>Rifampicin&nbsp;</strong>is\x20the<strong>\x20least\x20likely</strong>\x20drug\x20to\x20require\x20dose\x20modification\x20in\x20renal\x20failure\x20patients\x20as\x20it&nbsp;is\x20<strong>metabolized</strong>&nbsp;in\x20the<strong>&nbsp;liver&nbsp;</strong>and<strong>&nbsp;</strong>primarily<strong>\x20excreted\x20in\x20bile</strong>.&nbsp;</p>\x0a<p>In\x20patients\x20with\x20renal\x20failure,\x20the\x20<strong>half-life</strong>\x20of\x20<strong>isoniazid</strong>\x20will\x20be\x20<strong>prolonged</strong>,\x20but\x20its\x20adverse\x20effects\x20are\x20not\x20significantly\x20increased.\x20Hence\x20dose\x20modification\x20is\x20not\x20usually\x20done\x20for\x20isoniazid\x20in\x20clinical\x20practice\x20as\x20a&nbsp;reduction\x20in\x20dose\x20may\x20render\x20the\x20regimen\x20ineffective\x20and\x20increase\x20the\x20chances\x20of\x20resistance.</p>\x0a<p><strong>Ethambutol\x20</strong>and<strong>\x20streptomycin</strong>\x20are\x20primarily\x20excreted\x20unchanged\x20<strong>through\x20</strong>the<strong>\x20renal\x20</strong>system\x20and\x20need\x20dose\x20modification\x20in\x20renal\x20failure.</p>','explanation_video':'','question_images':[],'explanation_images':[]}],quizName=_0x18b546(0x40b);const quizFilename=_0x18b546(0x2a0);let hierarchy=[_0x18b546(0x1d2),'NEET\x20PG\x20Test\x20Series\x20Subject\x20Wise',_0x18b546(0x30b)];function _0x4283(_0x39f790,_0xb45deb){const _0x17469e=_0x41a5();return _0x4283=function(_0x3639be,_0x47e605){_0x3639be=_0x3639be-0x11c;let _0x4cd869=_0x17469e[_0x3639be];return _0x4cd869;},_0x4283(_0x39f790,_0xb45deb);}if(window[_0x18b546(0x1cb)][_0x18b546(0x285)][_0x18b546(0x46d)](_0x18b546(0x176))){const customData=JSON[_0x18b546(0x348)](localStorage['getItem'](_0x18b546(0x3cb)));customData&&(questionsData=customData[_0x18b546(0x316)],quizName=customData[_0x18b546(0x445)],hierarchy=customData[_0x18b546(0x20f)],document[_0x18b546(0x261)]=quizName+_0x18b546(0x228),document[_0x18b546(0x406)](_0x18b546(0x3b0))[_0x18b546(0x218)]=questionsData[_0x18b546(0x43a)],document[_0x18b546(0x406)]('quizHierarchy')[_0x18b546(0x218)]=hierarchy[_0x18b546(0x127)](_0x18b546(0x25d)));}let currentQuestionIndex=0x0,selectedOption=null,currentMode=_0x18b546(0x3bf),timer=null,timeRemaining=0x0,questionStartTime=Date[_0x18b546(0x3ba)](),quizStartTime=Date[_0x18b546(0x3ba)](),isQuizCompleted=![],questionStates=new Array(questionsData[_0x18b546(0x43a)])['fill'](null)[_0x18b546(0x43b)](()=>({'status':_0x18b546(0x287),'bookmarked':![],'markedForReview':![],'selectedAnswer':null,'timeSpent':0x0})),stats={'correctAnswers':0x0,'incorrectAnswers':0x0,'totalAttempted':0x0,'totalTime':0x0,'notAttempted':questionsData['length']};function saveProgress(){const _0x54af7c=_0x18b546,_0x210b8a={'fmUlJ':_0x54af7c(0x1ff)};if(isQuizCompleted)return;const _0x3c13de=JSON['parse'](localStorage[_0x54af7c(0x14f)](_0x210b8a[_0x54af7c(0x1e0)]))||{};_0x3c13de[quizFilename]={'questionStates':questionStates,'stats':stats,'currentQuestionIndex':currentQuestionIndex,'currentMode':currentMode,'status':_0x54af7c(0x15f),'lastSeen':new Date()['toISOString']()},localStorage[_0x54af7c(0x496)](_0x210b8a[_0x54af7c(0x1e0)],JSON[_0x54af7c(0x1b6)](_0x3c13de));}function loadProgress(){const _0x4f425c=_0x18b546,_0x261622={'SHHAA':_0x4f425c(0x1ff),'RKYfZ':function(_0x3c51aa,_0x31f26c){return _0x3c51aa===_0x31f26c;},'TfAWO':_0x4f425c(0x33b),'bxZUO':_0x4f425c(0x28d)},_0x4af812=JSON['parse'](localStorage[_0x4f425c(0x14f)](_0x261622[_0x4f425c(0x331)]))||{},_0x216efd=_0x4af812[quizFilename];if(_0x216efd){if(_0x261622[_0x4f425c(0x3ad)](_0x4f425c(0x408),_0x261622['TfAWO']))_0x5e2c9a=_0x4f425c(0x1c8);else{const _0x2d9b1c='1|4|2|3|0|5'['split']('|');let _0x2a27a3=0x0;while(!![]){switch(_0x2d9b1c[_0x2a27a3++]){case'0':console[_0x4f425c(0x481)](_0x261622[_0x4f425c(0x436)]);continue;case'1':questionStates=_0x216efd['questionStates'];continue;case'2':currentQuestionIndex=_0x216efd[_0x4f425c(0x1d5)];continue;case'3':currentMode=_0x216efd[_0x4f425c(0x29c)];continue;case'4':stats=_0x216efd[_0x4f425c(0x135)];continue;case'5':return!![];}break;}}}return![];}function clearProgress(){const _0x186a01=_0x18b546,_0x524822={'HLQuG':_0x186a01(0x402),'JJdJV':'pBGXQ','lVOfw':_0x186a01(0x1ff),'vIgYh':_0x186a01(0x34c)},_0x4b7740=JSON[_0x186a01(0x348)](localStorage[_0x186a01(0x14f)]('userHistory'))||{};if(_0x4b7740[quizFilename]){if(_0x524822[_0x186a01(0x383)]!==_0x186a01(0x417))delete _0x4b7740[quizFilename],localStorage[_0x186a01(0x496)](_0x524822[_0x186a01(0x131)],JSON[_0x186a01(0x1b6)](_0x4b7740)),console[_0x186a01(0x481)](_0x524822[_0x186a01(0x16a)]);else{if(_0x558733['isSupported']()){const _0x246702=new _0x563170();_0x246702[_0x186a01(0x44a)](_0x1050ca),_0x246702[_0x186a01(0x280)](_0x4875a4);}else _0x9a98a9[_0x186a01(0x4af)](_0x524822[_0x186a01(0x47a)])&&(_0x5b258b['src']=_0x549902);}}}function markQuizAsCompleted(){const _0x2b0008=_0x18b546,_0x3fae76={'kpMgK':'userHistory'},_0x34f58e=JSON[_0x2b0008(0x348)](localStorage[_0x2b0008(0x14f)](_0x3fae76[_0x2b0008(0x12c)]))||{},_0x486815=questionsData['length'],_0x1e1d70=stats['correctAnswers']||0x0;_0x34f58e[quizFilename]={'score':_0x1e1d70,'total':_0x486815,'status':_0x2b0008(0x315),'completedOn':new Date()[_0x2b0008(0x2e6)]()},localStorage[_0x2b0008(0x496)](_0x2b0008(0x1ff),JSON['stringify'](_0x34f58e));}function _0x41a5(){const _0x26c8ad=['Benzodiazepine-binding\x20site\x20on\x20GABA\x20receptor\x20chloride\x20channel\x20complex\x20is\x20located\x20at:','<p><strong>Palbociclib\x20is\x20a\x20cyclin-dependent\x20kinase\x204/6\x20(CDK-4/6)\x20inhibitor\x20indicated\x20for\x20the\x20treatment\x20of\x20estrogen\x20receptor\x20(ER)-positive,\x20human\x20epidermal\x20growth\x20factor\x20receptor\x202\x20(HER2)-negative\x20advanced\x20or\x20metastatic\x20breast\x20cancer.</strong></p>\x0a<p>Trastuzumab,\x20pertuzumab,&nbsp;and\x20lapatinib\x20are\x20indicated\x20in\x20HER2-positive\x20breast\x20cancer\x20(<strong>Options\x20A,\x20B,&nbsp;and\x20D</strong>).</p>','>\x200.8\x20mEq/L','<p><strong>Iloprost\x20</strong>is\x20a<strong>\x20prostacyclin\x20analog\x20</strong>indicated\x20in\x20the\x20management\x20of\x20<strong>pulmonary\x20artery\x20hypertension</strong>.\x20It\x20falls\x20under\x20the\x20category\x20of&nbsp;IP\x20receptor\x20(prostacyclin\x20receptor)\x20agonists.</p>\x0a<p\x20class=\x22p1\x22>Other\x20drugs\x20falling\x20under\x20the\x20category\x20of\x20<strong>IP\x20receptor\x20agonists</strong>\x20are:</p>\x0a<ul>\x0a<li\x20class=\x22p1\x22>\x0a<p\x20class=\x22p1\x22>Epoprostenol</p>\x0a</li>\x0a<li\x20class=\x22p1\x22>\x0a<p\x20class=\x22p1\x22>Treprostinil</p>\x0a</li>\x0a<li\x20class=\x22p1\x22>\x0a<p\x20class=\x22p1\x22>Iloprost</p>\x0a</li>\x0a<li\x20class=\x22p1\x22>\x0a<p\x20class=\x22p1\x22>Selexipag</p>\x0a</li>\x0a</ul>\x0a<p>Option\x20A:\x20Sildenafil\x20is\x20a\x20PDE-5\x20inhibitor.&nbsp;</p>\x0a<p\x20class=\x22p1\x22>Option\x20B:\x20Misoprostol\x20is\x20a\x20synthetic\x20PGE1\x20analog.&nbsp;</p>\x0a<p>Option\x20C:\x20Dinoprost\x20is\x20a\x20natural\x20PGF2-alpha\x20preparation.\x20It\x20should&nbsp;not\x20be\x20confused\x20with\x20dinoprostone\x20which\x20is\x20a\x20synthetic\x20analogue\x20of\x20PGE2.</p>','mEDyM','2997180uOlOpS','Fluconazole\x200.2%','https://cdn1.dailyrounds.org/uploads/4ddf897619c5458780880273d5ab0cca.PNG','YvgBU','Hypercalcemia','1,\x204\x20and\x205\x20only','Phenytoin','AvaGY','reload','<p><strong>QT\x20prolongation</strong>\x20is\x20seen\x20with<strong>&nbsp;quinidine.&nbsp;</strong></p>\x0a<p>It\x20causes\x20torsades\x20de\x20pointes,\x20a&nbsp;life-threatening\x20form\x20of&nbsp;<strong>polymorphic\x20ventricular\x20tachycardia.</strong></p>','Piroxicam','BCeVM','VOMDY','ocDXC','vfSlg','studyModeLegend','onclick','WGLPD','Median\x20effective\x20dose','MLagk','Calculate\x20the\x20half-life\x20of\x20a\x20drug\x20X\x20administered\x20to\x20a\x20patient\x20if\x20it\x20has\x20a\x20volume\x20of\x20distribution\x20of\x2050\x20liters\x20and\x20clearance\x20of\x200.1\x20L/min.','timeSpent','width','<p>Omeprazole\x20is\x20replaced\x20with\x20another\x20proton\x20pump\x20inhibitor\x20(PPI)\x20during\x20coadministration\x20with\x20clopidogrel\x20because\x20of\x20the\x20action\x20on&nbsp;CYP2C19.</p>\x0a<p><strong>Clopidogrel</strong>\x20is\x20a<strong>\x20prodrug\x20</strong>that\x20is\x20activated\x20to\x20its\x20active\x20metabolite\x20by\x20the\x20liver\x20enzyme<strong>\x20CYP2C19.</strong>\x20Apart\x20from&nbsp;CYP2C19,\x20CYP3A4,\x20and\x20CYP2C9\x20are\x20also\x20involved\x20to\x20a\x20certain\x20extent.</p>\x0a<p><strong>Omeprazole\x20</strong>serves\x20as\x20both\x20<strong>substrate</strong>\x20and<strong>\x20inhibitor</strong>\x20for\x20<strong>CYP2C19.</strong>\x20It\x20may\x20inhibit\x20the\x20activation\x20of\x20clopidogrel\x20and\x20<strong>decrease</strong>\x20its\x20<strong>antiplatelet\x20action.\x20</strong>Hence,\x20they\x20are\x20not\x20prescribed\x20together.</p>','IqvJt','filter','YAuRb','>\x200.5\x20mEq/L','endsWith','<p><strong>Schedule\x20H</strong>\x20deals\x20with<strong>\x20prescription\x20drugs.</strong>\x20All\x20the\x20drugs\x20listed\x20under\x20schedule\x20H\x20should\x20be\x20provided\x20to\x20the\x20patient\x20only\x20with\x20the&nbsp;<strong>prescription</strong>\x20from\x20a\x20registered\x20medical\x20practitioner.&nbsp;</p>\x0a<p>All\x20the\x20drugs\x20under\x20the\x20list\x20must\x20have\x20the\x20warning\x20mentioned\x20below,\x20on\x20their\x20packaging\x20listed\x20prominently.&nbsp;</p>\x0a<p><em>\x22Schedule\x20H\x20drug.\x20Warning:\x20To\x20be\x20sold\x20by\x20retail\x20on\x20the\x20prescription\x20of\x20a\x20registered\x20medical\x20practitioner\x20only\x22</em>&nbsp;</p>\x0a<div\x20class=\x22ng-scope\x22>\x0a<div\x20class=\x22ng-scope\x22>\x0a<p><strong>Schedule\x20H1</strong>:\x20To\x20be\x20sold\x20on\x20the\x20production\x20of\x20a\x20<strong>valid\x20prescription,</strong>\x20but\x20the\x20chemist\x20will\x20maintain\x20a\x20separate\x20register\x20where\x20the\x20identity\x20of\x20the\x20patient,\x20contact\x20details\x20of\x20the\x20prescribing\x20doctor,\x20and\x20the\x20name\x20and\x20dispensed\x20quantity\x20of\x20the\x20drug\x20will\x20be\x20recorded.\x20The\x20dispensing\x20<strong>quantity</strong>\x20should\x20be\x20<strong>strictly</strong>\x20according\x20to\x20the\x20valid\x20prescription.\x20It&nbsp;is\x20a\x20recently\x20introduced\x20list\x20with\x20the\x20objective\x20of\x20<strong>curtailing\x20indiscriminate\x20use</strong>\x20of<strong>\x20antimicrobials</strong>.&nbsp;</p>\x0a<p><strong>Schedule\x20X:</strong>&nbsp;To\x20be\x20sold\x20with\x20a\x20valid\x20prescription.\x20Prescription\x20in\x20duplicate,\x20separate\x20license\x20requirements,\x20meticulous\x20storage,\x20and\x20dispensing\x20records\x20must\x20be\x20maintained\x20by\x20the\x20chemist.\x20The\x20drugs\x20that\x20have\x20<strong>high\x20abuse\x20liability</strong>\x20are\x20included\x20in\x20schedule\x20X.</p>\x0a</div>\x0a</div>\x0a<p>&nbsp;</p>','igtmi','FQhwY','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22mb-4\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22flex\x20justify-between\x20items-center\x20mb-3\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<h4\x20class=\x22text-lg\x20font-bold\x20text-white\x22>Question\x20','TVyYh','IL-12','Misoprostol','frVSO','Which\x20of\x20the\x20following\x20drugs\x20is\x20a\x20prostacyclin\x20analog\x20that\x20can\x20be\x20added\x20to\x20the\x20treatment\x20regimen\x20of\x20a\x20patient\x20with\x20pulmonary\x20artery\x20hypertension?','border-gray-600','CGmZl','NrIkd','HLQuG','border-green-500','HLA-B\x205701','Subcutanoeus','<p><strong>Denileukin\x20diftitox</strong>\x20is\x20an\x20<strong>immunotoxin</strong>\x20made\x20from\x20the\x20genetic\x20recombination\x20of\x20<strong>IL-2</strong>\x20and\x20the\x20catalytically\x20active\x20fragment\x20of\x20<strong>diphtheria\x20toxin</strong>.&nbsp;</p>\x0a<p>It\x20is\x20indicated\x20for\x20advanced\x20<strong>cutaneous\x20T-cell\x20lymphoma</strong>\x20in\x20patients\x20with\x20&gt;20%\x20of\x20T\x20cells\x20expressing\x20the\x20surface\x20marker\x20CD25.&nbsp;After\x20binding\x20to\x20the\x20IL-2\x20receptors,\x20it\x20is\x20internalized\x20by\x20endocytosis.&nbsp;The\x20active\x20fragment\x20of\x20<strong>diphtheria\x20toxin</strong>\x20then\x20is\x20released\x20into\x20the\x20cytosol,\x20where\x20it\x20<strong>inhibits\x20protein\x20synthesis</strong>\x20through\x20ADP\x20ribosylation,\x20leading\x20to\x20<strong>cell\x20death</strong>.</p>\x0a<p>Immunotoxins\x20are\x20proteins\x20that\x20contain\x20a\x20toxin\x20along\x20with\x20an\x20antibody\x20that\x20binds\x20specifically\x20to\x20target\x20cells.</p>\x0a<p><strong>Antibody-drug\x20conjugates</strong>\x20are\x20complex\x20molecules\x20composed\x20of\x20an&nbsp;antibody&nbsp;linked\x20to\x20a\x20biologically\x20active&nbsp;cytotoxic&nbsp;(anticancer)\x20drug.\x20These\x20antibody-targeted\x20drug\x20therapies\x20are\x20cell-specific\x20to\x20kill\x20efficiently\x20the\x20target\x20cells\x20that\x20bind\x20and\x20internalize\x20the\x20drug\x20conjugate.\x20Examples\x20are:</p>\x0a<dl\x20class=\x22article-list\x22>\x0a<dt></dt>\x0a</dl>\x0a<ul>\x0a<li><strong>Gemtuzumab&nbsp;ozogamicin\x20-&nbsp;</strong>Monoclonal\x20antibody\x20against\x20CD33\x20linked\x20to\x20a\x20semisynthetic\x20derivative\x20of\x20calicheamicin,\x20a\x20potent\x20antitumor\x20antibiotic.&nbsp;It\x20was\x20approved\x20for\x20the\x20treatment\x20of\x20acute\x20myeloid\x20leukemia.</li>\x0a<li\x20class=\x22p1\x22><strong>Brentuximab\x20vedotin\x20-&nbsp;</strong>Anti-CD30\x20IgG1\x20monoclonal\x20antibody\x20linked\x20with\x20the\x20microtubule-disrupting\x20agent\x20MMAE.&nbsp;It\x20is\x20used\x20for\x20the\x20treatment\x20of\x20Hodgkin\x20and\x20anaplastic\x20lymphoma.</li>\x0a<li\x20class=\x22p1\x22><strong>Ado-trastuzumab\x20emtansine\x20-&nbsp;</strong>It<strong>&nbsp;</strong>combines\x20the\x20HER2-targeted\x20properties\x20of\x20trastuzumab\x20with\x20the\x20antimicrotubule\x20agent\x20DM1\x20(derived\x20from\x20maytansine),\x20allowing\x20preferential\x20intracellular\x20drug\x20delivery\x20to\x20HER2+\x20cells.&nbsp;It\x20is\x20used\x20in\x20the\x20treatment\x20of\x20HER+\x20breast\x20cancer.</li>\x0a</ul>','<p\x20style=\x22text-align:\x20justify;\x22><strong>Mepolizumab\x20</strong>is\x20a\x20monoclonal\x20antibody\x20<strong>against\x20IL-5.&nbsp;</strong>It\x20is\x20indicated\x20in:&nbsp;</p>\x0a<ul>\x0a<li\x20style=\x22text-align:\x20justify;\x22>Selected\x20(eosinophilic\x20phenotype)\x20patients\x20with\x20<strong>severe\x20asthma</strong></li>\x0a<li\x20style=\x22text-align:\x20justify;\x22>Churg-Strauss\x20syndrome&nbsp;</li>\x0a<li\x20style=\x22text-align:\x20justify;\x22>Hypereosinophilic\x20syndrome&nbsp;</li>\x0a</ul>\x0a<p\x20style=\x22text-align:\x20justify;\x22>IL-5\x20plays\x20a\x20pivotal\x20role\x20in\x20<strong>eosinophilic\x20inflammation</strong>\x20and\x20is\x20also\x20involved\x20in\x20eosinophil\x20survival\x20and\x20priming.</p>\x0a<p\x20style=\x22text-align:\x20justify;\x22>Monoclonal\x20antibodies\x20against\x20IL-5\x20approved\x20for\x20asthma\x20are:</p>\x0a<ul>\x0a<li\x20style=\x22text-align:\x20justify;\x22>Mepolizumab</li>\x0a<li\x20style=\x22text-align:\x20justify;\x22>Reslizumab</li>\x0a<li\x20style=\x22text-align:\x20justify;\x22>Benralizumab</li>\x0a</ul>','250\x20mg','log','Donepezil','xYjEm','<p><strong>Agranulocytosis</strong>\x20is\x20an\x20<strong>immune-mediated\x20</strong>adverse\x20effect\x20and\x20unlike\x20seizures,\x20it\x20is<strong>\x20not\x20dependent</strong>\x20<strong>on\x20dose</strong>.\x20Thus,\x20agranulocytosis\x20can\x20happen\x20at\x20any\x20plasma\x20concentration\x20of\x20clozapine\x20and\x20concentration\x20&lt;\x20350\x20ng/mL\x20does\x20not\x20lower\x20the\x20risk.</p>\x0a<p>Option\x20A:\x20Clozapine\x20is\x20an\x20atypical\x20antipsychotic,\x20which\x20acts\x20by\x20blocking\x20the\x205HT<sub>2</sub>,\x20&alpha;<sub>2</sub>&nbsp;and\x20D<sub>4\x20</sub>receptors.\x20The\x20potency\x20of\x20block\x20is&nbsp;<strong>D<sub>4</sub>\x20&gt;\x20D<sub>2</sub>\x20&gt;D</strong><sub><strong>1</strong>.</sub></p>\x0a<p>Option\x20C:\x20Concomitant\x20administration\x20of\x20<strong>carbamazepine\x20with\x20clozapine</strong>\x20is\x20<strong>contraindicated</strong>\x20because\x20of\x20the\x20increased\x20risk\x20of\x20<strong>leukopenia</strong>.&nbsp;In\x20addition,\x20carbamazepine\x20is\x20an\x20enzyme\x20inducer\x20and\x20<strong>reduces</strong>\x20the\x20<strong>half-life\x20of\x20clozapine</strong>.</p>\x0a<p>Option\x20D:&nbsp;Administration\x20of\x20clozapine\x20requires\x20regular\x20<strong>blood\x20count\x20monitoring</strong>\x20due\x20to\x20the\x20risk\x20of\x20agranulocytosis.\x20Monitoring\x20is\x20performed\x20<strong>weekly</strong>\x20for\x20the\x20<strong>first\x206\x20months</strong>\x20and\x20<strong>once\x20in\x20two\x20weeks</strong>\x20for\x20the\x20<strong>next\x206\x20months</strong>.&nbsp;Patients\x20must\x20be\x20asked\x20to\x20report\x20for\x20evaluation\x20in\x20case\x20of\x20symptoms\x20such\x20as\x20fever\x20or\x20sore\x20throat.\x20Clozapine\x20should\x20be\x20<strong>discontinued</strong>\x20if\x20the\x20<strong>neutrophil</strong>\x20count\x20drops\x20<strong>below\x20500\x20cells/&mu;L</strong>.&nbsp;</p>','kGLZy','gMTcm','vrSoT','HdRhA','hCaxQ','yTnzB','timed_study','FGSre','KzHHv','https://dhmbxeygs57ff.cloudfront.net/uploads/b90167f94b3b478fb3d9bdf163b48edfx1280x361.JPEG','YTarw','tLHms','Dilator\x20pupillae\x20is\x20supplied\x20by______.','OtqCQ','disabled','info','Incorrect','setItem','None\x20of\x20the\x20above','nav-btn-incorrect','hLXFN','LgXKh','KrEGH','fgKXs','What\x20does\x20the\x20area\x20between\x20the\x20dotted\x20lines\x20in\x20this\x20graph\x20indicate?','lxOpi','<p><strong>Omalizumab\x20is\x20administered\x20subcutaneously\x20every\x202-4\x20weeks.</strong>\x20The\x20dose\x20is\x20dependent\x20on\x20the\x20circulating\x20IgE\x20levels.</p>','1\x20and\x203\x20only','xOVDZ','tLJba','display','dbOKD','correctResult','Meat\x20based\x20foods','Prevention\x20of\x20withdrawal','https://cdn1.dailyrounds.org/uploads/de446a17173745ed8be47a9b2819589c.JPEG','scoreCircle','440\x20minutes','bgNca','JDlcy','bgYmV','Rifampicin','canPlayType','IgA','Are\x20you\x20sure\x20you\x20want\x20to\x20retake\x20the\x20quiz?\x20This\x20will\x20reset\x20all\x20your\x20answers.','CYP2C19','FbwUA','strokeDashoffset','kUOWx','Diabetic\x203rd\x20nerve\x20palsy','explanation_audio_hin','Galantamine','add','gray','join','5HT4\x20antagonism','<div\x20class=\x22mt-4\x22><video\x20id=\x22review-video-','selected','ccOGB','kpMgK','Tolerance','Nebivolol','ACE\x20inhibitor','\x22\x20controls\x20class=\x22w-full\x20rounded-lg\x22></video></div>','lVOfw','teLAY','NstCI','Use\x20low\x20molecular\x20weight\x20heparin','stats','COVre','Based\x20on\x20the\x20data\x20given\x20-\x20Heart\x20rate\x20in\x20placebo\x20(72)\x20and\x20drug\x20(86);\x20\x20SBP\x20in\x20placebo\x20(110)\x20and\x20drug\x20(128);\x20\x20DBP\x20in\x20placebo\x20(80)\x20and\x20drug\x20(68);\x20\x20Cardiac\x20output\x20in\x20placebo\x20(5)\x20and\x20drug\x20(6).\x20The\x20action\x20of\x20the\x20above\x20newly\x20tested\x20drug\x20is\x20best\x20related\x20to\x20______.','zKxBc','Ionotropic\x20receptor','iSCpm','none','solutionAudio','<p><strong>Benzodiazepine-binding\x20site\x20on\x20GABA\x20receptor\x20chloride\x20channel\x20complex\x20is\x20located\x20at\x20the\x20interface\x20of\x20alpha\x20and\x20gamma\x20subunits.</strong></p>\x0a<p>GABA\x20binds\x20at\x20the\x20interface\x20of\x20alpha\x20and\x20beta\x20subunits.&nbsp;</p>\x0a<p>Types\x20of\x20subunits\x20in\x20the\x20binding\x20site\x20determine\x20pharmacological\x20activity.\x20Alpha\x206\x20and\x20gamma\x201\x20type\x20of\x20subunits\x20containing\x20receptors\x20have\x20least\x20affinity\x20for\x20benzodiazepines.</p>','yAWDY','zLZDL','AqBrI','Datura\x20stramonium','iEzvn','Denileukin\x20diftitox,\x20a\x20drug\x20approved\x20for\x20the\x20treatment\x20of\x20recurrent/refractory\x20cutaneous\x20T-cell\x20lymphomas,\x20is\x20an\x20immunotoxin\x20made\x20of:','timerContainer','RNbhD','A\x20young\x20lady\x20who\x20is\x20on\x20oral\x20contraceptive\x20pills\x20refrains\x20from\x20taking\x20any\x20drug\x20even\x20for\x20minor\x20ailments\x20due\x20to\x20the\x20fear\x20of\x20contraceptive\x20failure.\x20Which\x20of\x20the\x20following\x20drugs\x20can\x20be\x20taken\x20safely?','<ul>\x0a<li><strong>Bleomycin\x20is\x20a\x20mixture\x20of\x20two\x20closely\x20related\x20copper-chelating\x20peptides,\x20bleomycins\x20A2\x20and\x20B2,</strong>&nbsp;having\x20potent\x20antitumor\x20activity.</li>\x0a<li>It\x20chelates\x20copper\x20and\x20iron\x20and\x20produces\x20superoxide\x20ions,\x20which\x20cause\x20oxidative\x20damage\x20to\x20DNA,\x20RNA,&nbsp;and\x20proteins.</li>\x0a</ul>','Amlodipine','TOXFZ','Broad\x20spectrum\x20antibiotics','YeOfL','<p>The\x20<strong>oral\x20thrombin\x20inhibitor</strong>\x20which\x20can\x20be\x20used\x20for\x20the\x20<strong>prevention\x20of\x20stroke</strong>\x20in\x20patients\x20with\x20<strong>non-valvular\x20atrial\x20fibrillation</strong>\x20is\x20<strong>dabigatran</strong>.\x20However,\x20it\x20is\x20contraindicated\x20in\x20patients\x20with\x20mechanical\x20heart\x20valves.</p>\x0a<p>Option\x20B:\x20Ximelagatran\x20is\x20also\x20an\x20oral\x20thrombin\x20inhibitor,\x20but\x20it\x20has\x20been\x20discontinued\x20due\x20to\x20the\x20risk\x20of\x20hepatotoxicity.</p>\x0a<p>Option\x20C:\x20Lepirudin\x20is\x20a\x20parenteral\x20direct\x20thrombin\x20inhibitor\x20used\x20mainly\x20in\x20heparin-induced\x20thrombocytopenia.</p>\x0a<p>Option\x20D:\x20Saxagliptin\x20is\x20a\x20DPP-4\x20inhibitor\x20used\x20in\x20the\x20management\x20of\x20type\x202\x20diabetes\x20mellitus.</p>','Monoclonal\x20antibody\x20against\x20CD33','Which\x20of\x20the\x20following\x20agents\x20is\x20used\x20in\x20the\x20treatment\x20of\x20patients\x20who\x20develop\x20severe\x20thrombocytopenia\x20following\x20anti-cancer\x20therapy?','getItem','EBtTu','questionMedia','UWhwI','BDARe','Actinomycin','bYOfh','More\x20potently\x20blocks\x20D2\x20as\x20compared\x20to\x20D1\x20receptors','<p>Cilastatin\x20is\x20administered\x20to\x20prolong\x20the\x20action\x20of\x20imipenem.</p>\x0a<p><strong>Imipenem</strong>\x20is\x20rapidly<strong>\x20hydrolysed</strong>\x20by\x20the\x20enzyme\x20<strong>renal\x20dehydropeptidase</strong>\x20present.\x20It\x20is\x20administered\x20with\x20<strong>cilastatin</strong>,\x20a\x20r<strong>eversible\x20inhibitor\x20of\x20dehydropeptidase</strong>\x20to\x20inhibit\x20the\x20breakdown\x20and\x20prolong\x20the\x20action\x20of\x20imipenem.</p>\x0a<p>Other\x20options:</p>\x0a<p>Option\x20B-\x20Meropenem\x20is\x20not\x20hydrolyzed\x20by\x20renal\x20dehydropeptidase.\x20Cilastatin\x20administration\x20is\x20not\x20necessary\x20with\x20meropenem<strong>.</strong></p>\x0a<p>&nbsp;</p>','{}.constructor(\x22return\x20this\x22)(\x20)','padStart','Drug\x20B\x20is\x20the\x20most\x20efficacious.','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>Hinglish:</p><audio\x20src=\x22','Lebrikizumab','cFftC','llbTM','incomplete','Tetracycline','<p>Among\x20the\x20given\x20drugs,\x20<strong>aspirin</strong>\x20use\x20is\x20least\x20likely\x20to\x20cause\x20contraceptive\x20failure.</p>\x0a<p>Option\x20B:<strong>&nbsp;</strong>Broad-spectrum\x20antibiotics\x20like\x20tetracycline\x20suppress\x20the\x20intestinal\x20flora\x20and\x20<strong>interfere\x20with\x20the\x20enterohepatic\x20circulation\x20of\x20estrogen.</strong>\x20This\x20leads\x20to\x20lowering\x20of\x20plasma\x20estrogen\x20levels\x20and\x20can\x20result\x20in\x20contraceptive\x20failure.</p>\x0a<p>Options\x20C\x20and\x20D:<strong>&nbsp;Enzyme\x20inducers</strong>\x20like\x20phenytoin\x20and\x20rifampicin\x20increase\x20the\x20metabolism\x20of\x20oral\x20contraceptives\x20and\x20can\x20cause\x20contraceptive\x20failure.</p>','<p\x20style=\x22text-align:\x20justify;\x22>This\x20is\x20a\x20case\x20of\x20<strong>fixed\x20drug\x20eruption\x20</strong>and\x20the\x20<strong>most\x20likely\x20cause</strong>\u00a0is<strong>\x20ibuprofen.</strong></p>\x0a<p\x20style=\x22text-align:\x20justify;\x22>Fixed\x20drug\x20eruptions\x20are\x20characterized\x20by\x20<strong>sharply\x20demarcated</strong>\x20<strong>dull\x20red</strong>\x20<strong>to\x20brown</strong>\x20lesions.\x20They\x20occur\x20in\x20lips,\x20hands,\x20legs,\x20face,\x20genitalia,\x20and\x20oral\x20mucosa,\x20and\x20cause\x20a\x20<strong>burning\x20sensation</strong>.\x20The\x20lesion\x20<strong>recurs</strong>\x20in\x20the\x20same\x20locations\x20upon\x20<strong>re-exposure</strong>\x20to\x20the\x20offending\x20drug.</p>\x0a<p\x20style=\x22text-align:\x20justify;\x22>Some\x20of\x20the\x20drugs\x20commonly\x20known\x20to\x20cause\x20fixed\x20drug\x20eruptions\x20are\x20Sulphonamides,\x20NSAIDs,\x20Analgesics,\x20and\x20Hypnotics.</p>\x0a<p\x20style=\x22text-align:\x20justify;\x22>Diagnosis\x20is\x20based\x20on\x20history\x20and\x20lesion\x20morphology.\x20<strong>Discontinuation\x20</strong>of\x20the\x20offending\x20drug\x20is\x20the\x20<strong>first\x20step</strong>\x20in\x20<strong>management</strong>.</p>\x0a<p\x20style=\x22text-align:\x20justify;\x22><strong>Phenytoin\x20</strong>and<strong>\x20carbamazepine</strong>\x20can\x20lead\x20to\u00a0Stevens-Johnson\u00a0syndrome\x20(<strong>SJS</strong>)/toxic\x20epidermal\x20necrolysis\x20(<strong>TEN</strong>)\x20and\x20drug\x20reaction\x20with\x20eosinophilia\x20and\x20systemic\x20symptoms\x20(<strong>DRESS\x20syndrome</strong>).<br\x20/><br\x20/></p>','<p>The\x20<strong>t<sub>1/2</sub></strong>\x20of\x20the\x20drug\x20would\x20be\x20<strong>140\x20minutes.</strong></p>\x0a<p>Plasma\x20half-life\x20(t<sub>1/2)</sub>\x20is\x20the\x20<strong>time</strong>\x20required\x20for\x20the\x20<strong>plasma\x20concentration</strong>\x20or\x20the\x20amount\x20of\x20a\x20drug\x20in\x20the\x20<strong>body</strong>\x20to\x20be\x20<strong>reduced</strong>\x20by\x20<strong>50%.</strong>\x20It\x20depends\x20on\x20its\u00a0<strong>clearance</strong>\u00a0and\u00a0<strong>volume</strong>\x20of\x20<strong>distribution.</strong>\u00a0</p>\x0a<table\x20style=\x22border-collapse:\x20collapse;\x20width:\x2013.9017%;\x22\x20border=\x221\x22>\x0a<tbody>\x0a<tr>\x0a<td\x20style=\x22width:\x20100%;\x22><strong>t<sub>1/2</sub>\x20=\x200.693\x20x\x20V<sub>d</sub>/CL</strong></td>\x0a</tr>\x0a</tbody>\x0a</table>\x0a<p>where,\u00a0</p>\x0a<ul>\x0a<li>V<sub>d</sub>\u00a0-\x20volume\x20of\x20distribution</li>\x0a<li>CL\x20-\x20clearance.</li>\x0a</ul>\x0a<p>In\x20the\x20given\x20question,\x20drug\x20clearance\x20(CL)\x20=\x200.2\x20L/min\x20and\x20Vd\x20=\x2040\x20L</p>\x0a<p>We\x20can\x20take\x200.693\x20approximately\x20as\x200.7</p>\x0a<p>Substituting,</p>\x0a<p>t<sub>1/2</sub>\x20=\x200.7\x20x\x2040\x20/0.2</p>\x0a<p>t<sub>1/2</sub>\x20=\x200.7\x20x\x20200</p>\x0a<p>t<sub>1/2</sub>\x20=\x20<strong>140\x20minutes</strong></p>\x0a<p>Clinical\x20implications:\x20Half-life\x20determines\x20the\x20duration\x20of\x20the\x20drug\x20effect.\x20It\x20also\x20indicates\x20whether\x20the\x20accumulation\x20of\x20the\x20drug\x20will\x20occur\x20under\x20multiple\x20dosage\x20regimens,\x20thereby\x20making\x20it\x20is\x20essential\x20to\x20decide\x20on\x20the\x20appropriate\x20dosing\x20interval.</p>','Constant\x20fraction\x20of\x20drug\x20is\x20eliminated\x20per\x20unit\x20time.','referrer','Meropenem','<p\x20class=\x22p1\x22><strong>Sargramostim&nbsp;</strong>is\x20a\x20<strong>recombinant\x20human\x20GM-CSF\x20</strong>(Granulocyte-macrophage\x20colony-stimulating\x20factor).</p>\x0a<p\x20class=\x22p1\x22>Indications\x20for\x20use:</p>\x0a<ul>\x0a<li>Autologous\x20<strong>bone\x20marrow\x20transplant</strong>&nbsp;<strong>-</strong>\x20reduces\x20the\x20duration\x20of\x20neutropenia</li>\x0a<li>Cancer\x20<strong>chemotherapy\x20-</strong>&nbsp;reduces\x20the\x20duration\x20of\x20neutropenia</li>\x0a<li>Peripheral\x20blood\x20<strong>stem\x20cell\x20collection\x20-</strong>&nbsp;to\x20mobilize\x20CD34\x20positive\x20progenitor\x20cells</li>\x0a</ul>\x0a<p\x20class=\x22p1\x22>It\x20is\x20administered\x20subcutaneously\x20or\x20by\x20slow\x20intravenous\x20infusion.&nbsp;</p>','questionText','\x22\x20alt=\x22Question\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>','vIgYh','button','correctCount','CCUUS','incorrectAnswers','Unfractionated\x20Heparin','Neutral\x20endopeptidase\x20inhibitor','kCUuA','<24\x20hours','GbSwX','The\x20inhibition\x20of\x20hydrochloric\x20acid\x20secretion\x20by\x20omeprazole\x20occurs\x20within\x20an\x20hour,\x20reaches\x20a\x20peak\x20at\x202\x20hours,\x20and\x20plateaus\x20by\x20the\x204th\x20day.\x20After\x20how\x20many\x20days\x20will\x20the\x20secretion\x20gradually\x20normalize\x20after\x20stopping\x20the\x20drug?','replace','custom_quiz.html','CYP3A4','<p>Generalized\x20urticaria,\x20swelling\x20of\x20lips,\x20hypotension,\x20and\x20bronchospasm\x20suggests\x20that\x20the\x20patient\x20is\x20developing\x20<strong>anaphylactic\x20shock.&nbsp;</strong><strong>Epinephrine\x20</strong>injection\x20administered<strong>\x20intramuscularly\x20</strong>is\x20the\x20preferred\x20choice\x20in\x20anaphylactic\x20shock.\x20Epinephrine\x20is\x20a&nbsp;<strong>powerful\x20bronchodilator</strong>&nbsp;and\x20it\x20is\x20a\x20<strong>potent\x20vasopressor</strong>.</p>\x0a<p>Antihistamines\x20have\x20only\x20an\x20adjuvant\x20role\x20in\x20anaphylactic\x20shock\x20and\x20are\x20not\x20routinely\x20used\x20in\x20emergency\x20cases.&nbsp;</p>','toggle','questionIndex','WJNBS','Esmolol','wgYbv','All\x20of\x20the\x20above','.m3u8','OoQCz','IworC','vPBDO','Months\x20–\x201\x20year','hyBCA','__proto__','jcDnl','SkROS','fIkom','Schedule\x20H','<p>The\x20absorption\x20of\x20iron\x20is\x20impeded\x20by\x20<strong>egg-based\x20</strong>foods.\x20They\x20contain\x20a\x20high\x20amount\x20of\x20<strong>phosphates</strong>\x20(egg\x20yolk)\x20that\x20<strong>form\x20complexes\x20with\x20iron</strong>\x20and\x20impede\x20absorption.</p>\x0a<p><strong>Heme-based\x20iron</strong>,\x20present\x20in\x20meat\x20products,\x20is\x20<strong>easily\x20absorbed</strong>\x20without\x20the\x20aid\x20of\x20a\x20carrier\x20and\x20is\x20not\x20much\x20affected\x20by\x20other\x20foods.\x20Inorganic\x20iron\x20is\x20affected\x20by\x20several\x20factors.</p>\x0a<p>Factors\x20<strong>increasing\x20</strong>iron\x20absorption\x20are:</p>\x0a<ul>\x0a<li><strong>Reducing\x20substances</strong>\x20such\x20as\x20ascorbic\x20acid\x20and\x20amino\x20acids\x20containing\x20&ndash;SH\x20groups&nbsp;-\x20reduce\x20ferric\x20iron\x20to\x20the\x20soluble\x20ferrous\x20form</li>\x0a<li><strong>Meat</strong>-based\x20foods\x20-\x20enhance\x20heme\x20absorption\x20and\x20increase\x20acid\x20secretion.</li>\x0a</ul>\x0a<p>Factors\x20<strong>decreasing\x20</strong>iron\x20absorption\x20are:</p>\x0a<ul>\x0a<li><strong>Phosphates</strong>,\x20phytates,\x20and\x20tetracyclines\x20-\x20by\x20forming\x20complexes</li>\x0a<li>Alkalies\x20-\x20prevents\x20the\x20reduction\x20of&nbsp;ferric\x20iron\x20to\x20the\x20soluble\x20ferrous\x20form</li>\x0a<li>Presence\x20of\x20other\x20food\x20in\x20the&nbsp;stomach\x20-\x20by\x20increasing\x20pH</li>\x0a</ul>','error','Warfarin','Reslizumab','gradient-yellow\x20px-6\x20py-3\x20text-white\x20transition-all\x20duration-300\x20flex\x20items-center','WZJCH','SGwZX','DgjVv','YlMnO','Mqegk','mydtI','<p>The\x20<strong>loading\x20dose</strong>\x20of\x20theophylline\x20in\x20this\x20patient\x20for\x20intravenous\x20administration\x20is\x20<strong>300mg.\u00a0</strong></p>\x0a<p>The\x20loading\x20dose\x20is\x20the\x20amount\x20or\x20dose\x20of\x20a\x20drug\x20given\x20to\x20achieve\x20target\x20plasma\x20concentration\x20quickly\x20when\x20the\x20treatment\x20requires\x20an\x20immediate\x20therapeutic\x20response.\x20It\x20is\x20usually\x20given\x20at\x20the\x20onset\x20of\x20therapy.</p>\x0a<p>Loading\x20Dose\x20is\x20given\x20by\x20the\x20formula:\u00a0</p>','Lapatinib','Chelators','MkDxo','FjCrA','feiqR','pop','fromCharCode','target','Apraclonidine','PMYnE','The\x20shortest\x20acting\x20calcium\x20channel\x20blocker\x20is\x20_______.','High\x20dose\x20corticosterone\x20tablet','src','3-4\x20days','<p><strong>Insulin\x20action\x20is\x20transmitted\x20through\x20a\x20receptor\x20tyrosine\x20kinase.&nbsp;</strong></p>\x0a<p>Insulin\x20receptors\x20have\x202\x20extracellular\x20alpha\x20subunits\x20and\x202\x20transmembrane\x20beta\x20subunits\x20having\x20intrinsic\x20tyrosine\x20kinase\x20activity.&nbsp;</p>\x0a<p>Alpha\x20subunits\x20inhibit\x20the\x20tyrosine\x20kinase\x20activity\x20of\x20beta\x20subunits;\x20on\x20the&nbsp;binding\x20of\x20insulin,\x20there\x20is\x20a\x20release\x20of\x20inhibition\x20by\x20alpha\x20subunits\x20and\x20downstream\x20signaling\x20continues.&nbsp;&nbsp;</p>','A\x20patient\x20is\x20undergoing\x20orthopedic\x20surgery.\x20Which\x20of\x20the\x20following\x20first-generation\x20cephalosporins\x20can\x20you\x20use\x20for\x20surgical\x20prophylaxis?','totalAttempted','AZvDZ','Drug\x20of\x20choice\x20for\x20hydatid\x20cyst\x20disease\x20is\x20____________.','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</button>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20','Mechanism\x20of\x20action\x20of\x20bromocriptine_____','href','<ul>\x0a<li>Clevidipine\x20is\x20a\x20novel\x20dihydropyridine\x20available\x20only\x20for\x20intravenous\x20administration.</li>\x0a<li>It\x20has\x20a\x20very\x20rapid\x20onset\x20of\x20action\x20(2&ndash;4\x20min)\x20and\x20<strong>a\x20very\x20short\x20half-life\x20(1&ndash;2\x20min).</strong></li>\x0a<li>It&nbsp;is\x20metabolized\x20by\x20esterases\x20in\x20blood.</li>\x0a<li>It\x20is\x20primarily\x20indicated\x20in\x20the\x20acute\x20management\x20of\x20hypertension.\x20&nbsp;</li>\x0a</ul>','The\x20risk\x20of\x20carbamazepine\x20induced\x20Steven\x20Johnson\x20syndrome\x20is\x20increased\x20in\x20the\x20presence\x20of\x20which\x20of\x20the\x20following\x20genes?','border-red-500','HLA-B\x201502','The\x20finding\x20shown\x20in\x20the\x20image\x20below\x20is\x20seen\x20as\x20a\x20side\x20effect\x20of\x20which\x20of\x20the\x20following\x20drugs?','htvag','<p>In\x20<strong>zero-order\x20kinetics,\x20</strong>the\x20<strong>rate\x20of\x20elimination\x20remains\x20constant,\x20irrespective\x20of\x20the\x20drug\x20concentration.</strong>\x20It\x20is\x20capacity-limited\x20elimination\x20and\x20only\x20a\x20constant\x20amount\x20of\x20drug\x20is\x20eliminated\x20per\x20unit\x20time.</p>\x0a<p>Examples\x20of\x20drugs\x20eliminated\x20by\x20zero-order\x20kinetics\x20include\x20(<strong>WATT\x20Power</strong>)</p>\x0a<ul>\x0a<li\x20style=\x22list-style-type:\x20none;\x22>\x0a<ul>\x0a<li><strong>W</strong>arfarin</li>\x0a<li><strong>A</strong>lcohol,&nbsp;<strong>A</strong>spirin</li>\x0a<li><strong>T</strong>olbutamide</li>\x0a<li><strong>T</strong>heophylline&nbsp;</li>\x0a<li><strong>P</strong>henytoin</li>\x0a</ul>\x0a</li>\x0a</ul>\x0a<p>The\x20constant\x20fraction\x20of\x20the\x20drug\x20is\x20eliminated\x20per\x20unit\x20time\x20occurs\x20in\x20first-order\x20kinetics\x20(Option\x20B).</p>\x0a<p>The\x20fraction\x20of\x20administered\x20drug\x20reaching\x20the\x20systemic\x20circulation\x20is\x20the\x20bioavailability\x20of\x20the\x20drug\x20(Option\x20C).</p>\x0a<p>The\x20time\x20required\x20for\x20the\x20reduction\x20of\x20drug\x20concentration\x20to\x20half\x20of\x20its\x20initial\x20value\x20is\x20the\x20half-life\x20of\x20the\x20drug\x20(Option\x20D).</p>','mWdjZ','https://cdn1.dailyrounds.org/uploads/99b112fb42c241358b7fcf4110b4e9a9.JPEG','bLSMz','stringify','notAttempted','loYPq','<p><strong>Aripiprazole</strong>\x20is\x20an\x20atypical\x20antipsychotic&nbsp;showing&nbsp;<strong>D<sub>2\x20</sub>partial\x20agonism</strong>.\x20It\x20has\x20a\x20higher\x20affinity\x20for\x20D<sub>2</sub>\x20receptors\x20than\x20for\x205HT2A\x20receptors.</p>\x0a<p>As\x20a\x20partial\x20agonist,\x20aripiprazole\x20has\x20a\x20<strong>dual-action</strong>\x20which\x20makes\x20it\x20<strong>useful</strong>\x20in\x20patients\x20with\x20<strong>both\x20positive\x20and\x20negative</strong>\x20<strong>symptoms</strong>\x20of\x20schizophrenia.</p>\x0a<p>Options\x20A\x20&amp;\x20D:\x20Clozapine\x20and\x20risperidone\x20are\x20atypical\x20antipsychotics\x20with\x20predominant\x205HT<sub>2A</sub>\x20antagonistic\x20activity\x20over\x20D<sub>2</sub>\x20antagonism.&nbsp;</p>\x0a<p>Option\x20B:\x20Fluphenazine\x20is\x20a<strong>\x20typical</strong>\x20<strong>antipsychotic</strong>.\x20They\x20have\x20predominant&nbsp;D<sub>2</sub>\x20antagonism\x20property\x20and\x20such\x20action\x20on\x20the\x20mesocortical\x20pathway\x20may\x20<strong>increase</strong>\x20the\x20<strong>negative\x20symptoms</strong>\x20of\x20schizophrenia.</p>','Which\x20of\x20the\x20following\x20shows\x20a\x20U-shaped\x20dose-response\x20curve?','Atezolizumab','<p><strong>Bezlotoxumab\x20is\x20a\x20monoclonal\x20antibody\x20against\x20<em>Clostridium\x20difficile</em>\x20toxin\x20B\x20that\x20neutralizes\x20the\x20toxin\x20after\x20binding\x20it.</strong></p>\x0a<p>It\x20is\x20indicated\x20for\x20reducing\x20recurrence\x20of\x20<em>C.\x20difficile</em>\x20infections\x20in\x20high-risk\x20patients.</p>','markReviewText','keydown','Panitumumab','Third\x20cranial\x20nerve','DELmB','yMtGZ','classList','PnZWx','https://dhmbxeygs57ff.cloudfront.net/uploads/2daab0c99dbc4a309b3638916161d3dbx1280x361.JPEG','<p><strong>Phase\x20III\x20trial,&nbsp;</strong>also\x20called\x20a\x20multisite\x20trial,\x20is\x20done\x20for\x203&ndash;5\x20years.</p>\x0a<p>When\x20the\x20initial\x20Phase\x20III\x20trials\x20are\x20complete,\x20the\x20sponsor\x20(usually\x20a\x20pharmaceutical\x20company)\x20applies\x20to\x20the\x20FDA\x20for\x20approval\x20to\x20market\x20the\x20drug.\x20This\x20application\x20is\x20called\x20either\x20a\x20New\x20Drug\x20Application\x20(NDA)\x20or\x20a\x20Biologics\x20License\x20Application\x20(BLA).</p>','Oral\x20voriconazole','nav-btn-bookmarked','Replace\x20warfarin\x20with\x20acenocoumarin','Ximelgatran','location','mfAvG','No\x20questions\x20available\x20for\x20this\x20quiz.','eRhox','Agonist\x20at\x20D2\x20receptor','HDUwr','Lipoxygenase','Marrow','<p><strong>Vitamins</strong>\u00a0and\x20<strong>essential\x20metals</strong>\x20show\x20a\x20<strong>U-shaped\x20dose-response\x20curve</strong>.</p>\x0a<div\x20class=\x22page\x22\x20title=\x22Page\x2074\x22>\x0a<div\x20class=\x22section\x22>\x0a<div\x20class=\x22layoutArea\x22>\x0a<div\x20class=\x22column\x22>\x0a<p>At\x20a\u00a0<strong>low\x20dose,</strong>\x20adverse\x20effects\x20are\x20observed\x20because\x20there\x20is\x20a\x20<strong>deficiency</strong>\x20of\x20these\x20nutrients\x20to\x20maintain\x20homeostasis.\x20As\x20<strong>dose\x20increases,\x20homeostasis</strong>\x20is\x20achieved,\x20and\x20the\x20bottom\x20of\x20the\x20U-shaped\x20dose-response\x20curve\x20is\x20reached.\x20As\x20the\x20<strong>dose\x20increases</strong>\x20to\x20surpass\x20the\x20amount\x20required\x20to\x20maintain\x20homeostasis,\x20<strong>toxicity</strong>\x20can\x20ensue.</p>\x0a<p>Thus,\x20<strong>adverse\x20effects</strong>\x20are\x20seen\x20at\x20both\x20<strong>low</strong>\x20and<strong>\x20high\x20doses.\u00a0</strong></p>\x0a</div>\x0a</div>\x0a</div>\x0a</div>','uwDTu','currentQuestionIndex','DbfCn','YVClI','3-5\x20years','>20\x20mcg/kg/min','KVzfK','nrbKz','</span></div>','strokeDasharray','Sympathetic\x20fibers\x20of\x20the\x20fronto-orbital\x20branch\x20of\x20the\x20trigeminal\x20nerve','question_video','fmUlJ','<p>The\x20anticoagulant\x20of\x20choice\x20for\x20the\x20management\x20of<strong>\x20cancer-associated\x20thromboembolism</strong>\x20is\x20<strong>l</strong><strong>ow-molecular-weight\x20heparin\x20</strong>(LMWH).</p>\x0a<p>It\x20is\x20the\x20preferred\x20agent\x20because\x20of\x20more\x20bioavailability,\x20lack\x20of\x20need\x20for\x20anticoagulant\x20monitoring,\x20and\x20a\x20long\x20t1/2.&nbsp;</p>\x0a<p>Venous\x20thromboembolism\x20(including\x20deep\x20vein\x20thrombosis,\x20pulmonary\x20embolism,\x20and\x20splanchnic\x20vein\x20thrombosis),\x20is\x20a\x20frequent\x20complication\x20of\x20cancer\x20and\x20is\x20the\x20second-leading\x20cause\x20of\x20death\x20in\x20cancer\x20patients\x20receiving\x20chemotherapy.</p>\x0a<p>Based\x20on\x20the\x20results\x20from\x20the&nbsp;<strong>C</strong>omparison\x20of\x20<strong>L</strong>ow-molecular-weight&nbsp;heparin\x20vs.&nbsp;<strong>O</strong>ral\x20anticoagulants\x20for\x20long-term\x20anticoagulation\x20in\x20cancer\x20patients\x20with\x20venous\x20<strong>T</strong>hromboembolism\x20(<strong>CLOT</strong>)\x20Trial,\x20all\x20recent\x20guidelines\x20now\x20advise\x20LMWH\x20for\x20cancer-associated\x20thromboembolism.&nbsp;</p>\x0a<p>However,\x20unfractionated\x20heparin\x20<strong>(UFH)</strong>\x20can\x20be\x20used\x20in\x20patients\x20with\x20<strong>renal\x20failure</strong>,\x20and\x20<strong>fondaparinux</strong>\x20can\x20be\x20considered\x20in\x20patients\x20with\x20heparin-induced\x20thrombocytopenia\x20(<strong>HIT</strong>).</p>','AYvwQ','lvkEy','Sulfonylureas','pONLu','aZiBs','SNsCH','Uncal\x20herniation','A\x20diabetic\x20female\x20patient\x20on\x20isoniazid\x20and\x20rifampicin\x20for\x20tuberculosis\x20developed\x20deep\x20vein\x20thrombosis.\x20She\x20was\x20started\x20on\x20warfarin,\x20but\x20there\x20was\x20no\x20elevation\x20in\x20prothrombin\x20time.\x20The\x20next\x20step\x20should\x20be?','totalQuestionsResult','eGGsO','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>','A\x20patient\x20with\x20a\x20history\x20of\x20mania,\x20on\x20lithium\x20therapy,\x20is\x20brought\x20with\x20complaints\x20of\x20vomiting\x20and\x20multiple\x20episodes\x20of\x20diarrhea.\x20On\x20examination,\x20coarse\x20tremors\x20and\x20an\x20ataxic\x20gait\x20are\x20noted.\x20What\x20is\x20the\x20expected\x20level\x20of\x20serum\x20lithium\x20in\x20this\x20patient?','DJmpA','forEach','status','gradient-purple\x20px-6\x20py-3\x20text-white\x20transition-all\x20duration-300\x20flex\x20items-center','timed_exam','findIndex','Palbociclib','jBqqi','hBpqm','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22bg-green-900\x20bg-opacity-20\x20p-4\x20rounded-lg\x20border\x20border-green-700\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<h5\x20class=\x22text-green-400\x20font-bold\x20mb-2\x22>Explanation:</h5>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22text-white\x20text-opacity-90\x22>','LcQbq','Penicillin','navBtn_','performanceModal','console','Doxycycline','rraWO','userHistory','\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20','Option\x20','What\x20is\x20the\x20most\x20probable\x20diagnosis\x20in\x20a\x20patient\x20with\x20a\x20dilated\x20pupil\x20not\x20responsive\x20to\x201%\x20pilocarpine?','https://dhmbxeygs57ff.cloudfront.net/uploads/6538f64b996042a2988f62f01335e095x1268x324.JPEG','Adalimumab','UxzDw','<ul>\x0a<li>Glucocorticoids\x20preferentially\x20affect\x20trabecular\x20bone\x20and\x20the\x20cortical\x20rim\x20of\x20vertebral\x20bones.</li>\x0a<li><strong>Ribs\x20and\x20vertebra\x20are\x20the\x20most\x20frequent\x20sites</strong>\x20of\x20fracture\x20with\x20glucocorticoids-induced\x20osteoporosis.</li>\x0a</ul>','OTMeX','dnJFS','Carbamazepine','ShQYw','wwAwz','KVVwl','reviewQuestionsContainer','Which\x20of\x20the\x20following\x20antiglaucoma\x20drug\x20is\x20unsafe\x20in\x20infants\x20?','hierarchy','NsPXw','Indomethacin','Digitalis\x20purpurea','reduce','Itsaw','Potassium\x20binder','fDNNW','Timolol','textContent','Aspirin','bookmarkBtn','Cefadroxil','accuracy','glass-light\x20px-6\x20py-3\x20text-white\x20hover:bg-yellow-500\x20hover:bg-opacity-20\x20transition-all\x20duration-300\x20flex\x20items-center','remove','question_images','BkPDf','<p>Mechanism\x20of\x20action\x20of\x20metoclopramide\x20does\x20not\x20include&nbsp;5HT4\x20antagonism.</p>\x0a<p>Metoclopramide\x20includes\x20the\x20following\x20action:</p>\x0a<ul>\x0a<li>5HT4\x20receptor\x20agonism</li>\x0a<li>5HT3\x20receptor\x20antagonism</li>\x0a<li>D2\x20antagonism</li>\x0a<li>Sensitization\x20of\x20muscarinic\x20receptors\x20on\x20smooth\x20muscles</li>\x0a</ul>','Anti-cancer\x20drugs','tncsH','bJwXX','4782844BmAcqq','Which\x20of\x20the\x20following\x20does\x20not\x20increase\x20the\x20risk\x20of\x20digoxin\x20toxicity?','KLCwT','\x20-\x20Brain\x20And\x20Scalpel','PKbVZ','Bookmarked','zsyDJ','QmRdw','kTQFZ','Acetaminophen','fvweS','ysZOL','jqkvc','Phase\x20III','Hypoglycemia','markReviewBtn','A\x20patient\x20having\x20both\x20positive\x20and\x20negative\x20symptoms\x20of\x20schizophrenia\x20was\x20prescribed\x20an\x20atypical\x20antipsychotic\x20with\x20partial\x20D2\x20agonism.\x20Identify\x20the\x20drug.','green','FUUdA','Low\x20molecular\x20weight\x20heparin','Isoniazid','solutionText','Nystatin\x203.5%','RbLSX','lqxXh','WsYnF','floor','apply','1-2\x20days','24\x20hours','Ibuprofen','qJXat','preventDefault','style','Zero-order\x20kinetics\x20means____.','5-10\x20mcg/kg/min','\x22\x20alt=\x22Explanation\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>','\x22>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22option-letter\x22>','Mebendazole','Metronidazole','Imatinib','RsHzt','1-3\x20years','Lubiprostone','Cytarabine','nKTho','<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><video\x20src=\x22','Etoricoxib','240\x20min','CYP2D6','Chlorpheniramine\x20injection','Thiazolidinediones','GgqAn','<div\x20class=\x22p-3\x20rounded-lg\x20border\x20','GDxVt','Sildenafil','\x20>\x20','BTxqW','Xuaat','A\x20neurology\x20resident\x20changed\x20the\x20current\x20oral\x20medication\x20of\x20a\x20patient\x20with\x20Alzheimer\x27s\x20disease\x20to\x20a\x20transdermal\x20patch\x20of\x20a\x20cholinesterase\x20inhibitor.\x20What\x20must\x20be\x20the\x20new\x20drug\x20that\x20was\x20prescribed?','title','cDdJt','VxUPt','<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><img\x20src=\x22','You\x20read\x20a\x20news\x20alert\x20that\x20mentions\x20a\x20novel\x20drug\x20has\x20received\x20marketing\x20approval\x20for\x20diabetes\x20mellitus\x20and\x20that\x20it\x20has\x20shown\x20positive\x20results\x20in\x20a\x20pivotal\x20trial.\x20The\x20trial\x20it\x20passed\x20corresponds\x20to\x20which\x20phase\x20of\x20clinical\x20trials?','Albendazole','Xiuim','Atropa\x20belladonna','lbqNC','isSupported','Fibula','jbbyi','<p><strong>Albendazole\x20is\x20the\x20drug\x20of\x20choice\x20for\x20hydatid\x20cyst\x20disease\x20due\x20to\x20Echinococcus\x20granulosus.</strong></p>','Felodipine','</span>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22text-white\x20mb-4\x22>','hUsoW','appendChild','Therapeutic\x20window','removeItem','<p>The\x20given\x20scenario\x20is\x20suggestive\x20of\x20<strong>invasive\x20mucormycosis\x20</strong>in\x20the\x20form\x20of<strong>\x20orbital\x20cellulitis.\x20Intravenous\x20</strong>administration\x20of<strong>\x20amphotericin\x20B\x20</strong>is\x20the\x20<strong>treatment\x20of\x20choice\x20</strong>for\x20invasive\x20mucormycosis<strong>.</strong></p>\x0a<p>Mucormycosis&nbsp;is\x20an\x20<strong>opportunistic\x20infection</strong>&nbsp;seen\x20in\x20patients\x20with\x20diabetes\x20mellitus,\x20leukaemia,\x20lymphoma\x20and\x20other\x20immunocompromised\x20states.\x20The\x20most\x20prevalent\x20species\x20is<em>\x20Rhizopus\x20Oryza.</em>&nbsp;</p>','111496gGBqSP','KBcjb','QJXcn','isArray','Vitamins','OZmSc','Beta\x20subunit','querySelectorAll','Dabigatran','flex','Insulin\x20receptors\x20belong\x20to\x20the\x20following\x20type\x20of\x20receptor','attachMedia','KkXEa','btowo','vBsnI','Diclofenac','pathname','All','not_attempted','Ciprofloxacin','golWM','(((.+)+)+)+$','lRoRd','KPvcH','Progress\x20loaded.','SfXeS','block','explanation_audio_eng','notAttemptedResult','startAt','Hyperkalemia','BCBxX','Valinomycin','prototype','SGLT-2\x20inhibitors','5HT4\x20agonism','<p><strong>Sacubitril</strong>\x20is\x20a\x20neutral\x20endopeptidase\x20<strong>(neprilysin)\x20inhibitor.</strong></p>\x0a<p>Sacubitril\x20is\x20a\x20prodrug\x20that\x20is\x20activated\x20to\x20<strong>sacubitrilat.</strong>\x20It\x20can\x20inhibit\x20the\x20enzyme\x20neprilysin\x20(neutral\x20endopeptidase),&nbsp;which\x20is\x20responsible\x20for\x20the\x20degradation\x20of\x20atrial\x20and\x20brain\x20natriuretic\x20peptides\x20(reduction\x20of\x20blood\x20volume).\x20Therefore,\x20it\x20<strong>increases</strong>\x20the\x20levels\x20of\x20<strong>atrial\x20and\x20brain\x20natriuretic\x20peptides</strong>\x20and\x20<strong>lowers\x20blood\x20pressure.</strong></p>\x0a<div>In\x202015,\x20the\x20FDA\x20approved\x20the\x20use\x20of\x20sacubitril\x20in\x20<strong>combination</strong>\x20with<strong>\x20valsartan</strong>,\x20at\x20a\x20ratio\x20of\x20<strong>1:1</strong>,&nbsp;for\x20the\x20treatment\x20of\x20chronic\x20heart\x20failure.</div>','cONJc','Rivastigmine','currentMode','Pertuzumab','MpgMy','Atezolimumab','pharmacology-test-i-acbfe926.html','sJlzr','Schedule\x20\x20D','Risperidone','jOVuA','Lepirudin','Nifedipine','includes','<p>The\x20action\x20of\x20the\x20above-mentioned\x20drug\x20can\x20be\x20explained\x20by\x20the\x20action\x20of\x20&beta;<sub>1</sub>&nbsp;+\x20&beta;<sub>2</sub><sub>&nbsp;</sub>agonists.</p>\x0a<p>The\x20parameters\x20of\x20the\x20new\x20drug\x20when\x20compared\x20to\x20placebo\x20are:</p>\x0a<ul>\x0a<li>Increase\x20in\x20heart\x20rate</li>\x0a<li>Increase\x20in\x20systolic\x20blood\x20pressure&nbsp;</li>\x0a<li>Decrease\x20in\x20diastolic\x20blood\x20pressure&nbsp;&nbsp;</li>\x0a<li>Increase\x20in\x20cardiac\x20output</li>\x0a</ul>\x0a<p>All\x20the\x20parameters\x20of\x20the\x20new\x20drug\x20are\x20compatible\x20with\x20<strong>isoproterenol</strong>\x20which\x20is\x20a\x20<strong>&beta;<sub>1</sub>&nbsp;+\x20&beta;<sub>2</sub>\x20agonist</strong>.\x20Therefore,\x20&beta;<sub>1</sub>&nbsp;+\x20&beta;<sub>2</sub>\x20agonism\x20is\x20the\x20most\x20appropriate\x20answer.&nbsp;</p>\x0a<p>Options\x20A\x20and\x20B\x20-\x20Heart\x20rate\x20is\x20increasing\x20with\x20the\x20drug\x20whereas\x20<strong>M<sub>2</sub>\x20agonism</strong>\x20would\x20result\x20in\x20a&nbsp;<strong>decrease\x20in\x20the\x20heart\x20rate</strong>.&nbsp;</p>\x0a<p>Option\x20D\x20-\x20DBP\x20is\x20decreasing\x20with\x20the\x20drug\x20whereas\x20<strong>&alpha;<sub>1</sub>\x20agonism</strong>\x20would\x20cause\x20an&nbsp;<strong>increase\x20in\x20DBP</strong>.</p>','https://cdn1.dailyrounds.org/uploads/05e0376fc11340daa9d74b749ff969d7.PNG','dsFZb','mcgpQ','Phase\x20IV','oLeaY','A\x20patient\x20of\x20chronic\x20low\x20back\x20pain\x20has\x20presented\x20to\x20your\x20OPD\x20with\x20deranged\x20LFT\x20reports.\x20He\x20tells\x20you\x20he\x20has\x20been\x20on\x20long\x20term\x20treatment\x20with\x20a\x20painkiller\x20for\x20his\x20condition.\x20Which\x20NSAID\x20has\x20he\x20most\x20likely\x20been\x20taking?','review-question\x20','QPvMx','Trastuzumab','<p>The\x20secretion\x20resumes\x20normally\x20in\x20<strong>3-4\x20days\x20of\x20stopping</strong>\x20the\x20drug\x20when\x20<strong>new\x20proton\x20pumps\x20are\x20synthesized</strong>.</p>\x0a<p>Omeprazole\x20after\x20absorption\x20enters\x20into\x20the\x20systemic\x20circulation,\x20after\x20which\x20it\x20diffuses\x20into\x20the\x20parietal\x20cells\x20and\x20accumulates\x20in\x20the\x20acidic\x20canaliculi.</p>\x0a<p>Inside\x20canaliculi,\x20it\x20is\x20activated\x20by\x20proton\x20catalyzed\x20the\x20formation\x20of\x20a\x20tetracyclic\x20sulfenamide\x20that\x20irreversibly\x20inhibits\x20H+/K+\x20ATPase.</p>\x0a<p>Inhibition\x20of\x20HCl\x20secretion\x20occurs\x20within\x201\x20hour\x20and\x20reaches\x20a\x20maximum\x20at\x202\x20hrs.</p>\x0a<p>The\x20inhibition\x20gradually\x20increases\x20over\x20daily\x20dosing\x20and\x20reaches\x20a\x20plateau\x20after\x204\x20days\x20(80-98%\x20inhibition).</p>\x0a<p>The\x20secretion\x20resumes\x20gradually\x20over\x203-4\x20days\x20of\x20stopping\x20the\x20drug\x20when\x20new\x20proton\x20pumps\x20are\x20synthesized<strong>.</strong></p>','selectedAnswer','btTDo','optionsContainer','submitSection','hMInX','18\x20hours','A\x20patient\x20diagnosed\x20with\x20Churg-Strauss\x20syndrome\x20is\x20started\x20on\x20Mepolizumab.\x20This\x20drug\x20acts\x20against:','HqEwb','GOmRI','140\x20min','Schedule\x20Y','5TozxlJ','IpArg','ILMEP','kjTYc','GIXFr','FofBR','toString','tvqVy','table','BzzXm','Postganglionic\x20sympathetic\x20from\x20cervical\x20sympathetic\x20chain','TiTxg','cJyNo','currentQuestion','foDYq','Tacrine','Constant\x20amount\x20of\x20drug\x20is\x20eliminated\x20per\x20unit\x20time.','0.5-2\x20mcg/kg/min','jdkXv','Treatment\x20of\x20withdrawal','xRLHz','Treatment\x20of\x20overdose','lXokU','constructor','Iulgm','round','DVbmq','PXFQt','WKrNW','hidden','OuGZB','bind','<p><strong>Vedolizumab</strong>\x20is\x20a\x20humanized\x20<strong>anti-alpha-4-beta-7&nbsp;integrin</strong>\x20<strong>monoclonal\x20antibody</strong>&nbsp;that\x20prevents\x20lymphocyte\x20recruitment\x20to\x20the\x20intestinal\x20mucosa.</p>\x0a<p>It\x20is\x20approved\x20for\x20use\x20in\x20moderate-severe\x20<strong>Crohn\x27s</strong>\x20disease\x20and\x20<strong>ulcerative</strong>\x20colitis.</p>\x0a<p><strong>Anti-TNF\x20alpha</strong>\x20monoclonal\x20antibodies\x20indicated\x20in\x20IBD\x20are:&nbsp;</p>\x0a<ul>\x0a<li>Infliximab</li>\x0a<li>Adalimumab</li>\x0a<li>Certolizumab\x20pegol</li>\x0a</ul>','<p><strong>Nebivolol</strong>\x20is\x20a\x20cardioselective\x20beta-blocker\x20with\x20additional\x20<strong>antioxidant</strong>\x20property.</p>\x0a<p><strong>Nebivolol:</strong></p>\x0a<ul>\x0a<li>Nebivolol\x20is\x20a\x20third-generation,\x20long-acting,\x20and\x20highly\x20selective\x20β1\x20adrenergic\x20receptor\x20antagonist</li>\x0a<li>It\x20stimulates\x20NO-mediated\x20vasodilation\x20via\x20β3\x20receptor\x20agonism</li>\x0a<li>Nebivolol\x20is\x20approved\x20for\x20the\x20treatment\x20of\x20hypertension</li>\x0a<li>It\x20has\x20potential\x20utility\x20in\x20the\x20treatment\x20of\x20heart\x20failure\x20with\x20reduced\x20ejection\x20fraction</li>\x0a<li>Nebivolol\x20reduces\x20<strong>oxidative\x20stress</strong>\x20and\x20may\x20have\x20favorable\x20effects\x20on\x20both\x20carbohydrate\x20and\x20lipid\x20metabolism</li>\x0a<li>This\x20can\x20be\x20used\x20in\x20<strong>metabolic\x20syndrome.</strong></li>\x0a</ul>','toLowerCase','Erlotinib','correct_choice_id','hwaSZ','Cefepime','https://dhmbxeygs57ff.cloudfront.net/uploads/86e4d0d5598943c3b1b9608e6621be8dx1279x1740.JPEG','toISOString','bIhLy','Renal\x20dose\x20of\x20dopamine\x20is\x20__________.','Vxqtz','addEventListener','video[data-src]','Absorption\x20of\x20iron\x20is\x20impeded\x20by\x20which\x20of\x20the\x20following?','Fusion\x20protein\x20of\x20IL-2\x20and\x20diptheria\x20toxin','Cilastatin\x20is\x20administered\x20to\x20prolong\x20the\x20action\x20of\x20_____.','EQVeN','quizPerformanceData','https://dhmbxeygs57ff.cloudfront.net/uploads/e88c3818bfea430391c09404932d7402x1280x2234.JPEG','Mechanism\x20of\x20action\x20of\x20metoclopramide\x20does\x20not\x20include\x20______.','eHIjM','vfhUd','Bezlotoxumab','XrrCt','-600\x20text-white\x22>','<p\x20style=\x22text-align:\x20justify;\x22><strong>Diclofenac</strong>\x20is\x20the\x20NSAID\x20that\x20has\x20the\x20<strong>highest\x20risk</strong>\x20of\x20<strong>hepatotoxicity</strong>\x20within\x20the\x20<strong>therapeutic\x20dose</strong>.</p>\x0a<p\x20style=\x22text-align:\x20justify;\x22>Liver\x20injury\x20occurs\x20in\x20acetaminophen\x20overdose\x20but\x20it\x20is\x20extremely\x20rare\x20in\x20therapeutic\x20dose.\x20NSAIDs\x20are\x20not\x20recommended\x20in\x20advanced\x20hepatic\x20and\x20renal\x20failure.&nbsp;</p>','Bleomycin','Iloprost','Increase\x20the\x20dose\x20of\x20warfarin','correct','G-CSF','wtDWZ','markedForReview','PaEXT','YoPwe','znKIn','Eluxadoline','exception','adOrb','kQDGL','https://cdn1.dailyrounds.org/uploads/a55588364afa413da3c7cb8df6bfc3f5.JPEG','Ascorbic\x20acid','Cbqew','kOlmi','Year\x202019\x20-\x2020','innerHTML','testModeReviewLegend','15-20\x20mcg/kg/min','<p><strong>Aminoglycosides&nbsp;</strong>has\x20to\x20be\x20avoided\x20in\x20a\x20patient\x20with\x20myasthenia\x20gravis<strong>.\x20</strong>It<strong>\x20blocks\x20Ca<sup>2+</sup>&nbsp;mediated\x20exocytosis\x20of\x20acetylcholine\x20</strong>from\x20the\x20presynaptic\x20membrane\x20in\x20the\x20neuromuscular\x20junction.<strong>&nbsp;</strong>The\x20<strong>decrease\x20in\x20ACh</strong>\x20levels\x20<strong>aggravates\x20myasthenia\x20gravis</strong>.&nbsp;</p>\x0a<p>Aminoglycosides\x20can\x20also\x20have\x20a\x20direct\x20inhibitory\x20effect\x20on\x20post-synaptic\x20acetylcholine\x20receptors.&nbsp;</p>\x0a<p>Drugs\x20that\x20may\x20aggravate\x20myasthenia\x20gravis\x20are</p>\x0a<ul>\x0a<li>Antibiotics\x20like\x20aminoglycosides,\x20quinolones,\x20and\x20macrolides</li>\x0a<li>Beta-blockers</li>\x0a<li>Botulinum\x20toxin</li>\x0a<li>Local\x20anesthetics</li>\x0a<li>Magnesium</li>\x0a<li>Non&ndash;depolarising\x20muscle\x20relaxants</li>\x0a<li>Penicillamine</li>\x0a<li>Quinine\x20derivatives</li>\x0a</ul>','<p>Cevimeline\x20is\x20a\x20<strong>muscarinic\x20agonist</strong>\x20with\x20affinity\x20for\x20both\x20<strong>M1</strong>\x20and<strong>&nbsp;M3\x20</strong>receptors\x20on\x20the&nbsp;lacrimal\x20and\x20salivary\x20glands.</p>\x0a<p>While\x20<strong>M1\x20activation\x20results\x20in\x20increased\x20secretion</strong>,\x20<strong>M3\x20activation\x20results\x20in\x20smooth\x20muscle\x20contraction</strong>\x20and\x20expulsion\x20of\x20the\x20secretions.</p>\x0a<p>Cevimeline\x20has\x20a\x20long-lasting\x20sialogogic\x20action\x20and\x20may\x20have\x20fewer\x20side\x20effects\x20than\x20pilocarpine.</p>\x0a<p>Cevimeline\x20enhances\x20lacrimal\x20secretions\x20in\x20<strong>Sjögren&rsquo;s\x20syndrome</strong>.\x20The\x20usual\x20dose\x20is\x20<strong>30\x20mg\x20three\x20times\x20daily</strong>.</p>','hrhjq','ZRKYn','12\x20hours','quizFile','completed','questions','explanation_video','bookmarkedQuestions','<p>The\x20image\x20shows\x20<strong>diabetic\x20macular\x20edema</strong>,\x20with\x20hard\x20exudates\x20surrounding\x20the\x20blood\x20vessels.&nbsp;It\x20is\x20a\x20rare\x20adverse\x20effect\x20seen\x20with\x20<strong>thiazolidinediones,</strong>\x20and\x20it\x20resolves\x20when\x20the\x20drug\x20is\x20discontinued.&nbsp;</p>','Aminoglycosides','Ethambutol','https://dhmbxeygs57ff.cloudfront.net/uploads/cbb79628483a49e5bce96265d68a0673x1280x1154.JPEG','VlwjD','true','fshiD','https://dhmbxeygs57ff.cloudfront.net/uploads/96d841174b9242b68b356f47e9dce071x800x794.PNG','qhOXS','fMaYV','accuracyScore','Netarsudil','nyqCM','The\x20drug\x20cevimeline\x20acts\x20on\x20which\x20receptor\x20for\x20the\x20expulsion\x20of\x20the\x20secretions\x20from\x20the\x20salivary\x20gland?','<p><strong>Doxycycline</strong>\x20is\x20the\x20drug\x20of\x20choice\x20for\x20<strong>scrub\x20typhus.</strong></p>\x0a<p>Azithromycin,\x20chloramphenicol,\x20or\x20rifampin\x20can\x20be\x20administered\x20as\x20alternatives\x20in\x20patients\x20allergic\x20to\x20doxycycline\x20and\x20in\x20pregnancy.&nbsp;</p>','LiVku','Latanoprost','avgTimeResult','bFRfS','cykZS','nav-btn-current','CFZfc','Filgrastim','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>Hinglish\x20Explanation:</p><audio\x20src=\x22','SHHAA','QExJf','https://cdn1.dailyrounds.org/uploads/20bee22a7c7d4df1b8fc065782163abd.JPEG','DPP-4\x20inhibtors','solutionVideo','Omalizumab\x20is\x20administered\x20in\x20bronchial\x20asthma\x20by\x20which\x20route?','The\x20schedule\x20that\x20deals\x20with\x20prescription\x20drugs\x20under\x20the\x20Drugs\x20and\x20Cosmetics\x20Act\x20is\x20______.','bKZHs','Cyclooxygenase\x202','Ceftazidime','gbFGo','Alosetron','Receptor\x20tyrosine\x20kinase','Should\x20be\x20discontinued\x20if\x20the\x20neutrophil\x20count\x20is\x20below\x20500/microL','Tibia','Both\x20a\x20and\x20b','text','\x22><span\x20class=\x22font-bold\x20mr-3\x22>','No\x20solution\x20provided','9796374cIdEBs','<p>Bromocriptine\x20is\x20an\x20ergot\x20derivative.\x20<strong>Most\x20of\x20its\x20action\x20is\x20due\x20to\x20agonist\x20activity\x20at\x20D2\x20receptors.</strong>\x20It\x20also\x20behaves\x20as\x20the\x20partial\x20agonist\x20or\x20as\x20an\x20antagonist\x20of\x20D1\x20receptor\x20only\x20in\x20certain\x20places\x20of\x20the\x20brain.</p>\x0a<p><strong>Bromocriptine\x20acts\x20as\x20a\x20sympatholytic\x20dopamine\x20agonist\x20and\x20improves\x20glycemic\x20control</strong></p>','1,\x203\x20and\x205\x20only','A\x2030-year-old\x20male\x20on\x20multiple\x20drugs\x20presents\x20with\x20a\x20round\x20macule\x20on\x20his\x20right\x20leg\x20for\x20the\x20last\x207\x20days.\x20The\x20patient\x20gives\x20a\x20history\x20of\x20similar\x20episodes\x20in\x20the\x20past\x20which\x20resolved\x20spontaneously.\x20Which\x20of\x20the\x20following\x20drugs\x20is\x20the\x20most\x20likely\x20cause?','parse','Are\x20you\x20sure\x20you\x20want\x20to\x20submit\x20the\x20quiz?','Sacubitril\x20is\x20a\x20new\x20drug\x20approved\x20for\x20chronic\x20heart\x20failure.\x20The\x20mechanism\x20of\x20action\x20of\x20sacubitril\x20is:','IL-5','Previous\x20progress\x20cleared.','<p><strong>Reslizumab</strong>\x20is\x20a\x20monoclonal\x20antibody\x20<strong>against\x20interleukin-5</strong>\x20that\x20is\x20approved\x20for\x20use\x20in\x20<strong>severe</strong>&nbsp;<strong>asthma.</strong></p>\x0a<p>Option\x20A\x20&amp;\x20B:\x20Omalizumab\x20is\x20an\x20anti-IgE\x20antibody\x20and\x20lebrikizumab\x20is\x20an\x20antibody\x20against\x20interleukin\x2013,\x20which\x20are\x20also\x20indicated\x20in\x20the\x20management\x20of\x20asthma.</p>\x0a<p>Option\x20D:\x20Atezolizumab\x20is\x20an\x20immune\x20checkpoint\x20modulator\x20that\x20inhibits\x20the\x20interaction\x20of\x20PD-L1\x20with\x20PD-1\x20and\x20B7-H1.\x20It\x20is\x20approved\x20for\x20use\x20in\x20metastatic\x20urothelial\x20cancer\x20and\x20for\x20NSCLC.</p>','VVuCn','get','Clozapine','ejwpL','β1\u00a0+\x20β2\x20agonism','choices','VqXRj','Which\x20of\x20the\x20following\x20is\x20a\x20cardioselective\x20beta\x20blocker\x20with\x20antioxidant\x20property?','eFcdc','Certolizumab\x20pegol','ArrowLeft','Valsartan','<p>The\x20<strong>more</strong>\x20the<strong>\x20curve</strong>\x20is\x20on\x20the<strong>\x20left\x20</strong>in\x20a\x20dose-response\x20curve\x20(DRC)<strong>,</strong>\x20the<strong>\x20greater</strong>\x20is\x20its<strong>\x20potency.\x20</strong>Hence<strong>,&nbsp;</strong>Drug\x20B\x20is\x20the\x20most\x20potent.</p>\x0a<p><strong>Potency:</strong></p>\x0a<ul>\x0a<li>It\x20is\x20defined\x20as\x20the\x20<strong>amount\x20of\x20drug\x20</strong>needed<strong>\x20to\x20produce\x20a\x20given\x20response.</strong></li>\x0a<li>A&nbsp;<strong>highly\x20potent\x20drug</strong>&nbsp;evokes\x20a\x20given&nbsp;<strong>response\x20at\x20low\x20concentrations</strong>&nbsp;and\x20vice-versa.</li>\x0a<li>In\x20the\x20above\x20image,\x20the\x20potency\x20is\x20Drug\x20B&gt;\x20Drug\x20A\x20&gt;\x20Drug\x20C\x20&gt;\x20Drug\x20D.</li>\x0a</ul>\x0a<p><strong>Efficacy:</strong></p>\x0a<ul>\x0a<li>It\x20is\x20defined\x20as\x20the<strong>&nbsp;maximum\x20effect</strong>&nbsp;produced\x20by\x20the\x20drug.\x20It\x20reflects\x20the\x20<strong>capacity</strong>\x20of\x20the\x20drug\x20<strong>to\x20activate</strong>\x20a\x20receptor\x20and\x20<strong>produce</strong>\x20the\x20<strong>response.</strong></li>\x0a<li>In\x20the\x20log\x20dose-response\x20curve,\x20the&nbsp;<strong>perpendicular\x20height</strong>&nbsp;represents\x20the\x20drug\x20efficacy.</li>\x0a<li>Thus,\x20in\x20the\x20above\x20image,\x20the\x20efficacy\x20is\x20Drug\x20A\x20=\x20Drug\x20C\x20=Drug\x20D\x20&gt;\x20Drug\x20B.</li>\x0a<li>Drugs\x20having\x20a\x20similar\x20pharmacological\x20effect\x20can\x20have\x20different\x20efficacies\x20e.g\x20furosemide\x20and\x20metolazone\x20are\x20both\x20diuretics\x20but\x20furosemide\x20has\x20greater\x20efficacy\x20than\x20metolazone.&nbsp;</li>\x0a</ul>','yxlzU','https://dhmbxeygs57ff.cloudfront.net/uploads/e0db32ffbadd42dd9c69b75a9398ff60x1280x1420.JPEG','NPYKQ','The\x20clearance\x20of\x20a\x20drug\x20which\x20follows\x20first-order\x20kinetics\x20(in\x20one\x20compartment\x20model)\x20is\x200.2\x20L/min\x20and\x20volume\x20of\x20distribution\x20is\x2040\x20L.\x20What\x20is\x20the\x20t1/2\x20of\x20that\x20drug?','Lignocaine','>\x201.5\x20mEq/L','</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20','Loperamide','IgE','Irbesartan','Sargramostim\x20is\x20a\x20recombinantly\x20engineered\x20analogue\x20of\x20which\x20of\x20the\x20following?','ENhyX','Aripiprazole','<p><strong>HLA\x20allele\x20B-1502\x20</strong>is\x20implicated\x20as\x20a\x20<strong>marker\x20for\x20carbamazepine-induced\x20Stevens-Johnson\x20syndrome\x20and\x20toxic\x20epidermal\x20necrolysis</strong>\x20in\x20Han\x20Chinese,\x20the\x20USFDA\x20recommends\x20genotyping\x20all\x20Asians\x20for\x20the\x20allele.</p>','glUTe','getAttribute','NXBMb','resume','cNmQl','KawIN','incorrectResult','Azithromycin','test','3365598NaSAhL','vLanR','YqIaW','NSAID\x20that\x20is\x20more\x20likely\x20to\x20reduce\x20the\x20antiplatelet\x20effect\x20of\x20low\x20dose\x20aspirin','Both\x20A\x20and\x20B','\x22\x20controls\x20class=\x22w-full\x22></audio></div>','RKxgx','nahWo','180\x20min','gdFnW','totalTime','Quinidine','QZANs','No\x20question\x20text\x20available','Which\x20of\x20the\x20following\x20drugs\x20is\x20associated\x20with\x20QT\x20prolongation?','Which\x20among\x20the\x20following\x20is\x20the\x20Interleukin-5\x20antagonist\x20indicated\x20in\x20the\x20management\x20of\x20asthma?','<p>The\x20<strong>half-life</strong>\x20of\x20this\x20drug\x20is\x20<strong>350\x20minutes.</strong></p>\x0a<p>In\x20first-order\x20kinetics:</p>','JJdJV','testModeLegend','Erythropoietin','.option-button','gSuND','sLnUw','<p\x20style=\x22text-align:\x20left;\x22>Clinical\x20features\x20are\x20suggestive\x20of<strong\x20data-stringify-type=\x22bold\x22>&nbsp;lithium\x20toxicity,&nbsp;</strong>where\x20serum<strong\x20data-stringify-type=\x22bold\x22>&nbsp;</strong><span\x20data-stringify-type=\x22bold\x22>levels&nbsp;</span><strong\x20data-stringify-type=\x22bold\x22>&gt;1.5\x20mEq/L&nbsp;</strong>are\x20considered<strong\x20data-stringify-type=\x22bold\x22>&nbsp;toxic.&nbsp;&nbsp;</strong></p>\x0a<p\x20style=\x22text-align:\x20left;\x22>Lithium\x20has\x20a\x20<strong>narrow\x20therapeutic\x20index\x20(0.8&ndash;1.2\x20mEq/L)</strong>&nbsp;and\x20therefore\x20requires\x20monitoring\x20to\x20suspect\x20toxicity.\x20The\x20toxic\x20effects\x20of\x20lithium\x20usually\x20start\x20manifesting\x20when\x20the\x20serum\x20level\x20crosses\x201.5\x20mEq/L.</p>\x0a<p\x20style=\x22text-align:\x20left;\x22>Acute\x20intoxication\x20is\x20characterized\x20by:&nbsp;</p>\x0a<ul>\x0a<li\x20style=\x22text-align:\x20left;\x22>Vomiting</li>\x0a<li\x20style=\x22text-align:\x20left;\x22>Profuse\x20diarrhea</li>\x0a<li\x20style=\x22text-align:\x20left;\x22>Coarse\x20tremors</li>\x0a<li\x20style=\x22text-align:\x20left;\x22>Ataxia</li>\x0a<li\x20style=\x22text-align:\x20left;\x22>Coma</li>\x0a<li\x20style=\x22text-align:\x20left;\x22>Convulsions.</li>\x0a</ul>\x0a<p>A\x20fine\x20action\x20tremor\x20is\x20common\x20in\x20patients\x20taking\x20lithium\x20at\x20therapeutic\x20doses\x20and\x20can\x20develop\x20at\x20any\x20time\x20during\x20treatment.&nbsp;Therapeutic\x20lithium\x20tremor\x20is\x20generally\x20symmetric,\x20limited\x20to\x20the\x20arms,\x20and\x20nonprogressive.Tremor\x20from\x20lithium\x20toxicity\x20is\x20<strong>coarser</strong>\x20and\x20<strong>more\x20disabling</strong>,\x20may\x20also\x20affect\x20the\x20legs,\x20and\x20occurs\x20with\x20other\x20symptoms\x20of\x20toxicity.</p>\x0a<p>Serious\x20effects\x20of\x20lithium\x20toxicity\x20will\x20involve\x20confusion,\x20hyperreflexia,\x20and\x20seizures.\x20Motor\x20and\x20cognitive\x20side\x20effects\x20can\x20become\x20irreversible\x20with<strong>\x20persistent\x20cerebellar\x20tremor</strong>\x20being\x20the\x20most\x20common.&nbsp;</p>','<p>Naltrexone\x20is\x20used\x20for\x20the<strong>\x20prevention\x20of\x20relapse</strong>&nbsp;in\x20opioid\x20addiction.</p>\x0a<p>It\x20is\x20given\x20only\x20after\x20initial\x20opioid\x20detoxification.&nbsp;The\x20patient\x20should\x20be\x20opioid-free\x20for\x207-10\x20days\x20and\x20have\x20a\x20negative\x20naloxone\x20challenge\x20(no\x20withdrawal\x20after\x20naloxone\x20administration).</p>\x0a<p>Naltrexone\x20is\x20a\x20pure\x20opioid\x20antagonist\x20which\x20is\x20more\x20potent\x20than\x20naloxone.\x20It\x20is\x20<strong>orally\x20active</strong>\x20and\x20has\x20a\x20<strong>long\x20duration\x20of\x20action</strong>\x20which\x20makes\x20it\x20suitable\x20for\x20opioid\x20blockade\x20therapy\x20in\x20post-addicts.</p>','Bqjks','PxcNd','className','jRBsr','eXGdP','modeModal','<p\x20style=\x22text-align:\x20justify;\x22><strong>Aspirin</strong>\x20at\x20<strong>low\x20doses</strong>&nbsp;(75mg)\x20primarily\x20acts\x20by\x20<strong>inhibiting&nbsp;</strong><strong>cyclooxygenase\x201\x20(COX-1).</strong></p>\x0a<p\x20style=\x22text-align:\x20justify;\x22>Low-dose\x20aspirin,\x20used\x20for\x20antiplatelet\x20action,\x20results\x20in\x20selective\x20inhibition\x20of\x20platelet\x20COX-1\x20(<strong>thromboxane\x20synthase</strong>)\x20inhibiting\x20its\x20ability\x20to\x20form\x20thromboxane\x20A2\x20(needed\x20for\x20platelet\x20aggregation).</p>\x0a<p\x20style=\x22text-align:\x20justify;\x22>As\x20platelets\x20lack\x20nuclei,\x20new\x20platelets\x20have\x20to\x20be\x20formed\x20(life\x20span\x20of\x20<strong>7-10\x20days</strong>)\x20for\x20the\x20return\x20of\x20COX-1\x20activity.</p>\x0a<p\x20style=\x22text-align:\x20justify;\x22>At\x20<strong>higher\x20doses</strong>\x20(~1g/day),\x20aspirin\x20also\x20<strong>inhibits\x20COX-2</strong>\x20and\x20results\x20in\x20decreased\x20production\x20of\x20prostacyclin\x20from\x20endothelium.\x20This\x20may\x20nullify\x20the\x20beneficial\x20anti-aggregatory\x20effect\x20of\x20aspirin.</p>','phExo','push','lLWiW','LEtbH','NDEqP','hFqka','bookmarked','Not\x20Attempted','correctAnswers','solution','lAkhE','vtVtO','Phase\x20I','Liposomal\x20amphotericin\x20B','contains','jObjt','QTetY','QjLBa','QuElu','Drug\x20B\x20is\x20the\x20most\x20potent.','kIaCj','<p><strong>Brimonidine</strong>\x20and\x20<strong>apraclonidine</strong>\x20can\x20cause<strong>\x20CNS\x20depression\x20and\x20apnea\x20in\x20neonates</strong>\x20and\x20are\x20contraindicated\x20in\x20children\x20below\x202\x20years.</p>','Alemtuzumab','PyuMn','vBhGi','zpRey','5\x20HT3\x20antagonism','RKYfZ','Egg\x20based\x20foods','nav-btn-correct','totalQuestions','mcGcR','GthwQ','OnOmP','tOZag','qVQBe','data-option-index','VpFCX','oPyVX','DOMContentLoaded','now','DnDcA','<p><strong>Irbesartan</strong>\x20is\x20an\x20angiotensin\x20receptor\x20blocker\x20that\x20is\x20claimed\x20to\x20have\x20thromboxane\x20A2\x20receptor\x20antagonism.</p>','You\x20are\x20planning\x20to\x20start\x20treatment\x20in\x20a\x20middle-aged\x20man\x20diagnosed\x20with\x20pulmonary\x20tuberculosis.\x20He\x20has\x20a\x20history\x20of\x20chronic\x20kidney\x20disease\x20and\x20his\x20current\x20creatinine\x20clearance\x20is\x2025\x20mL/min.\x20Which\x20of\x20the\x20following\x20drugs\x20is\x20least\x20likely\x20to\x20require\x20dose\x20modification?','div','study','The\x20most\x20frequent\x20fracture\x20site\x20due\x20to\x20osteoporosis\x20induced\x20by\x20glucocorticoids\x20is_____.','dMWiR','<div\x20class=\x22mt-4\x22><img\x20src=\x22','DSJIl','red','YXpGo','A\x20patient\x20with\x20a\x20history\x20of\x20myocardial\x20infarction\x20has\x20been\x20on\x2075\x20mg\x20aspirin\x20OD\x20for\x20two\x20years.\x20The\x20drug\x20primarily\x20acts\x20by\x20inhibiting\x20which\x20enzyme?','Renal\x20impairment','createElement','D2\x20antagonism','wmCET','customQuizData','A\x20farmer\x20presented\x20with\x20complaints\x20of\x20redness\x20and\x20excessive\x20watering\x20from\x20the\x20right\x20eye.\x20Slit-lamp\x20examination\x20reveals\x20the\x20following\x20finding.\x20Microscopy\x20of\x20the\x20corneal\x20ulcer\x20scraping\x20shows\x20branched\x20septate\x20hyphae.\x20Which\x20of\x20the\x20following\x20drugs\x20can\x20be\x20used\x20in\x20the\x20treatment\x20of\x20this\x20patient?','Which\x20antineoplastic\x20drug\x20is\x20a\x20peptide?','fcJdr','answered','Antagonist\x20at\x20D1\x20receptor','OyndS','<p>Thrombolysis\x20can\x20provide\x20mortality\x20reduction\x20for\x20patients\x20who\x20present\x20<strong>within\x2012\x20hours</strong>\x20of\x20symptom\x20onset,\x20especially\x20in\x20those\x20presenting\x20with\x20STEMI\x20and\x20continued\x20chest\x20discomfort.\x20However,\x20<strong>maximum\x20benefit</strong>\x20is\x20obtained\x20if\x20the\x20patient\x20can\x20undergo\x20fibrinolysis\x20<strong>within\x201-3\x20hours.</strong></p>','350\x20mg','warn','Vedolizumab','Calotropis\x20gigantea','<p><strong>Flagellate\x20dermatitis</strong>\x20is\x20caused\x20by\x20<strong>bleomycin</strong>.</p>\x0a<p>Flagellate\x20erythema/\x20dermatitis\x20is\x20characterized\x20by\x20<strong>multiple</strong>&nbsp;red,\x20macular\x20streaks\x20of\x20erythema\x20on\x20the\x20trunk\x20and\x20limbs.\x20The\x20streaks\x20are\x20aligned\x20in\x20a\x20criss‐cross\x20pattern,\x20giving\x20a&nbsp;<strong>whip-like</strong>&nbsp;or&nbsp;<strong>flagellate\x20appearance</strong>.\x20They\x20may\x20be\x20sore\x20or\x20pruritic.&nbsp;</p>\x0a<p>Flagellate\x20erythema\x20is\x20seen\x20in</p>\x0a<ul>\x0a<li\x20aria-level=\x221\x22>A\x20side\x20effect\x20of&nbsp;<strong>bleomycin</strong>&nbsp;chemotherapy</li>\x0a<li\x20aria-level=\x221\x22>The\x20toxic\x20effect\x20after\x20consumption\x20of\x20shitake\x20mushrooms</li>\x0a<li\x20aria-level=\x221\x22>Dermatomyositis</li>\x0a<li\x20aria-level=\x221\x22>Adult-onset\x20Still&rsquo;s\x20disease</li>\x0a<li\x20aria-level=\x221\x22>Docetaxel\x20therapy</li>\x0a</ul>\x0a<p>It\x20is&nbsp;<strong>self-limiting</strong>&nbsp;and\x20usually\x20resolves\x20within\x20a\x20few\x20days\x20to\x20weeks.\x20Topical\x20steroids\x20and\x20oral\x20antihistamines\x20can\x20be\x20given\x20to\x20relieve\x20the\x20associated\x20pruritis.</p>','Cyclooxygenase\x201','Hypomagnesemia','SqCTX','LvTuW','zNKNd','A\x2038-year-old\x20woman\x20complains\x20of\x20recurrent\x20episodes\x20of\x20constipation\x20and\x20crampy\x20abdominal\x20pain\x20for\x20the\x20last\x204\x20months.\x20The\x20pain\x20is\x20relieved\x20on\x20defecation.\x20After\x20investigations,\x20a\x20diagnosis\x20of\x20irritable\x20bowel\x20syndrome\x20with\x20constipation\x20is\x20considered.\x20Which\x20of\x20the\x20following\x20drugs\x20would\x20you\x20prescribe?','oExiX','6-10\x20days','JngeZ','rDydo','Angiotensin\x20II\x20inhibitor','M2\x20+\x20M3\x20agonism','rFVGh','Sregu','JkOGu','Brimonidine','Which\x20of\x20the\x20following\x20statements\x20is\x20true\x20about\x20the\x20given\x20dose-response\x20curve?','TXpSc','</span><span>','key','Median\x20lethal\x20dose','incorrect','progressBar','970042DcDfbH','8CgcFfC','Captopril','DjJss','click','KlCbe','Infliximab','6\x20hours','<p><strong>Oprelvekin&nbsp;</strong>is\x20used\x20in\x20the\x20treatment\x20of&nbsp;<strong>thrombocytopenia\x20secondary\x20to\x20anti-cancer\x20therapy</strong>.</p>\x0a<p>It\x20is\x20a\x20<strong>recombinant\x20human\x20interleukin-11</strong>.\x20Its\x20predominant\x20hemopoietic\x20activity\x20is\x20the\x20stimulation\x20of\x20<strong>megakaryocytopoiesis.</strong>\x20Oprelvekin\x20is\x20indicated\x20for\x20the\x20prevention\x20and\x20treatment\x20of\x20severe\x20thrombocytopenia\x20and\x20the\x20reduction\x20of\x20platelet\x20transfusion\x20requirements\x20following\x20myelosuppressive\x20chemotherapy\x20in\x20patients\x20with\x20non-myeloid\x20malignancies.</p>','Drug\x20concentration\x20is\x20kept\x20below\x20350ng/ml\x20to\x20avoid\x20agranulocytosis','2\x20and\x204\x20only','xhJab','vZhMo','BkeqP','explanation_images','A\x2040-year-old\x20male\x20patient\x20who\x20requires\x20weekly\x20hemodialysis\x20is\x20started\x20on\x20sevelamer.\x20Which\x20of\x20the\x20following\x20best\x20describes\x20the\x20mechanism\x20of\x20action\x20of\x20this\x20drug?','index.html','<ul>\x0a<li><strong>Sympathetic\x20distribution\x20to\x20the\x20head\x20and\x20neck\x20(vasomotor,\x20pupil\x20dilator,\x20and\x20pilomotor)\x20is\x20through\x20the\x20cervical\x20sympathetic\x20chain\x20and\x20its\x20three\x20ganglia.</strong></li>\x0a<li>Now,\x20it\x20looks\x20a\x20bit\x20confusing.\x20The\x20sympathetic\x20system\x20is\x20the\x20thoracolumbar\x20outflow,\x20and\x20here,\x20the\x20answer\x20is\x20the\x20cervical\x20sympathetic\x20chain.</li>\x0a<li>The\x20outflow\x20remains\x20the\x20same,\x20the\x20preganglionic\x20fibers\x20arise\x20from\x20upper\x20thoracic\x20segments\x20but\x20synapse\x20in\x20the\x20cervical\x20ganglia.</li>\x0a</ul>','pcADC','application/vnd.apple.mpegurl','\x22\x20class=\x22w-full\x20rounded-lg\x22\x20controls></video></div>','420\x20minutes','Aonqj','getElementById','bCjhs','AUFBm','GgLGI','Pharmacological\x20block','Pharmacology\x20Test\x20-\x20I','No\x20solution\x20available.','<div\x20class=\x22glass-light\x20p-4\x20mb-4\x22><audio\x20src=\x22','XXRxM','LVKeX','Antagonist\x20at\x20cholinergic\x20receptor','DqVXS','obnUb','Antagonist\x20at\x20D2\x20receptor','Intracellular\x20receptor','<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>English\x20Explanation:</p><audio\x20src=\x22','HZGdJ','aAJgO','Itraconazole','<p>The\x20next\x20step\x20should\x20be\x20<strong>using\x20low\x20molecular\x20weight\x20heparin</strong>\x20(LMWH).</p>\x0a<p>The\x20anticoagulant\x20effect\x20of\x20warfarin\x20is\x20assessed\x20by\x20the\x20measurement\x20of\x20prothrombin\x20time\x20(PT).\x20Failure\x20of\x20elevation\x20of\x20PT\x20indicates\x20the\x20decreased\x20effect\x20of\x20warfarin.\x20If\x20we\x20increase\x20the\x20dose\x20of\x20warfarin,\x20it\x20will\x20take\x205\x20days\x20to\x20prevent\x20DVT.\x20For\x20immediate\x20action,\x20heparin\x20or\x20LMWH\x20has\x20to\x20be\x20started.</p>\x0a<p><strong>LMWH</strong>\x20has\x20<strong>more\x20inhibitory\x20activity</strong>\x20on\x20factor\x20<strong>Xa</strong>\x20than\x20on\x20factor\x20IIa\x20due\x20to\x20the\x20conformational\x20changes\x20in\x20antithrombin\x20caused\x20by\x20the\x20short\x20molecules\x20of\x20LMWH.\x20This\x20conformational\x20change\x20the\x20rate\x20of\x20factor\x20Xa\x20inhibition.\x20LMWH\x20has\x20little\x20effect\x20on\x20platelets.\x20Heparin,\x20LMWH,\x20or\x20fondaparinux\x20are\x20used\x20in\x20the\x20treatment\x20of\x20<strong>deep\x20vein\x20thrombosis</strong>,\x20pulmonary\x20embolism,\x20unstable\x20angina,\x20or\x20acute\x20myocardial\x20infarction.\x20Some\x20of\x20the\x20examples\x20of\x20LMWH\x20preparations\x20are\x20<strong>enoxaparin</strong>\x20and\x20<strong>dalteparin</strong>.\x20The\x20major\x20adverse\x20effect\x20is\x20<strong>bleeding</strong>\x20and\x20there\x20is\x20a\x20low\x20incidence\x20of\x20thrombocytopenia.</p>\x0a<p>Other\x20options:</p>\x0a<p>Option\x20A-\u00a0Effect\x20of\x20warfarin\x20starts\x20in\x204-5\x20days.\x20Therefore,\u00a0<strong>heparin\x20or\x20LMWH</strong>\x20has\x20to\x20be\x20started\x20for\u00a0<strong>immediate\x20effect</strong>.</p>\x0a<p>Option\x20B-\x20<strong>Acenocoumarin</strong>\x20is\x20also\x20an\x20<strong>oral\x20anticoagulant</strong>.\x20Its\x20metabolism\x20is\x20also\x20subjected\x20to\x20<strong>induction</strong>\x20by\x20<strong>rifampicin</strong>.</p>\x0a<p>Option\x20C-\x20<strong>Rifampicin</strong>\x20is\x20an\x20<strong>enzyme\x20inducer</strong>\x20and\x20can\x20<strong>decrease</strong>\x20the\x20<strong>effect\x20of\x20warfarin</strong>.\x20Rifampicin\x20is\x20the\x20most\x20effective\x20drug\x20for\x20tuberculosis\x20and\x20should\x20not\x20be\x20replaced.</p>','OnxEF','<p>Sevelamer\x20is\x20a\x20<strong>phosphate\x20binder</strong>\x20indicated\x20in\x20chronic\x20kidney\x20disease.</p>\x0a<p>Sevelamer\x20is\x20a<strong>\x20nonabsorbable\x20polymer</strong>\x20that\x20acts\x20as\x20a\x20nonselective\x20anion\x20exchanger\x20that<strong>\x20lowers\x20serum\x20phosphate</strong>\x20concentration.&nbsp;</p>\x0a<p>It\x20is\x20indicated\x20to\x20lower\x20phosphate\x20levels\x20in\x20patients\x20with<strong>\x20chronic\x20kidney\x20disease</strong>\x20who\x20are\x20on\x20<strong>dialysis.</strong>&nbsp;</p>\x0a<p>Note:\x20Patiromer\x20is\x20a\x20potassium\x20binder\x20approved\x20for\x20use\x20in\x20hyperkalemia.&nbsp;</p>\x0a<p>&nbsp;</p>','A\x20patient\x20with\x20Crohn\x27s\x20disease,\x20refractory\x20to\x20steroid\x20therapy\x20is\x20planned\x20to\x20be\x20started\x20on\x20an\x20anti-TNF\x20alpha\x20monoclonal\x20antibody.\x20Which\x20of\x20the\x20following\x20drugs\x20does\x20not\x20belong\x20in\x20this\x20class?','A\x20diabetic\x20patient\x20presents\x20with\x20periorbital\x20swelling\x20as\x20shown\x20below.\x20She\x20complains\x20of\x20significant\x20visual\x20impairment\x20and\x20a\x20fungal\x20etiology\x20is\x20suspected.\x20What\x20is\x20the\x20most\x20appropriate\x20drug\x20for\x20this\x20patient?','Interface\x20of\x20alpha\x20and\x20gamma\x20subunits','A\x2055-year-old\x20woman\x20had\x20undergone\x20modified\x20radical\x20mastectomy\x20followed\x20by\x20chemotherapy\x20with\x20trastuzumab.\x20She\x20now\x20presents\x20with\x20liver\x20metastases.\x20Which\x20of\x20the\x20following\x20drugs\x20could\x20be\x20used\x20in\x20this\x20condition?','Celecoxib','UDIzu','A\x20patient\x20who\x20is\x20on\x20anti-glaucoma\x20therapy\x20presents\x20with\x20corneal\x20findings\x20as\x20shown\x20in\x20the\x20image\x20below.\x20This\x20finding\x20is\x20most\x20commonly\x20observed\x20with\x20which\x20of\x20the\x20following\x20drugs?','Tachycardia','iibpG','Natamycin\x205%','rKSQu','XcVrO','BEbyE','split','DHtTQ','A\x20physician\x20prescribes\x20naltrexone\x20to\x20a\x20patient\x20undergoing\x20treatment\x20for\x20opioid\x20addiction.\x20What\x20is\x20the\x20function\x20of\x20this\x20drug\x20in\x20opioid\x20addiction?','XTbqU','vBcmz','closest','A\x2055-year-old\x20patient\x20is\x20on\x20omeprazole\x20for\x20gastroesophageal\x20reflux\x20disease.\x20She\x20is\x20now\x20to\x20be\x20started\x20on\x20dual\x20antiplatelet\x20therapy\x20with\x20aspirin\x20and\x20clopidogrel.\x20You\x20decide\x20to\x20switch\x20to\x20pantoprazole\x20because\x20of\x20the\x20action\x20of\x20omeprazole\x20on\x20which\x20enzyme?','25013223AcegJz','The\x20oral\x20thrombin\x20inhibitor\x20which\x20can\x20be\x20used\x20for\x20prevention\x20of\x20stroke\x20in\x20patients\x20with\x20non-valvular\x20atrial\x20fibrillation\x20is?','Imipenem','Interface\x20of\x20alpha\x20and\x20beta\x20subunits','PCkjY','fwzDO','bxZUO','ArrowRight','cbShG','You\x20have\x20reached\x20the\x20end\x20of\x20the\x20quiz.\x20Would\x20you\x20like\x20to\x20submit\x20your\x20answers\x20now?','length','map','USdMo','\x22\x20data-option-index=\x22','Switch\x20ethambutol\x20for\x20rifampicin','statsBar','search','What\x20is\x20the\x20scientific\x20name\x20of\x20this\x20plant\x20whose\x20roots\x20&\x20leaves\x20were\x20historically\x20used\x20in\x20the\x20treatment\x20of\x20asthma?','Metoprolol','JUnuj','https://cdn1.dailyrounds.org/uploads/13fba814599e4468b06f6230f1b67101.JPEG','name','question_audio','Bookmark','w-8\x20h-8\x20text-sm\x20font-medium\x20rounded\x20transition-all\x20duration-200','AsvGI','loadSource','GM-CSF'];_0x41a5=function(){return _0x26c8ad;};return _0x41a5();}const urlParams=new URLSearchParams(window['location'][_0x18b546(0x440)]),startAt=parseInt(urlParams['get'](_0x18b546(0x292))),resume=urlParams[_0x18b546(0x34f)](_0x18b546(0x36c))===_0x18b546(0x31e);function goBack(){const _0x320f95=_0x18b546,_0x15755c={'zkIoa':_0x320f95(0x3ff)};if(!isQuizCompleted)saveProgress();window[_0x320f95(0x1cb)]['href']=document[_0x320f95(0x165)]||_0x15755c['zkIoa'];}function selectMode(_0x17082a){const _0x4f49f4=_0x18b546,_0x25350b={'USdMo':_0x4f49f4(0x390),'xOVDZ':function(_0x28c2e9){return _0x28c2e9();}};currentMode=_0x17082a,document['getElementById'](_0x25350b[_0x4f49f4(0x43c)])['style'][_0x4f49f4(0x4a3)]=_0x4f49f4(0x13b),_0x25350b[_0x4f49f4(0x4a1)](initializeQuiz);}function initializeQuiz(){const _0x5506b2=_0x18b546,_0x21bfcd={'cykZS':_0x5506b2(0x21a),'mfAvG':_0x5506b2(0x234),'Xuaat':_0x5506b2(0x30d),'WZJCH':'test','vfhUd':function(_0x2a1b8a,_0x2f0d39){return _0x2a1b8a===_0x2f0d39;},'GDxVt':_0x5506b2(0x1f2),'fwzDO':_0x5506b2(0x43f),'QTetY':_0x5506b2(0x13b),'vPBDO':_0x5506b2(0x28f),'QlJUN':_0x5506b2(0x460),'cNmQl':_0x5506b2(0x384),'TVyYh':_0x5506b2(0x2b6),'YqIaW':_0x5506b2(0x27e),'BDARe':_0x5506b2(0x48b),'hyBCA':'timerContainer','ZRKYn':function(_0x15b109,_0x3ca8f0){return _0x15b109(_0x3ca8f0);},'bLSMz':function(_0x3290fc,_0x566153){return _0x3290fc<_0x566153;},'eFcdc':function(_0x2286e6){return _0x2286e6();},'igtmi':function(_0x14d0a3){return _0x14d0a3();},'mcgpQ':function(_0x5ec158){return _0x5ec158();}};quizStartTime=Date['now']();const _0x20bfc4=document[_0x5506b2(0x406)](_0x21bfcd[_0x5506b2(0x32c)]),_0x436544=document[_0x5506b2(0x406)](_0x21bfcd[_0x5506b2(0x1cc)]),_0x378cd8=document[_0x5506b2(0x406)](_0x21bfcd[_0x5506b2(0x25f)]),_0x4f77d8=currentMode===_0x21bfcd[_0x5506b2(0x18f)]||_0x21bfcd[_0x5506b2(0x2f4)](currentMode,_0x21bfcd[_0x5506b2(0x25b)]);document[_0x5506b2(0x406)](_0x21bfcd[_0x5506b2(0x435)])[_0x5506b2(0x246)][_0x5506b2(0x4a3)]=_0x4f77d8?_0x21bfcd[_0x5506b2(0x3a2)]:_0x21bfcd['vPBDO'],document[_0x5506b2(0x406)](_0x21bfcd['QlJUN'])[_0x5506b2(0x246)][_0x5506b2(0x4a3)]=_0x4f77d8?_0x5506b2(0x13b):_0x21bfcd[_0x5506b2(0x182)],document[_0x5506b2(0x406)](_0x21bfcd[_0x5506b2(0x36d)])[_0x5506b2(0x246)][_0x5506b2(0x4a3)]=_0x4f77d8?_0x5506b2(0x28f):_0x21bfcd[_0x5506b2(0x3a2)],document['getElementById'](_0x21bfcd[_0x5506b2(0x472)])['style'][_0x5506b2(0x4a3)]=_0x4f77d8?_0x5506b2(0x28f):_0x21bfcd[_0x5506b2(0x3a2)],_0x20bfc4['style'][_0x5506b2(0x4a3)]=_0x4f77d8?_0x5506b2(0x13b):_0x5506b2(0x27e),_0x436544[_0x5506b2(0x246)][_0x5506b2(0x4a3)]=_0x4f77d8?_0x21bfcd['YqIaW']:'none',_0x378cd8[_0x5506b2(0x246)][_0x5506b2(0x4a3)]=_0x4f77d8?_0x21bfcd[_0x5506b2(0x374)]:_0x21bfcd[_0x5506b2(0x3a2)],(currentMode===_0x21bfcd[_0x5506b2(0x153)]||_0x21bfcd['vfhUd'](currentMode,_0x21bfcd[_0x5506b2(0x25b)]))&&document[_0x5506b2(0x406)](_0x21bfcd[_0x5506b2(0x184)])[_0x5506b2(0x1c3)][_0x5506b2(0x21e)](_0x5506b2(0x2db)),!_0x21bfcd[_0x5506b2(0x312)](isNaN,startAt)&&startAt>=0x0&&_0x21bfcd[_0x5506b2(0x1b5)](startAt,questionsData[_0x5506b2(0x43a)])&&(currentQuestionIndex=startAt),loadBookmarkedQuestions(),_0x21bfcd[_0x5506b2(0x356)](generateQuestionNav),_0x21bfcd[_0x5506b2(0x46f)](updateStats),_0x21bfcd[_0x5506b2(0x2ab)](displayQuestion);}function generateQuestionNav(){const _0x2cd12b=_0x18b546,_0x1c5e09={'pRQfz':'questionNav','yMtGZ':function(_0x1f6efb,_0xb3dc6){return _0x1f6efb<_0xb3dc6;},'eRhox':_0x2cd12b(0x16b),'dAZAP':function(_0x11f96b,_0x5a5e7f){return _0x11f96b+_0x5a5e7f;},'btowo':'w-8\x20h-8\x20text-sm\x20font-medium\x20rounded\x20transition-all\x20duration-200','MByrR':function(_0x15edfa){return _0x15edfa();}},_0x36d1cb=document[_0x2cd12b(0x406)](_0x1c5e09['pRQfz']);_0x36d1cb[_0x2cd12b(0x30c)]='';for(let _0x471bd2=0x0;_0x1c5e09[_0x2cd12b(0x1c2)](_0x471bd2,questionsData[_0x2cd12b(0x43a)]);_0x471bd2++){const _0xebf9e6=document[_0x2cd12b(0x3c8)](_0x1c5e09[_0x2cd12b(0x1ce)]);_0xebf9e6[_0x2cd12b(0x218)]=_0x1c5e09['dAZAP'](_0x471bd2,0x1),_0xebf9e6[_0x2cd12b(0x38d)]=_0x1c5e09[_0x2cd12b(0x282)],_0xebf9e6[_0x2cd12b(0x461)]=()=>jumpToQuestion(_0x471bd2),_0xebf9e6['id']='navBtn_'+_0x471bd2,_0x36d1cb['appendChild'](_0xebf9e6);}_0x1c5e09['MByrR'](updateQuestionNav);}function updateQuestionNav(){const _0x55b815=_0x18b546,_0x447b97={'nqtVb':_0x55b815(0x176),'YTarw':_0x55b815(0x3cb),'kOlmi':function(_0x5a72e9){return _0x5a72e9();},'mEDyM':_0x55b815(0x32d),'UDIzu':function(_0x566d73,_0x3708d1){return _0x566d73<_0x3708d1;},'qUshW':function(_0x5f117e,_0x1c00d9){return _0x5f117e!==_0x1c00d9;},'dsFZb':_0x55b815(0x2dc),'mWdjZ':function(_0x33ada0,_0x3d0f9c){return _0x33ada0!==_0x3d0f9c;},'Bqjks':'tQxTo','lRoRd':'nav-btn-bookmarked','SGKof':'nav-btn-marked-review','qzAuC':_0x55b815(0x3bf),'AZvDZ':function(_0x2aeeb6,_0x35cbc0){return _0x2aeeb6===_0x35cbc0;},'OyndS':_0x55b815(0x48b),'lvkEy':_0x55b815(0x305),'jpsDL':'mxwkO','CGmZl':function(_0x10e870,_0x5699a4){return _0x10e870===_0x5699a4;},'SkROS':_0x55b815(0x3ed),'zKxBc':'nav-btn-not-attempted\x20hover:bg-white\x20hover:bg-opacity-20','EekRs':function(_0x258d7a,_0x29450b){return _0x258d7a===_0x29450b;},'mcGcR':_0x55b815(0x152),'LcQbq':'AAfup','wmCET':'nav-btn-answered'};for(let _0x109c6e=0x0;_0x447b97[_0x55b815(0x421)](_0x109c6e,questionsData[_0x55b815(0x43a)]);_0x109c6e++){if(_0x447b97['qUshW'](_0x447b97[_0x55b815(0x2aa)],_0x447b97[_0x55b815(0x2aa)]))_0x11536e[_0x55b815(0x21f)][_0x55b815(0x1ef)](_0x431b02=>{const _0x24c6ca=_0x55b815;if(_0x431b02)_0x1a350e+=_0x24c6ca(0x264)+_0x431b02+_0x24c6ca(0x169);});else{const _0x5a0161=document[_0x55b815(0x406)](_0x55b815(0x1fa)+_0x109c6e),_0x25d0cf=questionStates[_0x109c6e];let _0x178111='';if(_0x109c6e===currentQuestionIndex)_0x178111=_0x55b815(0x32d);else{if(_0x25d0cf[_0x55b815(0x398)])_0x447b97['mWdjZ'](_0x447b97[_0x55b815(0x38b)],_0x447b97['Bqjks'])?(_0x363bf5['location']['pathname'][_0x55b815(0x46d)](_0x447b97['nqtVb'])&&_0x5d61cd[_0x55b815(0x273)](_0x447b97[_0x55b815(0x48f)]),_0x447b97[_0x55b815(0x30a)](_0xc38e44),_0x101259['reload']()):_0x178111=_0x447b97[_0x55b815(0x28b)];else{if(_0x25d0cf[_0x55b815(0x2ff)])_0x178111=_0x447b97['SGKof'];else{if(currentMode===_0x447b97['qzAuC']||_0x447b97[_0x55b815(0x1a7)](currentMode,_0x447b97[_0x55b815(0x3d1)])){if(_0x447b97[_0x55b815(0x1a7)](_0x447b97[_0x55b815(0x1e3)],_0x447b97['jpsDL'])){if(!_0x4f51a5)_0x447b97['kOlmi'](_0x1b44ab);_0x466cdd[_0x55b815(0x1cb)][_0x55b815(0x1ab)]=_0x38abd2[_0x55b815(0x165)]||_0x55b815(0x3ff);}else{if(_0x447b97[_0x55b815(0x478)](_0x25d0cf[_0x55b815(0x1f0)],_0x55b815(0x2fc)))_0x178111=_0x55b815(0x3af);else{if(_0x25d0cf[_0x55b815(0x1f0)]===_0x447b97[_0x55b815(0x187)])_0x178111=_0x55b815(0x498);else _0x178111=_0x447b97[_0x55b815(0x138)];}}}else{if(_0x447b97['EekRs'](_0x447b97[_0x55b815(0x3b1)],_0x447b97[_0x55b815(0x1f8)]))_0x562888=_0x447b97[_0x55b815(0x450)];else{if(_0x447b97[_0x55b815(0x1b3)](_0x25d0cf[_0x55b815(0x2b3)],null))_0x178111=_0x447b97[_0x55b815(0x3ca)];else _0x178111=_0x447b97[_0x55b815(0x138)];}}}}}_0x5a0161['className']='w-8\x20h-8\x20text-sm\x20font-medium\x20rounded\x20'+_0x178111;}}}function jumpToQuestion(_0x45812f){const _0x31f7b4=_0x18b546,_0x24317e={'DSsUF':function(_0x2e7686,_0x1ebba2){return _0x2e7686>=_0x1ebba2;},'COVre':function(_0x39fe14,_0x2b3552){return _0x39fe14<_0x2b3552;},'LzcZW':function(_0xf7fb3d,_0x5b3599){return _0xf7fb3d-_0x5b3599;},'lWpdT':function(_0x5e93fe){return _0x5e93fe();}};_0x24317e['DSsUF'](_0x45812f,0x0)&&_0x24317e[_0x31f7b4(0x136)](_0x45812f,questionsData[_0x31f7b4(0x43a)])&&(questionStartTime&&(questionStates[currentQuestionIndex][_0x31f7b4(0x466)]+=_0x24317e['LzcZW'](Date[_0x31f7b4(0x3ba)](),questionStartTime)),currentQuestionIndex=_0x45812f,displayQuestion(),_0x24317e['lWpdT'](saveProgress));}function updateStats(){const _0x101cae=_0x18b546,_0x2fa1b0={'SGwZX':function(_0x5d5b60,_0x52897e){return _0x5d5b60===_0x52897e;},'SfXeS':_0x101cae(0x3bf),'zNKNd':'correctCount','WKrNW':'incorrectCount','YGXrs':_0x101cae(0x1a6),'SNsCH':function(_0x480a62,_0x223681){return _0x480a62*_0x223681;},'XcVrO':function(_0x5d874c,_0x4a8837){return _0x5d874c/_0x4a8837;},'DgjVv':_0x101cae(0x21c),'FofBR':function(_0xcca501,_0x2ff233){return _0xcca501+_0x2ff233;},'UXinq':function(_0x26816d,_0x59b499){return _0x26816d/_0x59b499;},'bCjhs':function(_0x275366,_0x2f393b){return _0x275366%_0x2f393b;}};if(_0x2fa1b0['SGwZX'](currentMode,_0x2fa1b0[_0x101cae(0x28e)])||_0x2fa1b0[_0x101cae(0x190)](currentMode,'timed_study')){document[_0x101cae(0x406)](_0x2fa1b0[_0x101cae(0x3dc)])[_0x101cae(0x218)]=stats[_0x101cae(0x39a)],document[_0x101cae(0x406)](_0x2fa1b0[_0x101cae(0x2da)])[_0x101cae(0x218)]=stats[_0x101cae(0x16e)],document[_0x101cae(0x406)](_0x2fa1b0['YGXrs'])['textContent']=stats[_0x101cae(0x1a6)];const _0xd2093d=stats[_0x101cae(0x1a6)]>0x0?Math[_0x101cae(0x2d7)](_0x2fa1b0[_0x101cae(0x1e7)](_0x2fa1b0[_0x101cae(0x427)](stats[_0x101cae(0x39a)],stats[_0x101cae(0x1a6)]),0x64)):0x0;document[_0x101cae(0x406)](_0x2fa1b0[_0x101cae(0x191)])[_0x101cae(0x218)]=_0x2fa1b0[_0x101cae(0x2c3)](_0xd2093d,'%'),stats[_0x101cae(0x37c)]=questionStates[_0x101cae(0x213)]((_0x19eea2,_0x4656c4)=>_0x19eea2+_0x4656c4[_0x101cae(0x466)],0x0);const _0xf3bde4=Math['floor'](_0x2fa1b0[_0x101cae(0x427)](stats[_0x101cae(0x37c)],0x3e8)),_0x16c8ee=Math[_0x101cae(0x23f)](_0x2fa1b0['UXinq'](_0xf3bde4,0x3c)),_0x321d30=_0x2fa1b0[_0x101cae(0x407)](_0xf3bde4,0x3c);document['getElementById'](_0x101cae(0x466))[_0x101cae(0x218)]=_0x2fa1b0['FofBR'](_0x2fa1b0[_0x101cae(0x2c3)](_0x16c8ee,':'),_0x321d30[_0x101cae(0x2c4)]()[_0x101cae(0x159)](0x2,'0'));}}function setupVideo(_0x4d4d63,_0x4890bb){const _0x36b761=_0x18b546;if(Hls[_0x36b761(0x26a)]()){const _0x49d1a2=new Hls();_0x49d1a2[_0x36b761(0x44a)](_0x4890bb),_0x49d1a2[_0x36b761(0x280)](_0x4d4d63);}else _0x4d4d63[_0x36b761(0x4af)](_0x36b761(0x402))&&(_0x4d4d63[_0x36b761(0x1a2)]=_0x4890bb);}function displayQuestion(){const _0x5c3f10=_0x18b546,_0x3c59bf={'LVKeX':function(_0x1e6b16,_0x4d6ae2){return _0x1e6b16+_0x4d6ae2;},'aZiBs':function(_0x481466,_0x507dae){return _0x481466===_0x507dae;},'kCUuA':_0x5c3f10(0x3be),'dMWiR':_0x5c3f10(0x12a),'Xiuim':function(_0x235d42,_0x12c258){return _0x235d42+_0x12c258;},'pwQLP':_0x5c3f10(0x201),'gSuND':_0x5c3f10(0x386),'Sregu':function(_0x152654,_0x58236a){return _0x152654(_0x58236a);},'IkwZo':_0x5c3f10(0x3b6),'kGLZy':function(_0xc4079a,_0x3e1dbe){return _0xc4079a*_0x3e1dbe;},'eXGdP':function(_0x306dfd,_0x88bbce){return _0x306dfd/_0x88bbce;},'obnUb':function(_0x5de424,_0x4c715b){return _0x5de424+_0x4c715b;},'RKxgx':_0x5c3f10(0x3ee),'vfSlg':_0x5c3f10(0x2cb),'wwAwz':function(_0x53140e,_0x435c5c){return _0x53140e+_0x435c5c;},'phExo':function(_0x15a976){return _0x15a976();},'FADUk':'prevBtn','BEbyE':'solutionContainer','LiVku':'hidden','XTbqU':_0x5c3f10(0x168),'golWM':_0x5c3f10(0x151),'McKUX':_0x5c3f10(0x2b5),'VlwjD':_0x5c3f10(0x3cf),'NJrpP':_0x5c3f10(0x3f3),'kUOWx':function(_0x3fa2cf){return _0x3fa2cf();},'lAkhE':'timed_study','DbfCn':_0x5c3f10(0x1f2),'oLeaY':function(_0x306319){return _0x306319();}};if(!questionsData||_0x3c59bf[_0x5c3f10(0x1e6)](questionsData[_0x5c3f10(0x43a)],0x0)){document['getElementById'](_0x5c3f10(0x168))['innerHTML']=_0x5c3f10(0x1cd);return;};const _0x37d9a4=questionsData[currentQuestionIndex];questionStartTime=Date[_0x5c3f10(0x3ba)](),selectedOption=questionStates[currentQuestionIndex]['selectedAnswer'];const _0x39d1e0=_0x3c59bf[_0x5c3f10(0x485)](_0x3c59bf[_0x5c3f10(0x38f)](_0x3c59bf[_0x5c3f10(0x412)](currentQuestionIndex,0x1),questionsData[_0x5c3f10(0x43a)]),0x64);document['getElementById'](_0x3c59bf[_0x5c3f10(0x378)])[_0x5c3f10(0x246)][_0x5c3f10(0x467)]=_0x3c59bf['obnUb'](_0x39d1e0,'%'),document[_0x5c3f10(0x406)](_0x3c59bf[_0x5c3f10(0x45f)])[_0x5c3f10(0x218)]=_0x3c59bf[_0x5c3f10(0x20b)](currentQuestionIndex,0x1),_0x3c59bf[_0x5c3f10(0x392)](updateQuestionNav),document[_0x5c3f10(0x406)](_0x3c59bf['FADUk'])[_0x5c3f10(0x493)]=currentQuestionIndex===0x0,document[_0x5c3f10(0x406)](_0x3c59bf[_0x5c3f10(0x428)])[_0x5c3f10(0x1c3)][_0x5c3f10(0x125)](_0x3c59bf[_0x5c3f10(0x328)]),document[_0x5c3f10(0x406)](_0x3c59bf[_0x5c3f10(0x42c)])[_0x5c3f10(0x30c)]=_0x37d9a4['text']||_0x5c3f10(0x37f);let _0x3e477a='';if(_0x37d9a4['question_audio'])_0x3e477a+=_0x5c3f10(0x40d)+_0x37d9a4[_0x5c3f10(0x446)]+_0x5c3f10(0x377);if(_0x37d9a4[_0x5c3f10(0x1df)])_0x3e477a+=_0x5c3f10(0x253)+_0x37d9a4[_0x5c3f10(0x1df)]+_0x5c3f10(0x130);_0x37d9a4['question_images']&&_0x37d9a4[_0x5c3f10(0x21f)][_0x5c3f10(0x1ef)](_0x3a14c9=>{const _0x4f50ea=_0x5c3f10;if(_0x3a14c9)_0x3e477a+=_0x4f50ea(0x264)+_0x3a14c9+_0x4f50ea(0x169);});document[_0x5c3f10(0x406)](_0x3c59bf[_0x5c3f10(0x289)])[_0x5c3f10(0x30c)]=_0x3e477a;const _0x4896fa=document[_0x5c3f10(0x406)](_0x3c59bf['McKUX']);_0x4896fa['innerHTML']='',_0x4896fa['classList'][_0x5c3f10(0x21e)](_0x3c59bf[_0x5c3f10(0x31d)]),_0x37d9a4[_0x5c3f10(0x353)]&&Array[_0x5c3f10(0x278)](_0x37d9a4[_0x5c3f10(0x353)])&&(_0x37d9a4[_0x5c3f10(0x353)][_0x5c3f10(0x1ef)]((_0x2c2e0d,_0xb79ff8)=>{const _0x32657a=_0x5c3f10,_0x4907f2=String['fromCharCode'](_0x3c59bf[_0x32657a(0x40f)](0x41,_0xb79ff8)),_0x694c2a=_0x3c59bf[_0x32657a(0x1e6)](selectedOption,_0xb79ff8),_0x1f2c43=document[_0x32657a(0x3c8)](_0x3c59bf[_0x32657a(0x171)]);_0x1f2c43[_0x32657a(0x30c)]='\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<button\x20type=\x22button\x22\x20class=\x22option-button\x20'+(_0x694c2a?_0x3c59bf[_0x32657a(0x3c1)]:'')+_0x32657a(0x43d)+_0xb79ff8+_0x32657a(0x24a)+_0x4907f2+'</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22option-text\x22>'+(_0x2c2e0d['text']||_0x3c59bf[_0x32657a(0x267)](_0x3c59bf['pwQLP'],_0x3c59bf[_0x32657a(0x267)](_0xb79ff8,0x1)))+_0x32657a(0x1a9),_0x4896fa['appendChild'](_0x1f2c43);}),_0x4896fa[_0x5c3f10(0x2ea)](_0x3c59bf['NJrpP'],function(_0xeef021){const _0x360277=_0x5c3f10,_0x5c182a=_0xeef021['target'][_0x360277(0x42e)](_0x3c59bf[_0x360277(0x387)]);if(_0x5c182a){const _0x6d0b57=_0x3c59bf[_0x360277(0x3e5)](parseInt,_0x5c182a[_0x360277(0x36a)](_0x3c59bf['IkwZo']));_0x3c59bf[_0x360277(0x3e5)](selectOption,_0x6d0b57);}})),_0x3c59bf[_0x5c3f10(0x392)](updateBookmarkButton),_0x3c59bf[_0x5c3f10(0x121)](updateMarkReviewButton),(_0x3c59bf['aZiBs'](currentMode,_0x3c59bf[_0x5c3f10(0x39c)])||_0x3c59bf[_0x5c3f10(0x1e6)](currentMode,_0x3c59bf[_0x5c3f10(0x1d6)]))&&!isQuizCompleted&&_0x3c59bf[_0x5c3f10(0x2ad)](startTimer);}function selectOption(_0x593748){const _0x5866f7=_0x18b546,_0x21757d={'KBcjb':function(_0x2d7ced){return _0x2d7ced();},'bgClk':function(_0x3d1ba8,_0x111112){return _0x3d1ba8!==_0x111112;},'NXBMb':_0x5866f7(0x26c),'EFqQH':_0x5866f7(0x12a),'uwDTu':function(_0x53ba95,_0x50b9b2){return _0x53ba95===_0x50b9b2;},'yxlzU':'answered','filao':function(_0x3801d2,_0x5d319c){return _0x3801d2-_0x5d319c;},'VOMDY':'.option-button','zLZDL':'study','mydtI':function(_0x46ccb4,_0x372dea){return _0x46ccb4===_0x372dea;},'feiqR':'timed_study','ILMEP':function(_0x24263a,_0x3a4df9){return _0x24263a===_0x3a4df9;},'rraWO':'not_attempted'},_0x4d99a7=document[_0x5866f7(0x406)](_0x5866f7(0x2b5));if(_0x4d99a7[_0x5866f7(0x1c3)][_0x5866f7(0x3a0)](_0x21757d[_0x5866f7(0x35b)]))return;questionStartTime&&(questionStates[currentQuestionIndex]['timeSpent']+=_0x21757d['filao'](Date[_0x5866f7(0x3ba)](),questionStartTime),questionStartTime=Date[_0x5866f7(0x3ba)]()),selectedOption=_0x593748,questionStates[currentQuestionIndex][_0x5866f7(0x2b3)]=_0x593748,document[_0x5866f7(0x27c)](_0x21757d[_0x5866f7(0x45d)])['forEach']((_0x3d6554,_0x288715)=>{const _0xca31aa=_0x5866f7;_0x21757d['bgClk']('uFiNk',_0x21757d[_0xca31aa(0x36b)])?_0x3d6554['classList'][_0xca31aa(0x179)](_0x21757d['EFqQH'],_0x21757d[_0xca31aa(0x1d4)](_0x288715,_0x593748)):_0x21757d[_0xca31aa(0x276)](_0xe53059);}),_0x21757d[_0x5866f7(0x1d4)](currentMode,_0x21757d[_0x5866f7(0x13f)])||_0x21757d[_0x5866f7(0x194)](currentMode,_0x21757d[_0x5866f7(0x19a)])?processAnswer():(_0x21757d[_0x5866f7(0x2c0)](questionStates[currentQuestionIndex][_0x5866f7(0x1f0)],_0x21757d[_0x5866f7(0x1fe)])&&(questionStates[currentQuestionIndex]['status']=_0x21757d['yxlzU'],stats[_0x5866f7(0x1a6)]++,stats[_0x5866f7(0x1b7)]--),updateQuestionNav()),saveProgress();}function processAnswer(){const _0x2984c9=_0x18b546,_0x1e8a1a={'YXpGo':function(_0x18fd04,_0x1ab3f3){return _0x18fd04===_0x1ab3f3;},'NCMBX':_0x2984c9(0x287),'MpgMy':_0x2984c9(0x3ed),'ixVas':function(_0x15378b){return _0x15378b();},'xqTmO':function(_0x174b56){return _0x174b56();}},_0x223186=questionsData[currentQuestionIndex],_0xc8fc3d=_0x223186[_0x2984c9(0x2e2)];if(_0x1e8a1a[_0x2984c9(0x3c5)](selectedOption,null))return;const _0x593a46=_0x223186[_0x2984c9(0x353)][selectedOption],_0x2cfa51=_0x1e8a1a['YXpGo'](_0x593a46['id'],_0xc8fc3d);if(questionStates[currentQuestionIndex]['status']===_0x1e8a1a['NCMBX']){stats[_0x2984c9(0x1a6)]++,stats[_0x2984c9(0x1b7)]--;if(_0x2cfa51)stats[_0x2984c9(0x39a)]++;else stats['incorrectAnswers']++;}questionStates[currentQuestionIndex][_0x2984c9(0x1f0)]=_0x2cfa51?'correct':_0x1e8a1a[_0x2984c9(0x29e)],_0x1e8a1a['ixVas'](updateStats),showInlineFeedback(_0x2cfa51),_0x1e8a1a['xqTmO'](updateQuestionNav);}function showInlineFeedback(_0x56a7d5){const _0x34c279=_0x18b546,_0x2b23ea={'jcDnl':_0x34c279(0x12a),'eHIjM':function(_0x2c31de,_0x279fc7){return _0x2c31de===_0x279fc7;},'MLagk':_0x34c279(0x2fc),'AqBrI':_0x34c279(0x3ed),'bgNca':function(_0x14b02d,_0xc35384){return _0x14b02d!==_0xc35384;},'UxzDw':'timed_study','DHtTQ':_0x34c279(0x2b5),'AsvGI':_0x34c279(0x386),'RsHzt':'answered','cIwRL':function(_0x31ccf3){return _0x31ccf3();}};if(currentMode!==_0x34c279(0x3bf)&&_0x2b23ea[_0x34c279(0x4ab)](currentMode,_0x2b23ea[_0x34c279(0x205)]))return;const _0x1ef577=document[_0x34c279(0x406)](_0x2b23ea[_0x34c279(0x42a)]),_0x5e6ec8=_0x1ef577[_0x34c279(0x27c)](_0x2b23ea[_0x34c279(0x449)]),_0x3e1f50=questionsData[currentQuestionIndex],_0x5bd7c1=_0x3e1f50[_0x34c279(0x2e2)];let _0x4b8008=_0x3e1f50[_0x34c279(0x353)][_0x34c279(0x1f3)](_0x1616b6=>_0x1616b6['id']===_0x5bd7c1);_0x1ef577[_0x34c279(0x1c3)][_0x34c279(0x125)](_0x2b23ea[_0x34c279(0x24e)]),_0x5e6ec8[_0x34c279(0x1ef)]((_0x8f86c2,_0x5f3c7f)=>{const _0x24b64e=_0x34c279;_0x8f86c2[_0x24b64e(0x1c3)]['remove'](_0x2b23ea[_0x24b64e(0x186)]);if(_0x2b23ea[_0x24b64e(0x2f3)](_0x5f3c7f,_0x4b8008))_0x8f86c2[_0x24b64e(0x1c3)][_0x24b64e(0x125)](_0x2b23ea[_0x24b64e(0x464)]);else{if(_0x5f3c7f===selectedOption&&!_0x56a7d5)_0x8f86c2[_0x24b64e(0x1c3)]['add'](_0x2b23ea[_0x24b64e(0x140)]);}}),_0x2b23ea['cIwRL'](showSolution);}function showSolution(){const _0x491507=_0x18b546,_0x33d3b4={'LvTuW':function(_0x3a8434,_0x4cd70b){return _0x3a8434(_0x4cd70b);},'PKbVZ':_0x491507(0x11d),'NsPXw':'customQuizData','GOmRI':'study','KPvcH':function(_0x4305fc,_0x45412d){return _0x4305fc!==_0x45412d;},'UGgTi':_0x491507(0x48b),'nKTho':_0x491507(0x23a),'VpFCX':_0x491507(0x343),'bKZHs':_0x491507(0x335),'EBtTu':'explanationVideoPlayer','OnOmP':_0x491507(0x2db),'AYvwQ':_0x491507(0x17f),'DfpgX':_0x491507(0x479),'TvXBA':_0x491507(0x48a),'FQhwY':_0x491507(0x13c),'fRSlf':'solutionImages','EQVeN':'solutionContainer'};if(currentMode!==_0x33d3b4[_0x491507(0x2bb)]&&_0x33d3b4[_0x491507(0x28c)](currentMode,_0x33d3b4['UGgTi']))return;const _0x364ce4=questionsData[currentQuestionIndex];document[_0x491507(0x406)](_0x33d3b4[_0x491507(0x252)])['innerHTML']=_0x364ce4[_0x491507(0x39b)]||_0x33d3b4[_0x491507(0x3b7)];const _0x46b11a=document[_0x491507(0x406)](_0x33d3b4[_0x491507(0x338)]),_0x7500a5=document['getElementById'](_0x33d3b4[_0x491507(0x150)]),_0x4599c1=_0x364ce4[_0x491507(0x317)];if(_0x4599c1){_0x46b11a[_0x491507(0x1c3)][_0x491507(0x21e)](_0x33d3b4[_0x491507(0x3b3)]);if(_0x4599c1[_0x491507(0x2a7)](_0x33d3b4[_0x491507(0x1e2)]))setupVideo(_0x7500a5,_0x4599c1);else _0x7500a5[_0x491507(0x1a2)]=_0x4599c1;}else _0x33d3b4['DfpgX']!==_0x33d3b4['TvXBA']?_0x46b11a[_0x491507(0x1c3)][_0x491507(0x125)](_0x33d3b4[_0x491507(0x3b3)]):_0x33d3b4[_0x491507(0x3db)](_0x1b2bcf,_0x33d3b4[_0x491507(0x229)])&&(_0x2bb73a[_0x491507(0x1cb)][_0x491507(0x285)][_0x491507(0x46d)](_0x491507(0x176))&&_0x5f231d[_0x491507(0x273)](_0x33d3b4[_0x491507(0x210)]),_0x531f9b(),_0x3cad7f['reload']());const _0x18c927=document['getElementById'](_0x33d3b4[_0x491507(0x470)]);_0x18c927[_0x491507(0x30c)]='';_0x364ce4[_0x491507(0x290)]&&(_0x18c927[_0x491507(0x30c)]+=_0x491507(0x415)+_0x364ce4[_0x491507(0x290)]+_0x491507(0x377));_0x364ce4['explanation_audio_hin']&&(_0x18c927[_0x491507(0x30c)]+=_0x491507(0x330)+_0x364ce4['explanation_audio_hin']+_0x491507(0x377));const _0xc935f2=document[_0x491507(0x406)](_0x33d3b4['fRSlf']);_0xc935f2[_0x491507(0x30c)]='',_0x364ce4['explanation_images']&&_0x364ce4[_0x491507(0x3fd)]['forEach'](_0xf8d74f=>{const _0x2a8b68=_0x491507;if(_0xf8d74f)_0xc935f2[_0x2a8b68(0x30c)]+='<div\x20class=\x22mt-4\x22><img\x20src=\x22'+_0xf8d74f+'\x22\x20alt=\x22Explanation\x20Image\x22\x20class=\x22w-full\x20rounded-lg\x22></div>';}),document[_0x491507(0x406)](_0x33d3b4[_0x491507(0x2ef)])[_0x491507(0x1c3)]['remove'](_0x33d3b4[_0x491507(0x3b3)]);}function submitQuiz(){const _0x823587=_0x18b546,_0x5c6ccd={'HqEwb':'.m3u8','KzHHv':function(_0x2d3dbc,_0x3eb4ed){return _0x2d3dbc!==_0x3eb4ed;},'GgLGI':function(_0x1bbf4f,_0x5bb1b7){return _0x1bbf4f===_0x5bb1b7;},'GthwQ':'correct','DELmB':function(_0x4b79fd,_0x2a44d9){return _0x4b79fd===_0x2a44d9;},'vBsnI':_0x823587(0x366),'YAuRb':'incorrect','oPyVX':function(_0x21fbd5,_0x8de398){return _0x21fbd5(_0x8de398);},'gEcyY':_0x823587(0x349),'nahWo':function(_0x4d77e0,_0x51fa12){return _0x4d77e0-_0x51fa12;},'KrEGH':function(_0x4b9909,_0x1dc853){return _0x4b9909-_0x1dc853;},'oYTXD':function(_0x476bb4,_0x844d23){return _0x476bb4+_0x844d23;},'DcDTh':_0x823587(0x2f0),'mkIFT':function(_0x101b5c){return _0x101b5c();},'HRqIX':function(_0x51eff6,_0x337b74,_0x52b925,_0x337cab,_0x33f5e2){return _0x51eff6(_0x337b74,_0x52b925,_0x337cab,_0x33f5e2);},'VqXRj':function(_0x5bc557,_0x24d4e8){return _0x5bc557+_0x24d4e8;}};if(timer)_0x5c6ccd[_0x823587(0x3b8)](clearInterval,timer);if(!_0x5c6ccd[_0x823587(0x3b8)](confirm,_0x5c6ccd['gEcyY']))return;isQuizCompleted=!![];let _0x501176=0x0,_0x2fbe0c=0x0;const _0xcff170=_0x5c6ccd[_0x823587(0x379)](Date[_0x823587(0x3ba)](),quizStartTime);questionsData[_0x823587(0x1ef)]((_0x3a40b9,_0x725e92)=>{const _0x1697e2=_0x823587,_0x4fa125={'fgKXs':_0x5c6ccd[_0x1697e2(0x2ba)],'OoQCz':function(_0x5b67ce,_0x19c519,_0x4bafc9){return _0x5b67ce(_0x19c519,_0x4bafc9);}},_0x55430f=questionStates[_0x725e92];if(_0x5c6ccd[_0x1697e2(0x48d)](_0x55430f[_0x1697e2(0x2b3)],null)){if(_0x5c6ccd[_0x1697e2(0x409)](_0x3a40b9[_0x1697e2(0x353)][_0x55430f[_0x1697e2(0x2b3)]]['id'],_0x3a40b9[_0x1697e2(0x2e2)]))_0x501176++,_0x55430f[_0x1697e2(0x1f0)]=_0x5c6ccd[_0x1697e2(0x3b2)];else{if(_0x5c6ccd[_0x1697e2(0x1c1)](_0x5c6ccd[_0x1697e2(0x283)],_0x5c6ccd[_0x1697e2(0x283)]))_0x2fbe0c++,_0x55430f[_0x1697e2(0x1f0)]=_0x5c6ccd[_0x1697e2(0x46b)];else{_0x27b083[_0x1697e2(0x1c3)][_0x1697e2(0x21e)]('hidden');if(_0x22334e['includes'](_0x4fa125[_0x1697e2(0x49c)]))_0x4fa125[_0x1697e2(0x180)](_0x5ca203,_0x3bb7d5,_0x587828);else _0x39cc1a[_0x1697e2(0x1a2)]=_0x1c13a5;}}}});const _0x58d13e=JSON[_0x823587(0x348)](localStorage[_0x823587(0x14f)](_0x823587(0x2f0)))||[];_0x58d13e['push']({'quizName':quizName,'hierarchy':hierarchy,'timestamp':Date['now'](),'totalTime':_0xcff170,'stats':{'correct':_0x501176,'incorrect':_0x2fbe0c,'notAttempted':_0x5c6ccd[_0x823587(0x49b)](questionsData[_0x823587(0x43a)],_0x5c6ccd['oYTXD'](_0x501176,_0x2fbe0c))}}),localStorage[_0x823587(0x496)](_0x5c6ccd['DcDTh'],JSON['stringify'](_0x58d13e)),stats[_0x823587(0x39a)]=_0x501176,stats[_0x823587(0x16e)]=_0x2fbe0c,_0x5c6ccd['mkIFT'](markQuizAsCompleted),_0x5c6ccd['HRqIX'](showPerformanceAnalysis,_0x501176,_0x2fbe0c,questionsData[_0x823587(0x43a)]-_0x5c6ccd[_0x823587(0x354)](_0x501176,_0x2fbe0c),_0xcff170);}function showPerformanceAnalysis(_0x2f6f88,_0x37c4d3,_0x2ccf0f,_0x5ec3ed){const _0x2345b2=_0x18b546,_0x4a4dc1={'KYUPX':'performanceModal','wgYbv':function(_0x522e0b,_0x2dbf08){return _0x522e0b+_0x2dbf08;},'iibpG':function(_0x2527ac,_0x58d240){return _0x2527ac*_0x58d240;},'rDydo':function(_0x2b26cf,_0x59cd6d){return _0x2b26cf/_0x59cd6d;},'YeOfL':function(_0x49e4a8,_0x1c09ef){return _0x49e4a8/_0x1c09ef;},'hUsoW':_0x2345b2(0x323),'xYjEm':_0x2345b2(0x1ea),'COKDT':_0x2345b2(0x4a5),'Dbylm':_0x2345b2(0x36f),'CFZfc':function(_0x20a3c6,_0x5f9a31){return _0x20a3c6/_0x5f9a31;},'PMYnE':function(_0x59c4fd,_0x5af095){return _0x59c4fd%_0x5af095;},'OMHgD':'totalTimeResult','sLnUw':function(_0x35711a,_0x535c3b){return _0x35711a/_0x535c3b;},'JDlcy':_0x2345b2(0x2db)},_0x3b2951=document['getElementById'](_0x4a4dc1['KYUPX']),_0x2f47ca=_0x4a4dc1[_0x2345b2(0x17d)](_0x2f6f88,_0x37c4d3)>0x0?Math[_0x2345b2(0x2d7)](_0x4a4dc1['iibpG'](_0x4a4dc1[_0x2345b2(0x3e1)](_0x2f6f88,_0x4a4dc1['wgYbv'](_0x2f6f88,_0x37c4d3)),0x64)):0x0,_0x32f6e2=_0x4a4dc1[_0x2345b2(0x424)](_0x4a4dc1[_0x2345b2(0x424)](0x2,Math['PI']),0x41),_0x40e1f7=document[_0x2345b2(0x406)](_0x2345b2(0x4a9));_0x40e1f7[_0x2345b2(0x246)][_0x2345b2(0x1dd)]=_0x32f6e2+'\x20'+_0x32f6e2,_0x40e1f7[_0x2345b2(0x246)][_0x2345b2(0x120)]=_0x32f6e2-_0x4a4dc1[_0x2345b2(0x14b)](_0x2f47ca,0x64)*_0x32f6e2,document['getElementById'](_0x4a4dc1[_0x2345b2(0x270)])[_0x2345b2(0x218)]=_0x2f47ca+'%',document[_0x2345b2(0x406)](_0x4a4dc1[_0x2345b2(0x483)])[_0x2345b2(0x218)]=questionsData[_0x2345b2(0x43a)],document[_0x2345b2(0x406)](_0x4a4dc1['COKDT'])[_0x2345b2(0x218)]=_0x2f6f88,document[_0x2345b2(0x406)](_0x4a4dc1['Dbylm'])['textContent']=_0x37c4d3,document[_0x2345b2(0x406)](_0x2345b2(0x291))['textContent']=_0x2ccf0f;const _0x41326c=Math[_0x2345b2(0x23f)](_0x4a4dc1[_0x2345b2(0x32e)](_0x5ec3ed,0xea60)),_0x526956=Math[_0x2345b2(0x23f)](_0x4a4dc1[_0x2345b2(0x32e)](_0x4a4dc1[_0x2345b2(0x19f)](_0x5ec3ed,0xea60),0x3e8));document[_0x2345b2(0x406)](_0x4a4dc1['OMHgD'])[_0x2345b2(0x218)]=_0x41326c+':'+_0x526956['toString']()[_0x2345b2(0x159)](0x2,'0');const _0x4997d1=_0x4a4dc1[_0x2345b2(0x388)](_0x5ec3ed,questionsData[_0x2345b2(0x43a)]),_0x1efc54=Math[_0x2345b2(0x23f)](_0x4997d1/0xea60),_0x4eb1fc=Math['floor'](_0x4a4dc1['sLnUw'](_0x4997d1%0xea60,0x3e8));document[_0x2345b2(0x406)](_0x2345b2(0x32a))[_0x2345b2(0x218)]=_0x1efc54+':'+_0x4eb1fc[_0x2345b2(0x2c4)]()[_0x2345b2(0x159)](0x2,'0'),_0x3b2951[_0x2345b2(0x1c3)][_0x2345b2(0x21e)](_0x4a4dc1[_0x2345b2(0x4ac)]);}function closePerformanceModal(){const _0x40398a=_0x18b546,_0x554ec0={'REwhj':'hidden'};document['getElementById'](_0x40398a(0x1fb))[_0x40398a(0x1c3)][_0x40398a(0x125)](_0x554ec0['REwhj']);}function reviewQuestions(){const _0x1e6b4b=_0x18b546,_0x4bfb58={'vtVtO':function(_0x1fcae6){return _0x1fcae6();},'vBhGi':function(_0x949bbf,_0x3263e4){return _0x949bbf===_0x3263e4;},'LEtbH':_0x1e6b4b(0x47b),'qJXat':'border-red-500','fMaYV':'not-attempted','HDUwr':_0x1e6b4b(0x399),'yAWDY':function(_0x41e6f2,_0x4d869d){return _0x41e6f2!==_0x4d869d;},'fcJdr':function(_0x21a5b8,_0x4e7987){return _0x21a5b8!==_0x4e7987;},'bIhLy':_0x1e6b4b(0x487),'gWTxP':'Correct','aDOLL':_0x1e6b4b(0x495),'FGSre':function(_0x7b9bba,_0x2afdc7){return _0x7b9bba+_0x2afdc7;},'QmRdw':'correct','xhJab':'incorrect','zAtBv':_0x1e6b4b(0x3c4),'BkeqP':_0x1e6b4b(0x126),'DnDcA':_0x1e6b4b(0x40c),'CCUUS':'questionReviewSection','zpRey':_0x1e6b4b(0x2db),'cFftC':_0x1e6b4b(0x20d),'fIkom':function(_0x569fda){return _0x569fda();}};document[_0x1e6b4b(0x406)](_0x4bfb58[_0x1e6b4b(0x16d)])[_0x1e6b4b(0x1c3)][_0x1e6b4b(0x21e)](_0x4bfb58[_0x1e6b4b(0x3ab)]);const _0x152389=document[_0x1e6b4b(0x406)](_0x4bfb58[_0x1e6b4b(0x15d)]);_0x152389['innerHTML']='',questionsData[_0x1e6b4b(0x1ef)]((_0x1ec844,_0x2fd8ac)=>{const _0x185310=_0x1e6b4b,_0x2a837a={'NFKzx':function(_0x17a0db,_0x2de779){return _0x17a0db-_0x2de779;},'BkPDf':function(_0x44a028){const _0x3ad2c3=_0x4283;return _0x4bfb58[_0x3ad2c3(0x39d)](_0x44a028);},'byzAU':function(_0x295ce6,_0x4a56f6){const _0x5ae94d=_0x4283;return _0x4bfb58[_0x5ae94d(0x3aa)](_0x295ce6,_0x4a56f6);},'QJXcn':_0x4bfb58[_0x185310(0x395)],'OnxEF':_0x4bfb58[_0x185310(0x244)],'VVuCn':function(_0x221ae0,_0x2ad74b){return _0x221ae0+_0x2ad74b;}},_0x3e0100=questionStates[_0x2fd8ac],_0x5c50d6=_0x1ec844[_0x185310(0x2e2)];let _0x2be687=_0x4bfb58[_0x185310(0x322)],_0x57d915=_0x4bfb58[_0x185310(0x1d0)];if(_0x4bfb58[_0x185310(0x13e)](_0x3e0100[_0x185310(0x2b3)],null)){if(_0x4bfb58[_0x185310(0x3ce)](_0x185310(0x155),_0x185310(0x12b))){const _0x123c59=_0x1ec844[_0x185310(0x353)][_0x3e0100[_0x185310(0x2b3)]];_0x4bfb58[_0x185310(0x3aa)](_0x123c59['id'],_0x5c50d6)?_0x4bfb58[_0x185310(0x2e7)]===_0x185310(0x3a1)?(_0x3558f5[_0x2ad102][_0x185310(0x466)]+=_0x2a837a['NFKzx'](_0x59b437['now'](),_0x36a9a8),_0x47c97b=_0x1d311b[_0x185310(0x3ba)]()):(_0x2be687=_0x185310(0x2fc),_0x57d915=_0x4bfb58['gWTxP']):(_0x2be687=_0x185310(0x3ed),_0x57d915=_0x4bfb58['aDOLL']);}else _0x2a837a[_0x185310(0x220)](_0x5b72b8);}const _0x1ac0d0=document['createElement'](_0x185310(0x3be));_0x1ac0d0['className']=_0x185310(0x2af)+_0x2be687;let _0x4ff09f=(_0x1ec844[_0x185310(0x353)]||[])['map']((_0x156970,_0x4f71d3)=>{const _0x48bc5e=_0x185310,_0xaf5613=_0x2a837a['byzAU'](_0x3e0100[_0x48bc5e(0x2b3)],_0x4f71d3),_0x5d63c4=_0x156970['id']===_0x5c50d6;let _0x528874=_0x48bc5e(0x477);if(_0x5d63c4)_0x528874=_0x2a837a[_0x48bc5e(0x277)];else{if(_0xaf5613)_0x528874=_0x2a837a[_0x48bc5e(0x41a)];}return'<div\x20class=\x22p-3\x20rounded-lg\x20border\x20'+_0x528874+_0x48bc5e(0x342)+String[_0x48bc5e(0x19c)](_0x2a837a[_0x48bc5e(0x34e)](0x41,_0x4f71d3))+'</span><span>'+_0x156970[_0x48bc5e(0x341)]+'</span></div>';})[_0x185310(0x127)]('');const _0x457e7d=_0x1ec844[_0x185310(0x317)]?_0x185310(0x129)+_0x2fd8ac+'\x22\x20data-src=\x22'+_0x1ec844['explanation_video']+_0x185310(0x403):'';let _0x3dc46c='';if(_0x1ec844[_0x185310(0x290)])_0x3dc46c+='<div\x20class=\x22mt-2\x22><p\x20class=\x22text-sm\x20text-white\x20text-opacity-70\x20mb-1\x22>English:</p><audio\x20src=\x22'+_0x1ec844[_0x185310(0x290)]+_0x185310(0x377);if(_0x1ec844[_0x185310(0x123)])_0x3dc46c+=_0x185310(0x15b)+_0x1ec844[_0x185310(0x123)]+'\x22\x20controls\x20class=\x22w-full\x22></audio></div>';let _0x504625=(_0x1ec844[_0x185310(0x3fd)]||[])[_0x185310(0x43b)](_0xc1c006=>_0xc1c006?_0x185310(0x3c2)+_0xc1c006+_0x185310(0x249):'')['join']('');_0x1ac0d0[_0x185310(0x30c)]=_0x185310(0x471)+_0x4bfb58[_0x185310(0x48c)](_0x2fd8ac,0x1)+'</h4>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<span\x20class=\x22text-sm\x20px-3\x20py-1\x20rounded-full\x20bg-'+(_0x2be687===_0x4bfb58[_0x185310(0x22c)]?_0x185310(0x236):_0x4bfb58[_0x185310(0x3aa)](_0x2be687,_0x4bfb58[_0x185310(0x3fa)])?_0x4bfb58['zAtBv']:_0x4bfb58[_0x185310(0x3fc)])+_0x185310(0x2f7)+_0x57d915+_0x185310(0x26f)+_0x1ec844[_0x185310(0x341)]+'</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20</div>\x0a\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20\x20<div\x20class=\x22space-y-2\x20mb-4\x22>'+_0x4ff09f+_0x185310(0x1f7)+(_0x1ec844[_0x185310(0x39b)]||_0x4bfb58[_0x185310(0x3bb)])+_0x185310(0x361)+_0x457e7d+_0x185310(0x200)+_0x3dc46c+_0x185310(0x200)+_0x504625+_0x185310(0x1ec),_0x152389[_0x185310(0x271)](_0x1ac0d0);}),_0x4bfb58[_0x1e6b4b(0x188)](initializeReviewVideos);}function initializeReviewVideos(){const _0x219891=_0x18b546,_0x140a0b={'foDYq':_0x219891(0x168),'iEzvn':_0x219891(0x1cd),'NPYKQ':_0x219891(0x17f),'sJlzr':function(_0x3894a5,_0x161359){return _0x3894a5===_0x161359;},'tncsH':_0x219891(0x17b),'GgqAn':_0x219891(0x486),'FjCrA':function(_0x2dff00,_0x474c30,_0x124df4){return _0x2dff00(_0x474c30,_0x124df4);}};document[_0x219891(0x27c)](_0x219891(0x2eb))[_0x219891(0x1ef)](_0x1ccefe=>{const _0x586bda=_0x219891,_0x1c3f95=_0x1ccefe['dataset'][_0x586bda(0x1a2)];if(_0x1c3f95&&_0x1c3f95[_0x586bda(0x2a7)](_0x140a0b[_0x586bda(0x35d)])){if(_0x140a0b[_0x586bda(0x2a1)](_0x140a0b[_0x586bda(0x223)],_0x140a0b[_0x586bda(0x259)])){_0x2d82f0[_0x586bda(0x406)](_0x140a0b[_0x586bda(0x2cc)])[_0x586bda(0x30c)]=_0x140a0b[_0x586bda(0x142)];return;}else _0x140a0b[_0x586bda(0x199)](setupVideo,_0x1ccefe,_0x1c3f95);}else _0x1c3f95&&(_0x1ccefe[_0x586bda(0x1a2)]=_0x1c3f95);});}function retakeQuiz(){const _0x32c039=_0x18b546,_0x29534f={'DjJss':function(_0x5b76a6,_0x2f3290){return _0x5b76a6(_0x2f3290);},'MbCdT':'Are\x20you\x20sure\x20you\x20want\x20to\x20retake\x20the\x20quiz?\x20This\x20will\x20reset\x20all\x20your\x20answers.','YlMnO':'custom_quiz.html','xRLHz':_0x32c039(0x3cb),'QZANs':function(_0x17ac1d){return _0x17ac1d();}};_0x29534f[_0x32c039(0x3f2)](confirm,_0x29534f['MbCdT'])&&(window[_0x32c039(0x1cb)]['pathname'][_0x32c039(0x46d)](_0x29534f[_0x32c039(0x192)])&&localStorage['removeItem'](_0x29534f[_0x32c039(0x2d2)]),_0x29534f[_0x32c039(0x37e)](clearProgress),location[_0x32c039(0x459)]());}function loadBookmarkedQuestions(){const _0x3d2bf7=_0x18b546,_0x504a9e={'Iulgm':_0x3d2bf7(0x144),'kTQFZ':'hidden','TOXFZ':'bookmarkBtn','DqVXS':_0x3d2bf7(0x18e),'GIXFr':_0x3d2bf7(0x447),'jqkvc':function(_0x20a2ea,_0x203667){return _0x20a2ea!==_0x203667;},'oExiX':_0x3d2bf7(0x1ee),'DTIUf':function(_0x56a00c,_0x431178){return _0x56a00c<_0x431178;},'tvqVy':function(_0x30a9b3,_0x134b69){return _0x30a9b3===_0x134b69;},'hwaSZ':'oIVJo'},_0xb09f95=JSON[_0x3d2bf7(0x348)](localStorage[_0x3d2bf7(0x14f)](_0x3d2bf7(0x318)))||[];_0xb09f95['forEach'](_0x1d1f27=>{const _0x2bb618=_0x3d2bf7,_0x540e67={'Vxqtz':_0x504a9e[_0x2bb618(0x149)],'bFRfS':_0x504a9e[_0x2bb618(0x411)],'ThLrw':_0x504a9e[_0x2bb618(0x2c2)]};if(_0x504a9e[_0x2bb618(0x231)](_0x2bb618(0x227),_0x2bb618(0x227))){const _0x385e2b=_0x348189[_0x2bb618(0x406)](_0x540e67[_0x2bb618(0x2e9)]),_0x3b4383=_0x163363[_0x2bb618(0x406)]('bookmarkText'),_0x39cc39=_0x12c45a[_0x1205a5]['bookmarked'];_0x385e2b['className']=_0x39cc39?_0x540e67[_0x2bb618(0x32b)]:_0x2bb618(0x21d),_0x3b4383[_0x2bb618(0x218)]=_0x39cc39?_0x2bb618(0x22a):_0x540e67['ThLrw'];}else{if(_0x1d1f27[_0x2bb618(0x314)][_0x2bb618(0x2a7)](quizName[_0x2bb618(0x2e0)]()['replace'](/ /g,'-'))){if(_0x504a9e[_0x2bb618(0x3de)]===_0x504a9e['oExiX'])_0x504a9e['DTIUf'](_0x1d1f27[_0x2bb618(0x17a)],questionsData[_0x2bb618(0x43a)])&&(_0x504a9e[_0x2bb618(0x2c5)](_0x504a9e[_0x2bb618(0x2e3)],_0x2bb618(0x309))?_0x251f65[_0x2bb618(0x406)](_0x504a9e[_0x2bb618(0x2d6)])['classList'][_0x2bb618(0x21e)](_0x504a9e[_0x2bb618(0x22d)]):questionStates[_0x1d1f27[_0x2bb618(0x17a)]][_0x2bb618(0x398)]=!![]);else{const _0x5c4d84=_0x56d589?function(){const _0x389bf6=_0x2bb618;if(_0x916bc7){const _0x5d9a15=_0xa60d87[_0x389bf6(0x240)](_0x298ab3,arguments);return _0x3c7a3b=null,_0x5d9a15;}}:function(){};return _0x55f771=![],_0x5c4d84;}}}});}function toggleBookmark(){const _0x225ae0=_0x18b546,_0x4ee06a={'frVSO':_0x225ae0(0x448),'fDNNW':function(_0x1837ee,_0x1dc8a6){return _0x1837ee-_0x1dc8a6;},'JrJuX':function(_0x3317e5,_0x502c57){return _0x3317e5(_0x502c57);},'JUnuj':_0x225ae0(0x386),'WsYnF':function(_0x248cf9,_0x35cd3c){return _0x248cf9<_0x35cd3c;},'kIaCj':function(_0xc8e60a,_0x5a400c){return _0xc8e60a(_0x5a400c);},'GsLes':_0x225ae0(0x318),'jOVuA':function(_0x428dac,_0x2ab6d3){return _0x428dac!==_0x2ab6d3;},'usndM':'teLAY','lqxXh':'kVfgU','KVVwl':function(_0x312f5f){return _0x312f5f();}},_0x3c7dc1=!questionStates[currentQuestionIndex][_0x225ae0(0x398)];questionStates[currentQuestionIndex][_0x225ae0(0x398)]=_0x3c7dc1;let _0x59b62a=JSON['parse'](localStorage[_0x225ae0(0x14f)](_0x4ee06a['GsLes']))||[];if(_0x3c7dc1){if(_0x4ee06a[_0x225ae0(0x2a4)](_0x225ae0(0x132),_0x4ee06a['usndM'])){const _0x1a24e1=_0x2f25da[_0x225ae0(0x3c8)]('button');_0x1a24e1[_0x225ae0(0x218)]=_0x1c73ec+0x1,_0x1a24e1[_0x225ae0(0x38d)]=_0x4ee06a[_0x225ae0(0x475)],_0x1a24e1[_0x225ae0(0x461)]=()=>_0x38736a(_0x3c9f55),_0x1a24e1['id']='navBtn_'+_0x5a80fc,_0x3c8b00[_0x225ae0(0x271)](_0x1a24e1);}else{const _0x1d980c={'quizName':quizName,'quizFile':window[_0x225ae0(0x1cb)][_0x225ae0(0x285)][_0x225ae0(0x429)]('/')[_0x225ae0(0x19b)](),'questionIndex':currentQuestionIndex,'question':questionsData[currentQuestionIndex],'hierarchy':hierarchy,'timestamp':Date[_0x225ae0(0x3ba)]()};_0x59b62a[_0x225ae0(0x393)](_0x1d980c);}}else{if(_0x4ee06a[_0x225ae0(0x23d)]!==_0x4ee06a[_0x225ae0(0x23d)]){const _0x51b528=_0x4ee06a[_0x225ae0(0x216)](_0x4ee06a['JrJuX'](_0x26c84f,_0x3d5088[_0x225ae0(0x3eb)]),0x1),_0x53d926=_0x1e9204['querySelectorAll'](_0x4ee06a[_0x225ae0(0x443)]);if(_0x4ee06a[_0x225ae0(0x23e)](_0x51b528,_0x53d926[_0x225ae0(0x43a)]))_0x4ee06a[_0x225ae0(0x3a6)](_0x469809,_0x51b528);}else _0x59b62a=_0x59b62a[_0x225ae0(0x46a)](_0x2453d2=>!(_0x2453d2[_0x225ae0(0x314)][_0x225ae0(0x2a7)](quizName['toLowerCase']()[_0x225ae0(0x175)](/ /g,'-'))&&_0x2453d2[_0x225ae0(0x17a)]===currentQuestionIndex));}localStorage['setItem'](_0x225ae0(0x318),JSON[_0x225ae0(0x1b6)](_0x59b62a)),_0x4ee06a[_0x225ae0(0x20c)](updateBookmarkButton),_0x4ee06a[_0x225ae0(0x20c)](updateQuestionNav);}function updateBookmarkButton(){const _0x123ea9=_0x18b546,_0x4f8e74={'hFqka':'bookmarkText','jdkXv':_0x123ea9(0x18e),'hCaxQ':_0x123ea9(0x21d),'kQDGL':'Bookmarked'},_0x264182=document['getElementById']('bookmarkBtn'),_0x1a2b20=document[_0x123ea9(0x406)](_0x4f8e74[_0x123ea9(0x397)]),_0x5ef2b9=questionStates[currentQuestionIndex][_0x123ea9(0x398)];_0x264182[_0x123ea9(0x38d)]=_0x5ef2b9?_0x4f8e74[_0x123ea9(0x2d0)]:_0x4f8e74[_0x123ea9(0x489)],_0x1a2b20[_0x123ea9(0x218)]=_0x5ef2b9?_0x4f8e74[_0x123ea9(0x306)]:_0x123ea9(0x447);}function toggleMarkForReview(){const _0x189f9a=_0x18b546,_0x1cfcd3={'gdFnW':function(_0x2cdc97){return _0x2cdc97();},'ePsQK':function(_0x20aa89){return _0x20aa89();}};questionStates[currentQuestionIndex][_0x189f9a(0x2ff)]=!questionStates[currentQuestionIndex][_0x189f9a(0x2ff)],_0x1cfcd3[_0x189f9a(0x37b)](updateMarkReviewButton),_0x1cfcd3['ePsQK'](updateQuestionNav);}function updateMarkReviewButton(){const _0x4bb62a=_0x18b546,_0x599867={'vBcmz':_0x4bb62a(0x1f1),'znKIn':'glass-light\x20px-6\x20py-3\x20text-white\x20hover:bg-purple-500\x20hover:bg-opacity-20\x20transition-all\x20duration-300\x20flex\x20items-center','PCkjY':'Marked','NDEqP':'Mark\x20for\x20Review'},_0x1ee7df=document[_0x4bb62a(0x406)]('markReviewBtn'),_0x5d8a39=document[_0x4bb62a(0x406)](_0x4bb62a(0x1bd)),_0x39fc0b=questionStates[currentQuestionIndex]['markedForReview'];_0x1ee7df[_0x4bb62a(0x38d)]=_0x39fc0b?_0x599867[_0x4bb62a(0x42d)]:_0x599867[_0x4bb62a(0x302)],_0x5d8a39[_0x4bb62a(0x218)]=_0x39fc0b?_0x599867[_0x4bb62a(0x434)]:_0x599867[_0x4bb62a(0x396)];}function previousQuestion(){const _0x1e542d=_0x18b546,_0x5c663b={'XXRxM':function(_0x2d3b6c,_0x3252f9){return _0x2d3b6c-_0x3252f9;},'rFVGh':function(_0x1f6976){return _0x1f6976();},'tLJba':function(_0x1e6a05){return _0x1e6a05();}};currentQuestionIndex>0x0&&(questionStartTime&&(questionStates[currentQuestionIndex]['timeSpent']+=_0x5c663b[_0x1e542d(0x40e)](Date[_0x1e542d(0x3ba)](),questionStartTime)),currentQuestionIndex--,_0x5c663b[_0x1e542d(0x3e4)](displayQuestion),_0x5c663b[_0x1e542d(0x4a2)](saveProgress));}function nextQuestion(){const _0x407b81=_0x18b546,_0x77478b={'WGLPD':function(_0x4f87c9,_0x11d2b4){return _0x4f87c9===_0x11d2b4;},'LgXKh':'border-gray-600','RbLSX':'border-green-500','hrhjq':function(_0x198ecf,_0x5b7cb1){return _0x198ecf+_0x5b7cb1;},'kKGbU':function(_0x366f39,_0x3d4b8d){return _0x366f39-_0x3d4b8d;},'hMInX':function(_0x50c3bb,_0xab9a83){return _0x50c3bb<_0xab9a83;},'CWgQq':_0x407b81(0x45e),'Aonqj':_0x407b81(0x2f6),'rKSQu':function(_0x3f293a,_0x9348e9){return _0x3f293a===_0x9348e9;},'KkXEa':_0x407b81(0x371),'OZmSc':'timed_exam','tOZag':_0x407b81(0x230),'lxOpi':_0x407b81(0x439),'Itsaw':function(_0x2d0008){return _0x2d0008();},'zsyDJ':function(_0x504c5c,_0x49c3f3){return _0x504c5c(_0x49c3f3);},'PXFQt':'You\x20have\x20completed\x20all\x20questions.\x20Would\x20you\x20like\x20to\x20review\x20from\x20the\x20beginning?'};questionStartTime&&(questionStates[currentQuestionIndex][_0x407b81(0x466)]+=_0x77478b['kKGbU'](Date[_0x407b81(0x3ba)](),questionStartTime));if(_0x77478b[_0x407b81(0x2b7)](currentQuestionIndex,_0x77478b['kKGbU'](questionsData[_0x407b81(0x43a)],0x1))){if(_0x77478b['CWgQq']!==_0x77478b[_0x407b81(0x405)])currentQuestionIndex++,displayQuestion(),saveProgress();else{const _0x46f2eb=new _0x2a0ffb();_0x46f2eb[_0x407b81(0x44a)](_0x294593),_0x46f2eb[_0x407b81(0x280)](_0x39ce39);}}else{if(_0x77478b[_0x407b81(0x426)](currentMode,_0x77478b[_0x407b81(0x281)])||_0x77478b[_0x407b81(0x462)](currentMode,_0x77478b[_0x407b81(0x27a)])){if(_0x77478b[_0x407b81(0x3b4)]!==_0x407b81(0x230)){const _0x99e489=_0x77478b[_0x407b81(0x462)](_0x2d07e6[_0x407b81(0x2b3)],_0x5a63fe),_0x4aa7fc=_0x77478b['WGLPD'](_0x58adb1['id'],_0x3cf8c0);let _0x5ff028=_0x77478b[_0x407b81(0x49a)];if(_0x4aa7fc)_0x5ff028=_0x77478b[_0x407b81(0x23c)];else{if(_0x99e489)_0x5ff028=_0x407b81(0x1ae);}return _0x407b81(0x25a)+_0x5ff028+'\x22><span\x20class=\x22font-bold\x20mr-3\x22>'+_0x462440[_0x407b81(0x19c)](_0x77478b[_0x407b81(0x311)](0x41,_0x1c95b6))+_0x407b81(0x3ea)+_0x5d43e0[_0x407b81(0x341)]+_0x407b81(0x1dc);}else confirm(_0x77478b[_0x407b81(0x49e)])&&_0x77478b[_0x407b81(0x214)](submitQuiz);}else _0x77478b[_0x407b81(0x22b)](confirm,_0x77478b[_0x407b81(0x2d9)])&&(currentQuestionIndex=0x0,_0x77478b[_0x407b81(0x214)](displayQuestion),saveProgress());}}function startTimer(){const _0x40bbe5=_0x18b546,_0x3353e={'MkDxo':_0x40bbe5(0x16c),'glUTe':function(_0x1672e0,_0x3c7b25){return _0x1672e0>_0x3c7b25;},'McjXG':_0x40bbe5(0x21c),'TiTxg':function(_0x23a2ae,_0xbd4cf5){return _0x23a2ae/_0xbd4cf5;},'fshiD':function(_0x3ef42c,_0xf51644){return _0x3ef42c/_0xf51644;},'GbSwX':function(_0x2ee07b){return _0x2ee07b();},'ShQYw':function(_0x5763fe,_0x46f1d7){return _0x5763fe<=_0x46f1d7;},'UEFlt':function(_0x1e745e,_0x1835a7){return _0x1e745e===_0x1835a7;},'cbShG':_0x40bbe5(0x3e9),'kkXuN':function(_0x519651,_0x27aa1e){return _0x519651(_0x27aa1e);},'SqCTX':function(_0x2c078a,_0xfe473d){return _0x2c078a===_0xfe473d;},'BTxqW':'timed_exam','cONJc':function(_0x4df4b3,_0xdad286){return _0x4df4b3!==_0xdad286;},'jRBsr':_0x40bbe5(0x4a4),'bJwXX':function(_0xd2ee9){return _0xd2ee9();}};if(timer)_0x3353e['kkXuN'](clearInterval,timer);timeRemaining=0x78,_0x3353e[_0x40bbe5(0x224)](updateTimerDisplay),timer=setInterval(()=>{const _0x5ec85f=_0x40bbe5;timeRemaining--,_0x3353e[_0x5ec85f(0x173)](updateTimerDisplay);if(_0x3353e[_0x5ec85f(0x20a)](timeRemaining,0x0)){if(_0x3353e['UEFlt'](_0x3353e[_0x5ec85f(0x438)],_0x3353e[_0x5ec85f(0x438)])){_0x3353e['kkXuN'](clearInterval,timer);if(_0x3353e[_0x5ec85f(0x3da)](currentMode,_0x3353e[_0x5ec85f(0x25e)])){if(_0x3353e[_0x5ec85f(0x29a)](_0x3353e[_0x5ec85f(0x38e)],_0x3353e[_0x5ec85f(0x38e)])){const _0x8ec9e8=_0x123e67?function(){const _0x28dd47=_0x5ec85f;if(_0x534a85){const _0x2f71ae=_0x3f481a[_0x28dd47(0x240)](_0x43892f,arguments);return _0x3ec4d8=null,_0x2f71ae;}}:function(){};return _0x174e0d=![],_0x8ec9e8;}else submitQuiz();}else nextQuestion();}else{_0x32d9c3['getElementById'](_0x3353e[_0x5ec85f(0x198)])[_0x5ec85f(0x218)]=_0x288c11[_0x5ec85f(0x39a)],_0xc66385['getElementById']('incorrectCount')[_0x5ec85f(0x218)]=_0x2b0444[_0x5ec85f(0x16e)],_0x372f4f['getElementById']('totalAttempted')[_0x5ec85f(0x218)]=_0xd06866[_0x5ec85f(0x1a6)];const _0x42cb71=_0x3353e[_0x5ec85f(0x369)](_0x3729b3[_0x5ec85f(0x1a6)],0x0)?_0xf89f73[_0x5ec85f(0x2d7)](_0x5b1bab[_0x5ec85f(0x39a)]/_0x19a126[_0x5ec85f(0x1a6)]*0x64):0x0;_0x337556[_0x5ec85f(0x406)](_0x3353e['McjXG'])['textContent']=_0x42cb71+'%',_0x9a60a[_0x5ec85f(0x37c)]=_0x869ab2[_0x5ec85f(0x213)]((_0x2c3388,_0x362585)=>_0x2c3388+_0x362585[_0x5ec85f(0x466)],0x0);const _0x160536=_0x14143c['floor'](_0x3353e[_0x5ec85f(0x2c9)](_0x376898[_0x5ec85f(0x37c)],0x3e8)),_0x473f58=_0x209294['floor'](_0x3353e[_0x5ec85f(0x31f)](_0x160536,0x3c)),_0x5c0c0c=_0x160536%0x3c;_0x277437[_0x5ec85f(0x406)](_0x5ec85f(0x466))[_0x5ec85f(0x218)]=_0x473f58+':'+_0x5c0c0c[_0x5ec85f(0x2c4)]()[_0x5ec85f(0x159)](0x2,'0');}}},0x3e8);}function updateTimerDisplay(){const _0x36fa19=_0x18b546,_0x121589={'ejwpL':function(_0x4fb21b,_0x32565a){return _0x4fb21b/_0x32565a;},'BCBxX':'timeDisplay','rsqYS':function(_0x456b93,_0x1a6c08){return _0x456b93+_0x1a6c08;},'cDdJt':function(_0x59d213,_0x19eeca){return _0x59d213+_0x19eeca;}},_0xb65630=Math['floor'](_0x121589[_0x36fa19(0x351)](timeRemaining,0x3c)),_0x1ed05b=timeRemaining%0x3c;document[_0x36fa19(0x406)](_0x121589[_0x36fa19(0x294)])[_0x36fa19(0x218)]=_0x121589['rsqYS'](_0x121589[_0x36fa19(0x262)](_0xb65630,':'),_0x1ed05b['toString']()[_0x36fa19(0x159)](0x2,'0'));}function toggleSidebar(){const _0x542443=_0x18b546,_0x56b281={'lEXQp':'open'};document[_0x542443(0x406)]('quizSidebar')[_0x542443(0x1c3)][_0x542443(0x179)](_0x56b281['lEXQp']);}document[_0x18b546(0x2ea)](_0x18b546(0x3b9),()=>{const _0x43d05f=_0x18b546,_0x238b81={'VxUPt':function(_0x56cfb0,_0x51d44f){return _0x56cfb0(_0x51d44f);},'IpArg':function(_0x14a8cf,_0x24cec1){return _0x14a8cf===_0x24cec1;},'kjTYc':_0x43d05f(0x1f2),'btTDo':function(_0x3e9c7e){return _0x3e9c7e();},'lbqNC':function(_0x1b68eb){return _0x1b68eb();},'QjLBa':_0x43d05f(0x390),'bgYmV':_0x43d05f(0x13b),'FYTaw':function(_0x354984){return _0x354984();},'LlEFG':_0x43d05f(0x27e),'hBpqm':_0x43d05f(0x325),'QuElu':function(_0x3439d4){return _0x3439d4();}};if(resume)_0x238b81[_0x43d05f(0x269)](loadProgress)?(document[_0x43d05f(0x406)](_0x238b81['QjLBa'])[_0x43d05f(0x246)][_0x43d05f(0x4a3)]=_0x238b81[_0x43d05f(0x4ad)],_0x238b81['FYTaw'](initializeQuiz)):(clearProgress(),document[_0x43d05f(0x406)](_0x238b81[_0x43d05f(0x3a3)])[_0x43d05f(0x246)][_0x43d05f(0x4a3)]=_0x238b81['LlEFG']);else!window['location'][_0x43d05f(0x285)][_0x43d05f(0x46d)](_0x43d05f(0x176))?_0x238b81[_0x43d05f(0x1f6)]==='pLkvr'?(_0x238b81[_0x43d05f(0x263)](_0x19a2c0,_0x5976b6),_0x238b81[_0x43d05f(0x2bf)](_0x219a28,_0x238b81[_0x43d05f(0x2c1)])?_0x238b81[_0x43d05f(0x2b4)](_0x3105ea):_0x238b81[_0x43d05f(0x2b4)](_0x10a6f4)):(_0x238b81[_0x43d05f(0x269)](clearProgress),document[_0x43d05f(0x406)](_0x238b81[_0x43d05f(0x3a3)])[_0x43d05f(0x246)]['display']=_0x238b81['LlEFG']):_0x238b81[_0x43d05f(0x3a4)](initializeQuiz);}),document[_0x18b546(0x2ea)](_0x18b546(0x1be),function(_0x27d475){const _0x3615cb=_0x18b546,_0x4a7fbf={'QPvMx':_0x3615cb(0x13b),'wtDWZ':function(_0x13db6b){return _0x13db6b();},'llbTM':function(_0x1b1396,_0x28b0b9){return _0x1b1396!==_0x28b0b9;},'NiKMs':_0x3615cb(0x390),'BCeVM':function(_0x2e7bbe,_0x229262){return _0x2e7bbe===_0x229262;},'KawIN':_0x3615cb(0x1fb),'pcADC':_0x3615cb(0x2db),'DVbmq':function(_0x594dda,_0x3ec34e){return _0x594dda<_0x3ec34e;},'HZGdJ':function(_0xcb0791,_0x4bafdf){return _0xcb0791(_0x4bafdf);},'lXokU':function(_0x2f970d,_0x157956){return _0x2f970d===_0x157956;},'OTMeX':_0x3615cb(0x358),'qVQBe':function(_0x3d67cd){return _0x3d67cd();},'KVzfK':function(_0x5859db,_0xa5e48a){return _0x5859db===_0xa5e48a;},'lLWiW':function(_0x5784c2){return _0x5784c2();},'VtajG':function(_0x2ea844,_0x59aa43){return _0x2ea844===_0x59aa43;},'AvaGY':function(_0x4aa270,_0x196b1d){return _0x4aa270===_0x196b1d;},'NstCI':_0x3615cb(0x3bf),'OtqCQ':_0x3615cb(0x237),'hLXFN':_0x3615cb(0x469),'vLanR':function(_0x1ac184){return _0x1ac184();},'XMXuE':function(_0x32bcb9,_0x5e220a){return _0x32bcb9===_0x5e220a;},'NZXfV':function(_0x3d1dc1,_0x48dacc){return _0x3d1dc1===_0x48dacc;},'BzzXm':_0x3615cb(0x1f2),'eGGsO':function(_0x21510f){return _0x21510f();},'tLHms':function(_0x367616,_0x1e0f17){return _0x367616===_0x1e0f17;}};if(_0x4a7fbf[_0x3615cb(0x15e)](document[_0x3615cb(0x406)](_0x4a7fbf['NiKMs'])['style'][_0x3615cb(0x4a3)],_0x4a7fbf[_0x3615cb(0x2b0)]))return;if(_0x4a7fbf[_0x3615cb(0x45c)](document['getElementById'](_0x4a7fbf[_0x3615cb(0x36e)])[_0x3615cb(0x1c3)][_0x3615cb(0x3a0)](_0x4a7fbf[_0x3615cb(0x401)]),![]))return;if(_0x27d475[_0x3615cb(0x3eb)]>='1'&&_0x27d475[_0x3615cb(0x3eb)]<='4'){const _0x34e690=parseInt(_0x27d475[_0x3615cb(0x3eb)])-0x1,_0x468cf9=document['querySelectorAll'](_0x3615cb(0x386));if(_0x4a7fbf[_0x3615cb(0x2d8)](_0x34e690,_0x468cf9[_0x3615cb(0x43a)]))_0x4a7fbf[_0x3615cb(0x416)](selectOption,_0x34e690);}else{if(_0x4a7fbf['lXokU'](_0x27d475[_0x3615cb(0x3eb)],_0x4a7fbf[_0x3615cb(0x207)]))_0x4a7fbf[_0x3615cb(0x3b5)](previousQuestion);else{if(_0x27d475[_0x3615cb(0x3eb)]===_0x3615cb(0x437)||_0x4a7fbf[_0x3615cb(0x1da)](_0x27d475[_0x3615cb(0x3eb)],'\x20'))_0x27d475[_0x3615cb(0x245)](),_0x4a7fbf[_0x3615cb(0x394)](nextQuestion);else{if(_0x4a7fbf['VtajG'](_0x27d475['key']['toLowerCase'](),'b')&&(_0x4a7fbf[_0x3615cb(0x458)](currentMode,_0x4a7fbf[_0x3615cb(0x133)])||currentMode===_0x3615cb(0x48b)))_0x4a7fbf[_0x3615cb(0x492)]!==_0x4a7fbf[_0x3615cb(0x499)]?_0x4a7fbf[_0x3615cb(0x373)](toggleBookmark):(_0x1a62c3['getElementById'](_0x3615cb(0x390))[_0x3615cb(0x246)][_0x3615cb(0x4a3)]=_0x4a7fbf['QPvMx'],_0x4a7fbf[_0x3615cb(0x2fe)](_0x4639ef));else{if(_0x27d475[_0x3615cb(0x3eb)][_0x3615cb(0x2e0)]()==='m'&&(_0x4a7fbf['XMXuE'](currentMode,_0x3615cb(0x371))||_0x4a7fbf['NZXfV'](currentMode,_0x4a7fbf[_0x3615cb(0x2c7)])))_0x4a7fbf[_0x3615cb(0x1eb)](toggleMarkForReview);else _0x4a7fbf[_0x3615cb(0x490)](_0x27d475[_0x3615cb(0x3eb)][_0x3615cb(0x2e0)](),'s')&&(currentMode===_0x3615cb(0x371)||_0x4a7fbf[_0x3615cb(0x2d4)](currentMode,_0x4a7fbf[_0x3615cb(0x2c7)]))&&submitQuiz();}}}}});</script>

</body></html>